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EFFECTS OF ELECTRICAL STIMULATION AND TESTOSTERONE ON 
REGENERATION-ASSOCIATED GENE EXPRESSION AND FUNCTIONAL 
RECOVERY IN A RAT MODEL OF SCIATIC NERVE CRUSH INJURY 
 
Although peripheral motoneurons are phenotypically endowed with robust 
regenerative capacity, functional recovery is often suboptimal following peripheral 
nerve injury (PNI). Research to date indicates that the greatest success in 
achieving full functional recovery will require the use of a combinatorial approach 
that can simultaneously target different aspects of the post-injury response. In 
general, the concept of a combinatorial approach to neural repair has been 
established in the scientific literature but has yet to be successfully applied in the 
clinical situation. Emerging evidence from animal studies supports the use of 
electrical stimulation (ES) and testosterone as one type of combinatorial 
treatment after crush injury to the facial nerve (CN VII). With the facial nerve 
injury model, we have previously demonstrated that ES and testosterone target 
different stages of the regeneration process and enhance functional recovery 
after facial nerve crush injury. What is currently unknown, but critical to 
determine, is the impact of a combinatorial treatment strategy of ES and 
testosterone on functional recovery after crush injury to the sciatic nerve, a mixed 
sensory and motor spinal nerve which is one of the most serious PNI clinical 
problems. The results of the present study indicate that either treatment alone or 
in combination positively impact motor recovery. With regard to molecular effects, 
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single and combinatorial treatments differentially alter the expression of 
regeneration-associated genes following sciatic nerve crush injury relative to 
facial nerve injury. Thus, our data indicate that not all injuries equally respond to 
treatment. Furthermore, the results support the importance of treatment strategy 
development in an injury-dependent manner and based upon the functional 
characteristics of spinal vs. cranial nerves. 
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CHAPTER 1:  INTRODUCTION 
 
Peripheral nerve injuries (PNI) affect nearly 3% of trauma patients and are 
caused by physical trauma, such as motor vehicle accidents, fractures, and 
damage incurred during surgery, or through disease, including multiple sclerosis 
and amyotrophic lateral sclerosis (ALS; Kline et al., 1998; Noble et al., 1998; 
Genain et al., 1999; Marcuzzo et al., 2011). It is well-established that robust 
regeneration occurs following damage to peripheral nerves (Lieberman, 1971); 
however, functional recovery following PNI is often suboptimal, particularly when 
nerves are transected and require surgical repair (Höke & Brushart, 2010). A 
major limiting factor in successful recovery from PNI in humans appears to be 
related to the large size of human peripheral nerves, long distances over which 
injured nerves need to regenerate, and the specificity of motor-sensory 
reinnervation related to functional outcomes associated with activities of daily 
living (Scheib & Höke, 2013). 
PNI frequently results in sensory and/or motor deficits and, in severe 
cases, paralysis that negatively impacts quality of life. Additionally, individuals 
with a PNI typically undergo long-term rehabilitation and have an increased risk 
for additional medical complications. The ability of a nerve to regenerate and 
achieve complete functional recovery is dependent on a multitude of factors: type 
and location of injury, age of individual, and regeneration distance to target (Birch 
& Raji, 1991; Perry et al., 1992; Fu & Gordon, 1995a, 1995b) and, if surgical 
repair is required, enough intact nerve or availability of nerve grafts. Currently, 
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there are no non-surgical treatment strategies in clinical use for PNI, thus finding 
a non-surgical therapy that enhances functional recovery offers immediate 
translational opportunity in the clinical setting. 
Our laboratory has extensively studied the effects of the combination of 
the gonadal steroid testosterone and electrical stimulation (ES) on properties of 
regeneration and functional recovery utilizing several models of nerve injury, 
including extratemporal and intratemporal facial nerve, recurrent laryngeal nerve, 
and sciatic nerve injuries. These models have allowed us to investigate treatment 
effects in motor vs. mixed (i.e. motor and sensory) nerves, cranial vs. spinal 
nerves, and proximal vs. distal injuries. From these studies, we have discovered 
that ES and testosterone propionate (TP) target two different aspects of the 
regeneration process: delay time before sprout formation and regeneration rate, 
respectively (Kujawa et al., 1991; Sharma et al., 2009). Likewise, we have shown 
that ES and TP differentially enhance regeneration-associated genes after facial 
nerve crush injury which further supports the concept that ES and TP may be 
working through separate, yet interconnected, mechanisms (Sharma et al., 
2010a). Interestingly, the combination of ES and TP significantly improves 
functional recovery compared to either ES or TP alone after facial nerve crush 
injury, but not after recurrent laryngeal nerve crush injury (Sharma et al., 2010b; 
Monaco et al., 2013). These findings have led to the idea that not all injuries 
equally respond to treatment. Additionally, location of injury and whether the 
injured nerve carries motor and/or sensory information are important factors in 
determining the most appropriate therapeutic interventions.  
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Although the combination of ES and TP has shown promise as a 
treatment after proximal nerve injury, as observed with the facial nerve injury 
model, the question remains as to whether ES and TP improve functional 
recovery after distal injury to a spinal nerve, such as the sciatic nerve. The 
central hypothesis of this dissertation is that ES and TP will additively improve 
regeneration, functional recovery, and the increased expression of regeneration-
associated genes in a spinal injury model, comparable to improvements 
observed in the facial nerve injury model.  The central hypothesis was tested by 
the following specific aims:  
 
Specific Aim 1: Evaluate whether ES and/or TP alter the expression of 
regeneration-associated genes after sciatic nerve crush injury. The working 
hypothesis for this aim was that the combination of ES and TP will differentially 
enhance the molecular response following sciatic nerve crush injury. Real time 
PCR was used in Aim 1 to examine changes in several regeneration-associated 
genes in order to elucidate the molecular profile following injury to the sciatic 
nerve. The results demonstrate that the two treatments differentially enhance the 
expression of regeneration-associated genes after sciatic nerve injury in a 
manner distinct from that observed after facial nerve injury. 
 
Specific Aim 2: Determine if ES and/or TP improve axon regeneration and 
functional recovery after sciatic nerve crush injury. The working hypothesis 
for this aim was the combination of ES and TP will accelerate axon regeneration 
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leading to an enhanced functional recovery after sciatic nerve crush injury 
compared to either treatment alone. It has been well-established that the 
combination of ES and TP enhances functional recovery after facial nerve crush 
axotomy more effectively than either treatment alone. In contrast, the 
combination of ES and TP provides no benefit in functional recovery after 
recurrent laryngeal injury. Experiments performed in Aim 2 specifically 
investigated functional recovery of rats in a different injury model, sciatic nerve 
crush, by employing several motor behavior tests, electromyography, and 
examining anatomical correlates. The results of the present study indicate that 




CHAPTER 2:  LITERATURE REVIEW 
 
A. The mammalian nervous system: a general overview  
Neurons work collectively to execute sensory, motor, and secretory 
functions and process information through four functional units: (1) dendrites, (2) 
cell body, (3) axon, and (4) presynaptic axon terminal. Dendrites extend from the 
neuron as branched, tree-like projections and play a critical role in receiving 
incoming signals through receptors that line their surface. Upon stimulation, 
neurotransmitters, i.e proteins or chemical compounds, bind to their receptors on 
the dendrites. The cell nucleus and other organelles contained within the soma, 
or cell body, are vital components that carry out normal housekeeping functions, 
including protein synthesis and processing. Incoming signals from dendrites 
accumulate at the axon hillock. In order for a message to be carried down the 
axon and converted into a response, the incoming signals must reach a critical 
threshold. Only if threshold is achieved will the signal be propagated down the 
axon in the form of an action potential. Once the action potential reaches the final 
portion of the neuron, the presynaptic axon terminal, a cascade of events leads 
to the release of neurotransmitters from the terminal. Next, the neurotransmitters 
cross a small gap, or synapse, toward a nearby target. Lastly, the 
neurotransmitters bind to their receptors and communicate their signal to 
adjacent cells (Kiernan & Rajakumar, 2013). 
Neurons are characterized by their morphology, size, and function and 
based upon these criteria, can be classified into three general categories: (1) 
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sensory neurons, (2) motoneurons, and (3) interneurons. The connections 
among these three classes of neurons are intricate, as well as necessary for all 
aspects of the mammalian nervous system to communicate. Interneurons are 
enclosed entirely within the central nervous system (CNS) and connect sensory 
neuron terminals to motoneurons (Kiernan & Rajakumar, 2013). This literature 
review will briefly describe sensory neurons as their input on motoneurons is of 
extreme importance; however the work presented in this dissertation will focus 
primarily on motoneurons.  
The nervous system is a complex, sophisticated system comprised of a 
network of neurons that is responsible for receiving, comprehending, and 
sending information from all parts of the body. In mammals, the nervous system 
is divided into three functionally distinct, yet connected, entities: (1) CNS, (2) 
peripheral nervous system (PNS), and (3) autonomic nervous system (ANS).  
 
1. Central nervous system (CNS) 
The CNS is the largest part of the nervous system and is formed by two 
main organs, the spinal cord and brain. A highly selective permeability barrier 
comprised of capillary endothelial cells connected by tight junctions known as the 
blood-brain barrier anatomically divides the CNS from the PNS and protects the 
CNS from potentially harmful chemicals and pathogens, while regulating 
transport of essential nutrients and molecules that are necessary to maintain a 
stable environment. Although neurons are considered to be the main component 
of the nervous system, non-neuronal cells exceed the number of neurons in the 
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nervous system. Neuroglia, often referred to as glia, in Greek means “nerve 
glue;” though this simple definition undervalues their function. As an ancillary cell 
of the nervous system, glia maintain neuronal life by providing support, myelin, 
nutrients, and protection for neurons in both the CNS and PNS. The chief types 
of glia in the CNS are oligodendrocytes, ependymal cells, microglia, and 
astrocytes; whereas, in the PNS, glial cells include satellite cells in autonomic 
and sensory ganglia, enteric glial cells, and Schwann cells. 
 
2. Peripheral nervous system (PNS) 
 The PNS communicates to the CNS through bundles of axons called 
nerves. Primary afferent or sensory neurons are located within the PNS and 
detect several types of modalities, such as proprioception, touch, temperature, 
and pain, through specialized receptors. Sensory neurons convert external 
signals from the environment into internal electrical signals and have a unique 
pseudounipolar morphology that distinguishes them from other neuron types. 
These particular sensory neurons have a cell body that gives rise to one axon 
that bifurcates and sends a long process to the periphery while a second, shorter 
process terminates in the spinal cord. The cell bodies of pseudounipolar sensory 
neurons are grouped within a distinct structure called a dorsal root ganglion 
(DRG). The axon diameter of a sensory axon signifies the type of modality it 
transmits. For example, sensory neurons that carry pain and temperature 
information are small in size and are defined as either unmyelinated C or lightly 
myelinated Aδ fibers. Sensory axons that are myelinated and have a thicker 
9 
 
diameter detect cutaneous and subcutaneous mechanical stimuli and are 
referred to as Aα or Aβ fibers (Kiernan & Rajakumar, 2013).  
After a sensory signal is interpreted by the CNS, a motor response is 
delivered to the PNS through motoneurons. A distinguishing characteristic of a 
somatic motoneuron is that their cell bodies and dendrites are located entirely 
within the CNS. Two types of motoneurons, upper and lower motoneurons, relay 
efferent signals from the CNS to skeletal muscle to elicit movement. Upper 
motoneurons are essential in regulating lower motoneurons, but remain entirely 
within the CNS and do not directly synapse on the target musculature. The cell 
body of an upper motoneuron is located in the motor cortex of the cerebral cortex 
or brain stem.  Additionally, axons from upper motoneurons bundle together to 
form a tract and connect to lower motoneurons in the brainstem or spinal cord. In 
contrast, lower motoneurons act as a link between the upper motoneurons and 
skeletal muscle. Particular classes of lower motoneurons, known as alpha- 
motoneurons (α-motoneurons), send their axons from the brain stem or spinal 
cord to the periphery as a nerve and innervate the extrafusal fibers of skeletal 
muscle. It is important to note that extrafusal muscle fibers are located outside 
the muscle spindle, encompass the majority of the muscle belly, and are involved 
in skeletal muscle contraction. An α-motoneuron and all of the muscle fibers it 
innervates is referred to as a motor unit. Importantly, interneurons, descending 
tracts from the forebrain and brainstem, and some sensory neurons activate α-
motoneurons and can trigger a variety of responses, such as withdrawal reflexes 
or muscle contraction (Kiernan & Rajakumar, 2013).  
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In the mid 1800’s, it was discovered that an α-motoneuron did not directly 
contact muscle, but rather is separated from the muscle interface by a small gap 
referred to as the neuromuscular junction (NMJ) (Hughes et al., 2006). The NMJ 
is a specialized synapse that allows electrical signals from the α-motoneuron to 
be easily transmitted to the skeletal muscle via the neurotransmitter acetylcholine 
(ACh). The structure of a NMJ has three main components: (1) presynaptic nerve 
terminal, (2) synaptic cleft, and (3) postsynaptic motor endplate (Hughes et al., 
2006). Synaptic vesicles filled with ACh are located within the presynaptic axon 
terminal of an α-motoneuron. The second component of the NMJ connects the 
presynaptic terminal to the motor endplate, which is characterized by the 
presence of nicotinic ACh receptors (AChR). When an action potential reaches 
the end of the nerve terminal, it causes the release of ACh into the synaptic cleft. 
Next, ACh traverses the cleft to the postsynaptic motor endplate where it binds to 
the AChR. Binding of ACh to its receptor triggers a cascade of events that 
ultimately leads to muscle contraction and movement (Hughes et al., 2006).  
  Lastly, the CNS and PNS are structurally connected by a third portion of 
the nervous system, known as the ANS. The ANS is functionally distinct from the 
CNS and PNS and is vital in regulating and controlling visceral or involuntary 
functions of internal organs, such as heart rate, blood pressure, digestion, 





3. Regenerative capabilities of the CNS vs. PNS  
The first estimations of the rates of nerve regeneration were based on 
clinical observation. Tinel estimated regeneration rate to be 1-2 mm/day using 
the “Tinel’s sign,” where he tapped the tip of regenerating axons to elicit 
paresthesias or tingling (Tinel, 1916). Other reports using this technique 
estimated nerve regeneration to occur at a rate of 2-5 mm/day, depending on the 
nerve tested (Dustin, 1917). Sunderland reported a case of a 23-year-old male 
who had a laceration of the sciatic nerve at the buttock level (Sunderland et al., 
1993). Over the next 7 years, Sunderland used Tinel’s sign with 
electromyography (EMG) recordings to estimate the rate of sciatic nerve 
regeneration and found the rates to be 2.6 mm/day in the thigh, 1.2 mm/day in 
the proximal ¾ of the leg, and 0.9 mm/day in the distal ¼ of the leg. Using these 
rates, Sunderland calculated that motor axons regenerated a total distance of 70 
cm and sensory axons regenerated 90 cm, which indicates sensory axons 
regenerate at a faster rate than motor axons. Various methods in rabbit, rat, and 
hamster confirm regeneration is the fastest after crush injury (3.5-4.6 mm/day), 
followed by transection and suture (3.2-3.5 mm/day) of the nerve. The slowest 
rate of regeneration is after nerve graft repair (1.5 mm/day; Gutmann & 
Guttmann, 1942; McQuarrie et al., 1977; Forman et al., 1979; Kanje et al., 1988; 
Kujawa et al., 1991; Holmquist et al., 1993; Sharma et al., 2009). Taken together, 
the aforementioned studies indicate that nerve regeneration is much slower in 
humans compared to what has been observed in rodent studies. A major limiting 
factor in successful recovery from peripheral nerve injury (PNI) in humans 
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appears to be related to the large size of human peripheral nerves, long 
distances over which injured nerves need to regenerate, and the specificity of 
motor-sensory reinnervation related to functional outcomes associated with 
activities of daily living (Scheib & Höke, 2013). 
Following injury to an axon, the somata of adult mammalian neurons 
respond by undergoing chromatolysis and substantially increasing RNA and 
protein synthesis (Lieberman, 1971). Of particular interest, the inherent capacity 
of a neuron to respond to injury is markedly reduced in the CNS compared to the 
PNS. It was first thought that the inability of axons in the CNS to regenerate was 
due to CNS neurons lacking intrinsic growth capacity to regenerate. In the 
1980’s, Aguayo and colleagues demonstrated CNS neurons could in fact 
regenerate when provided with a PNS graft; however, axon elongation was 
arrested if axons were redirected from the PNS graft back to the CNS 
(Richardson et al., 1980; David & Aguayo, 1981; Benfey & Aguayo, 1982; 
Richardson et al., 1984). Their results provided a substantial body of evidence 
that not only disproved the theory that CNS neurons lack inherent regenerative 
capability but also that a permissive environment is critical for axon elongation. It 
was later determined that the lag in CNS neuron growth was due to the presence 
of the degenerated nerve that produced an inhibitory milieu which ultimately 
stunted axon regeneration (Filbin, 2003; Vargas & Barres, 2007; Huebner & 
Strittmatter, 2009). The aforementioned studies reiterate the importance of 
clearing remnants of the degenerated nerve in order to have a permissive 
environment in favor of axon regeneration.  
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Augustus Volney Waller was the first to describe in the mid 1800’s the 
detailed process of regressive changes in severed nerves (Augustus volney 
waller (1816-1870) wallerian degeneration, 1969). After transecting the 
glossopharyngeal nerve of the frog, Waller observed diminished movement of 
tongue muscles and loss of sensation. Additionally, he noticed alterations in the 
nerve tubes within the papillae having an appearance he described as “curdling” 
or coagulated. Upon further inspection, he discovered after two weeks many of 
the single tubules disappeared post-injury (Waller, 1850). It was not until years 
later that Waller received praise for his incredible work describing the process 
that would take his name, “Wallerian degeneration.”  
Wallerian degeneration is a cascade of events that leads to the removal of 
axonal debris and is essential in order to clear the path for an injured nerve to 
regenerate back to its target. Much of our understanding on the process of 
Wallerian degeneration has come from studies utilizing the Wallerian 
degeneration (WldS) mouse model which was initially termed Ola (Lunn et al., 
1989; Perry et al., 1990; Glass et al., 1993). Lunn and colleagues reported that 
WldS mouse nerves degenerated more slowly than wild-type mouse nerves by 
several weeks, suggesting the WldS gene delayed the process of Wallerian 
degeneration (Lunn et al., 1989).  
PNI elicits a multitude of changes in the axon, including the onset of 
Wallerian degeneration. Wallerian degeneration occurs in several stages: acute 
axon degeneration, latency in distal axon, and granular fragmentation (Wang et 
al., 2012). These phases are followed by axon regeneration, successful target 
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reinnervation, and functional recovery. As early as 5-30 minutes after PNI, both 
proximal and distal axonal segments surrounding the injury site begin to fragment 
and undergo degeneration that continues to occur over several hours (Lubińska, 
1977; Kerschensteiner et al., 2005; Brushart, 2011; Wang et al., 2012). An influx 
of extracellular calcium initiates the process of acute axon degeneration and 
increases the number of injured axons that undergo acute axon degeneration 
(Knöferle et al., 2010). In addition, calcium influx leads to axoplasmic organelles 
from anterograde and retrograde transport to pool at the terminals of transected 
axon ends (Griffin et al., 1977). Subsequently, calcium activates the protease 
calpain which cleaves neurofilaments and microtubule-associated proteins 
resulting in dissembly of the axon (Zimmerman & Schlaepfer, 1982; Fischer et 
al., 1991). During this process, the blood-nerve barrier degenerates allowing 
proteins, hormones, and ions from the blood to enter the nerve and trigger focal 
edema (Gaudet et al., 2011; Weerasuriya & Mizisin, 2011).  
Despite the rapid process of degeneration in the proximal stump, 
degeneration in the distal stump exhibits a period of quiescence after acute axon 
degeneration. The latent period before the onset of fragmentation in the distal 
axon depends on fiber diameter, intermodal length, temperature, and species 
(Lubińska, 1977; Tsao et al., 1999; Wang et al., 2012) and can last anywhere 
from 25.6 to 45.0 hours in the rat phrenic nerve (Lubińska, 1977), or up to 
several days in humans (Chaudhry & Cornblath, 1992). The end of this latent 
period is defined by the onset of cytoskeletal breakdown. 
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After the end of the latent period, the distal axon begins to undergo a final 
stage of granular fragmentation. Axon destruction proceeds at a rate of 46 
mm/day for large axons to a rapid rate of 250 mm/day for small axons (Lubińska, 
1977). Depending on the severity of injury, degeneration can occur in an 
anterograde or retrograde manner. Recently, Beirowski and colleagues reported 
axons degenerated anterogradely after a transection injury, but retrogradely after 
a crush injury (Beirowski et al., 2005).  
Products of axon fragmentation prompt myelin breakdown and clearance. 
Since the myelin debris is inhibitory, it must be removed rapidly by Schwann cells 
and macrophages in order to clear the way for an axon to regenerate 
(McKerracher et al., 1994; Mukhopadhyay et al., 1994; Shen et al., 1998). One 
cell that is responsible for myelin phagocytosis is the Schwann cell (Stoll et al., 
1989; Liu et al., 1995). Once Schwann cells are no longer associated with an 
axon, they stop producing myelin and dedifferentiate, in a mechanism dependent 
on the ubiquitin-proteasome system (White et al., 1989; Lee et al., 2009). This 
process of dedifferentiation drives the Schwann cell to proliferate and upregulate 
regeneration-associated genes, such as glial cell line-derived neurotrophic factor 
(GDNF) and growth-associated protein (Gap-43; Mehta et al., 1993; Murinson et 
al., 2005; Xu et al., 2013). Lee et al. (2006) reported necrotic neuronal cells 
stimulated the upregulation of several inflammatory factors in Schwann cells, 
such as leukemia inhibitory factor (LIF), macrophage chemoattractant protein-1 
(MCP-1), tumor necrosis factor alpha (TNF-α), and nitric oxide synthase (iNOS). 
NOS is an enzyme that converts L-arginine to nitric oxide. The product nitric 
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oxide is important in the Wallerian degeneration process by participating in the 
breakdown of myelin and subsequent nerve regeneration (Levy et al., 2001; 
Keilhoff et al., 2002).  
Macrophages assist in the removal of myelin debris by facilitating myelin 
breakdown and removing myelin debris through phagocytosis (Liu, 1974; Perry et 
al., 1987; Stoll et al., 1989). In vitro studies show two substances released from 
Schwann cells, LIF and MCP-1, attract macrophages (Tofaris et al., 2002), while 
another substance produced by Schwann cells, TNF-α, augments the injury 
response by increasing expression of MCP-1 and interleukin-1β (IL-1β; Subang 
& Richardson, 2001; Shamash et al., 2002). After macrophages are recruited to 
the denervated nerve, they must be activated before assisting in the breakdown 
of myelin. Shamash and colleagues report that both TNFα and IL-1β augment 
myelin phagocytosis by macrophages in vitro (Shamash et al., 2002).  
 
B. Peripheral nervous system injury 
1. Statement of the problem 
PNI were first classified by Seddon (1942) into three broad categories: (1) 
neurotmesis (herein defined as transection), (2) axonotmesis, and (3) 
neurapraxia. The most severe injury is neurotmesis, where the epineurium is cut 
into two. In an axonotmesis injury the enclosed nerve fibers are severed similar 
to that observed with transection, but the epineurium is spared. Neurapraxia is 
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the least severe injury type and is described as the presence of a short-lived 
paralysis without true regeneration.  
PNI frequently results in sensory and/or motor deficits and, in severe 
cases, nerve paralysis that negatively impact quality of life. Additionally, 
individuals with a PNI typically undergo long-term rehabilitation and have an 
increased risk for additional medical complications. The ability of a nerve to 
regenerate and achieve complete functional recovery is dependent on a 
multitude of factors: type and location of injury, age of individual, and 
regeneration distance to target (Birch & Raji, 1991; Perry et al., 1992; Fu & 
Gordon, 1995a, 1995b) and, if surgical repair is required, enough intact nerve or 
availability of appropriate grafting materials. Currently, there are no non-surgical 
treatment strategies in clinical use for PNI, thus finding a non-surgical therapy 
that enhances functional recovery offers immediate translational opportunity in 
the clinical setting. 
 
2. Anatomy of the peripheral nerve  
Named after German physiologist Theodor Schwann, Schwann cells are 
indispensable cells and play numerous roles in the PNS. Two types of Schwann 
cells, myelinating and non-myelinating, ensheath and insulate all axons in the 
periphery by wrapping them with a substance known as myelin. Myelinating 
Schwann cells form myelin sheaths around axons in a 1:1 Schwann cell to axon 
ratio, while a non-myelinating Schwann cell encases several axons into a group 
known as a Remak bundle. A nerve and its accompanying Schwann cell are 
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surrounded by a continuous tube known as the Schwann cell basal lamina. This 
specialized tube consists of the matrix proteins laminin and collagen, and has an 
essential role in the uninjured nerve by acting as a supporting structure to 
promote and guide nerve regeneration (Brushart, 2011). It is important to note 
that the Schwann cell basal lamina remains intact throughout Wallerian 
degeneration.  
The interaction between a nerve and Schwann cell is necessary for basal 
lamina formation (Bunge et al., 1982). The Schwann cell basal lamina plays a 
key structural role at the neuromuscular junction (NMJ) by capping the 
presynaptic nerve terminal portion of the NMJ and providing a means of cell 
adhesion amongst the nerve and NMJ components. Within the past decade, the 
importance of Schwann cells during development and maintenance of NMJ has 
been investigated (Feng & Ko, 2008; Zuo & Bishop, 2008). During development 
of the NMJ, multiple alpha-motoneurons (α-motoneurons) send axonal branches 
to the same target musculature. Interestingly, within the first several postnatal 
weeks all but one of the axonal branches withdraws from its target and eventually 
disappears. Bishop and colleagues recently used time-lapse imaging of 
fluorescently labeled axons and serial electron microscopy to examine the 
phenomenon of synapse elimination at the NMJ (Bishop et al., 2004). Their work 
revealed that α-motoneurons disintegrate and shed membrane-bound remnants 
referred to as axosomes that are subsequently engulfed by surrounding glia. It 
has been postulated that the mixing of axonal and glial cytoplasm could signal 
the Schwann cell to migrate away or undergo apoptosis leading to synapse 
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elimination (Nakao et al., 1997). Although additional studies are warranted to 
better support whether glia signal synapse elimination of α- motoneurons, 
Schwann cells are likely to play an essential role in maintaining NMJ structure 
and function after injury (Koirala et al., 2000; Court et al., 2008). 
Several layers of connective tissue encase a peripheral nerve to prevent 
the nerve from potential injury. The outermost layer of nerve sheath, the 
epineurium, consists of collagen and elastin fibers that act together to protect the 
nerve fibers and form a supporting wall. Within the epineurium are nerve fibers 
enclosed in a bundle or funiculi by perineurium (Sunderland, 1965). Layers of 
flattened cells and collagen fibers give the perineurium tensile strength to further 
protect the nerve fibers (Thomas, 1963; Sunderland, 1965). Each nerve fiber and 
its accompanying Schwann cells within the nerve bundle are ensheathed by a 
thin, delicate layer of connective tissue called the endoneurium that functions in 
cushioning the nerve fiber. Lastly, between the Schwann cell layer and 
endoneurium is an additional delicate sheath referred to as the neurilemma or 
inner endoneurium (Sunderland, 1965). Together, these three sheaths form a 
protective defense barrier and allow the nerve to efficiently transmit electrical 







3. Current status of peripheral nerve injury (PNI) and repair 
a. Therapeutic rationale  
Typically, the severity of injury determines the treatment regimen that will 
be administered. For minor injuries, physical therapy, splints, or administration of 
analgesic or other medications may be possible; though more severe injuries that 
do not respond to therapy and medication may improve with surgical intervention. 
Recently, the outcomes of neurolysis surgery, or cutting of the epineurium, were 
examined in a retrospective study. The results indicated that half of the patients 
that undergone neurolysis surgery were considered to have an excellent 
outcome (Maalla et al., 2013). Decompression, suture, and nerve grafting also 
have been utilized as surgical interventions and have had some success. Despite 
this success, functional recovery was not seen up to 18 months after surgical 
repair (Kline et al., 1998; Kim et al., 2004). These reports indicate mixed nerves 
are capable of regeneration over long distances and the ability for a nerve to 
regenerate after injury is not purely limited by distance. 
Although surgery is the standard treatment for PNI, only half of individuals 
with PNI regain functional recovery (Kallio & Vastamäki, 1993). Suboptimal 
results observed with surgical intervention stress the need for additional non-
surgical approaches for the treatment of PNI. Finding a novel therapy that 
enhances functional recovery would not only repair sensory and motor deficits 
resulting from injury, but would significantly reduce the time that an individual 
would undergo rehabilitation. 
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Successful functional recovery following nerve injury is dependent upon a 
sequence of events, each of which can be manipulated with treatment to promote 
successful target reinnervation. In the first phase following injury, the intrinsic 
growth state must be activated and maintained. Following injury, neurons 
undergo molecular changes, such as chromatolysis and an increase in RNA and 
protein synthesis, to prepare for regeneration (Lieberman, 1971). Treatments that 
stimulate the intrinsic growth state of a neuron by increasing the expression of 
regeneration-associated genes produce a regenerative neuronal phenotype and 
promote axon elongation across the injury site (Lieberman, 1971; Sharma et al., 
2010a). There are two general phases of the regeneration process that can be 
targeted to decrease the time to functional recovery: (1) time before sprout 
formation and (2) axon regrowth to the appropriate target (Kujawa et al., 1993). 
The time from the start of the Wallerian degeneration process until the daughter 
axon sprouts is defined as the time before sprout formation (Oblinger & Lasek, 
1984). During Wallerian degeneration, the distal axon stump dissembles and is 
removed. By removing the inhibitory myelin debris and creating a permissive 
environment, the nerve can regenerate towards its target (McKerracher et al., 
1994). Treatments that either decrease the time before sprout formation or 
accelerate axon regrowth enhance functional recovery and decrease the time 
individuals will need for rehabilitation services. In humans, regeneration rates are 
relatively slow and an injured nerve likely will have to regenerate over a long 
distance. For successful target reinnervation and functional recovery, it is of 
extreme importance to guide the regenerating motor nerve to the correct distal 
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stump path to prevent synkinesis or involuntary muscle actions accompanying 
voluntary movements (Al-Majed et al., 2000b). One method of achieving 
appropriate target reinnervation is utilizing treatments that increase regeneration 
specificity. Most importantly, the target musculature must remain viable and 
intact during the slow regeneration process to preserve the ability for the 
establishment of new functional neuromuscular junctions (Fischer et al., 2004; 
Hughes et al., 2006; Marcuzzo et al., 2011). 
 
b. Surgical approaches  
The standard surgical care for transection injuries when epineurium 
reattachment is necessary is nylon suture. Unfortunately, only approximately 
50% of individuals regain functional recovery with nylon suture treatment (Kallio 
& Vastamäki, 1993). The low success rate appears to be due to the difficulty of 
aligning the fascicles in the right orientation prior to suture. Additionally, the 
success of surgical repair after nerve injury is dependent upon several factors, 
including the nature of the injury, type and timing of repair, requirement for a 
nerve graft, location of injury (i.e., how far the injury is from target muscle or 
skin), and age of patient (Omer, 1974; Navarro et al., 1988; Birch & Raji, 1991; 
Kawabuchi et al., 1998; Kim et al., 2004; Ruijs et al., 2005; Höke, 2006). A nerve 
graft is required for transection injuries that have stumps that cannot be 
reattached with primary surgical care without causing excessive tension. Two 
general types of nerve grafts, each with their own potential advantages, are in 
clinical use, autografts and allografts. Autografts utilize an individual’s own nerve 
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tissue and are considered the standard nerve graft material. The most common 
source for an autograft is the sural nerve, due to its size, ease of harvest, and 
moderate dispensability (Lee & Wolfe, 2000); although other sources include the 
anterior branch of the medial antebrachial cutaneous nerve, lateral femoral 
cutaneous nerve, and the superficial radial sensory nerve (Sunderland, 1991). 
While an autograft is a safe and fast healing option, making it the standard 
choice for nerve graft repair, harvesting the autograft tissue creates a second 
surgical site which takes time to heal and may cause discomfort. The second 
category of graft, allograft, utilizes donor tissue. Although a second surgical site 
is not created, an allograft takes longer to incorporate into the recipient’s body 
(Squintani et al., 2013). 
Axon fusion with fibrin glue or polyethylene glycol (PEG) also has been 
explored as a therapy for PNI. Earlier studies found fibrin glue alone to be inferior 
to microsuture when examining electrophysiological properties of the nerve and 
fibrin glue was less reliable in keeping the proximal and distal stumps connected 
(Moy et al., 1988; Maragh et al., 1990; Sames et al., 1997). In contrast, recent 
reports demonstrate fibrin glue alone significantly accelerated motor recovery, 
axonal regeneration, and nerve conduction properties compared to microsuture 
(Ornelas et al., 2006a; Ornelas et al., 2006b; Barbizan et al., 2013). Although 
mixed results utilizing fibrin glue as a treatment after PNI have been observed, it 
is relatively quick and easy to use and still remains an attractive alternative to 
microsuture. PEG has been utilized as a method to fuse the plasmalemmas of 
proximal and distal stumps of severed axons. Several years ago, Bittner and 
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coworkers discovered PEG could fuse severed crayfish and earthworm axons 
(Bittner et al., 1986; Krause & Bittner, 1990). The ground breaking in vitro results 
stimulated Bittner and colleagues to investigate the use of PEG as a treatment to 
reconnect severed mammalian axons in vivo (Stavisky et al., 2005; Britt et al., 
2010). The aforementioned studies reveal that additional treatments in 
combination with surgical repair may be necessary to obtain full functional 
recovery. 
 
c. Non-surgical approaches 
Non-surgical approaches are an attractive form of treatment after PNI 
since they are less invasive. Although no non-surgical treatment is approved in 
the clinical setting, several non-surgical therapies have shown promise in in vitro 
and in vivo studies. ES, gonadal steroids, trophic factors, and exercise are a few 
non-surgical therapies that are being actively investigated. Utilizing a non-
surgical therapy in combination with surgical repair may enhance functional 
recovery. 
 
i. Electrical stimulation (ES) 
Electrical stimulation (ES) is currently being investigated as a therapeutic 
approach following injury and has been utilized in the clinical setting as a therapy 
to enhance nerve regeneration following PNI (Gordon et al., 2009; Gordon et al., 
2010). Concurrent with carpal tunnel release surgery, brief, low frequency ES (20 
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Hz) for 1 hour has been used clinically as a method to treat carpal tunnel 
syndrome (Gordon et al., 2010). The results from this study demonstrated a 
significant increase in motor unit number and sensory nerve conduction values in 
the stimulated group at 6-8 months compared to the unstimulated control group. 
In vitro studies suggest ES can promote neurite outgrowth, orientation, and 
sprouting (Patel & Poo, 1982; Manivannan & Terakawa, 1994; Matthew & 
Rebecca Kuntz, 2009). Moreover, various forms of ES have shown promising 
results in the clinic for a variety of neurobiological disorders, including Bell’s 
palsy, chronic pain, PNI, and multiple sclerosis (Gordon et al., 2010; Buchmuller 
et al., 2012; Happe & Bunten, 2012; Heller et al., 2013). 
The effect of ES on the morphological properties of neurons has been 
extensively studied in vitro. In 1979, Jaffe and Poo discovered that electrical 
fields increase neurite outgrowth of chick dorsal root ganglion (DRG) explants 
(Jaffe & Poo, 1979). Later reports confirmed these results in Xenopus laevis, but 
also revealed that electrical fields alter neurite orientation and branching in a way 
that is dependent upon duration, amplitude, and frequency of the stimulus pulse 
(Patel & Poo, 1982; Patel & Poo, 1984; McCaig, 1990). From these studies, it 
was concluded that ES alters neurite morphology; however the question of 
whether these changes have functional benefit remains to be tested. 
The capability of ES to enhance neurite outgrowth and orientation led 
scientists to investigate whether ES could promote cell survival and axon 
regeneration after injury. Several elegant experiments completed by Borgens and 
coworkers laid the foundation for ES as a potential therapy following injury. In the 
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late 1980’s, they established that ES enhanced neuronal regeneration and 
behavioral recovery across a spinal cord lesion in adult guinea pigs (Borgens et 
al., 1986; Borgens et al., 1987). A decade later, they utilized naturally injured, 
neurologically intact paraplegic dogs as a model of spinal cord injury and 
discovered that oscillating electrical field stimulation significantly improved 
neurological recovery (Borgens et al., 1999). Another group examined whether 
ES would promote cell survival (Morimoto et al., 2002). In this study, Morimoto et 
al. observed that ES increased retinal ganglion cell survival if ES was applied at 
20 Hz for 2 hours after optic nerve transection. These innovative findings 
stimulated others to explore the beneficial effects of ES after PNI. 
Currently, ES has been hypothesized to enhance neurite outgrowth via an 
increase in intracellular Ca2+, followed by an increase in the second messenger 
cyclic adenosine monophosphate (cAMP; Fig. 1). In the early 1990’s, Garyantes 
and Regehr stimulated cultured superior cervical ganglion neurons at 10 Hz for 
up to 1 hour. This brief, low frequency stimulation was enough to elicit a rise in 
intracellular Ca2+ but was not sufficient to increase neurite outgrowth (Garyantes 
& Regehr, 1992). Others experimented using a frequency of 10 Hz and found 
contradictory results to those observed by Garyantes and Regehr. Lin and 
coworkers stimulated DRG neurons at 10 Hz but increased the time of stimulus 
delivery to 3 days (Lin et al., 1993). They concluded that extending the delivery of 
the stimulus from 1 hour to several days increased neurite outgrowth of the 
cultures which supported earlier in vitro findings. Okazaki and colleagues later 





Fig. 1: Schematic of the proposed mechanism by which a brief, low 
frequency electrical stimulation alters regeneration-associated gene 
expression in motoneurons. 
Electrical stimulation increases intracellular calcium and cAMP levels that in turn 




stimulation period and 10, 20, and 50 Hz frequencies (Okazaki et al., 2008). 
Their results showed a minimum of 30 minutes of ES was necessary to promote 
survival of retinal ganglion cells and a 20 Hz stimulation frequency was most 
effective. Of note, both 10 Hz and 20 Hz stimulation frequencies have been 
shown to increase levels of cAMP which is thought to mediate neuron survival 
and axon growth (Udina et al., 2008; Corredor et al., 2012). The use of a 20 Hz 
stimulation frequency to elicit neuroregenerative effects has been confirmed by 
our laboratory, as well as others (Ahlborn et al., 2007; Hetzler et al., 2008; 
Alrashdan et al., 2010; Wan et al., 2010). 
Following a rise in intracelulluar Ca2+, ES enhances the expression of 
regeneration-associated genes. Al-Majed et al. examined the effects of a 20 Hz 
ES on regeneration-associated genes expression utilizing in situ hybridization 
and a model of femoral nerve transection with suture repair (Al-Majed et al., 
2000a). They observed a significant increase in gap-43 and αI–tubulin mRNA 
expression 2 days post-axotomy, followed by a significant increase in brain-
derived neurotrophic factor (bdnf) and trkB mRNA expression 7 days post-
axotomy in motoneurons (Al-Majed et al., 2000a; Al-Majed et al., 2004). These 
data suggest that ES upregulates gap-43 and αI–tubulin prior to activating BDNF 
signaling following injury. A few studies suggest that ES triggers BDNF signaling 
in a manner dependent on both Ca2+ and extracellular signal-regulated kinase 
(Erk) activation (Wenjin et al., 2011; Yan et al., 2013). In addition, Al-Majed and 
coworkers found that the 20 Hz ES paradigm significantly decreased the 
cytoskeletal medium-molecular-weight neurofilament protein 2 days post-
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axotomy (Al-Majed et al., 2004). This result is not surprising since neurofilament 
has been shown to interfere with the axonal transport by other cytoskeletal 
proteins, actin and tubulin, and is associated with enhanced regeneration (Bisby 
& Tetzlaff, 1992). Lin and coworkers did not observe an increase gap-43 
expression following ES treatment; however, this could be due to utilization of an 
insufficient ES frequency (10 Hz) that does not stimulate neurite outgrowth (Lin et 
al., 1993). Recently, we confirmed that a 20 Hz ES stimulation after facial nerve 
injury enhances early expression of αI–tubulin, gap-43, and bdnf mRNA (Sharma 
et al., 2010a). In addition, we found significant increases in neuritin and pituitary 
adenylate cyclase-activating peptide (pacap) mRNA. Neuritin, also known as 
candidate plasticity gene 15, has been shown to enhance neurite extension and 
arborization (Naeve et al., 1997; Javaherian & Cline, 2005; Marron et al., 2005), 
while PACAP has been reported to increase after spinal cord injury (Tsuchikawa 
et al., 2012) and promote axonal sprouting after facial nerve transection (Suarez 
et al., 2006). In addition to enhancing regeneration-associated genes expression, 
ES recently has been shown to induce the expression of the myelin associated 
gene p0, Schwann cell polarity gene par-3, and stimulate myelination (Wan et al., 
2010; Yang et al., 2012). In 2002, Brushart et al. demonstrated that ES promotes 
the onset of motor axon regeneration, but not the speed of regeneration 
(Brushart et al., 2002). We later confirmed this finding after facial nerve axotomy 
in rats (Sharma et al., 2009). Recently, the ability of ES to enhance axonal 
regeneration was reported to signal through androgen receptors (Thompson et 
al., 2013). Collectively, these data support the ability of ES to increase 
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expression of regeneration-associated genes early after injury and decrease the 
delay to sprout formation in a way that is dependent on androgen receptor 
signaling. 
Although accumulating evidence has shown that ES enhances neurite 
outgrowth and promotes survival of neurons following injury, the protocol by 
which ES should be administered is controversial. An ES protocol of 1 hour to 2 
weeks was applied after femoral nerve transection with immediate repair in rats 
(Al-Majed et al., 2000b). The results from this study demonstrated that ES 
reduced the time it took for motoneurons to regenerate by 5 weeks and 
enhanced preferential motor reinnervation, which is a key feature of motor axon 
regeneration and the tendency of regenerating motor axons in a mixed nerve to 
selectively reinnervate muscle. In support of the results reported by Al-Majed and 
colleagues, ES increases the number of regenerated axons across suture gaps 
to their appropriate target (Brushart et al., 2002; Vivó et al., 2008). We have 
shown that 30 minute daily administration of a 20 Hz ES frequency starting 
immediately after injury shortened functional recovery by nearly a week 
compared to unstimulated rats (Lal et al., 2008). Recently, we demonstrated that 
a one-time, 30 minute ES treatment at 20 Hz immediately after facial nerve crush 
injury is just as effective as daily ES treatments for up to 1 week (Foecking et al., 
2012). Analogous results have been observed in rodents after sciatic nerve injury 
(Hamilton et al., 2011; Singh et al., 2012). Together, these data confirm that 
short- and long-term ES are equally effective in motoneuron reinnervation of their 
appropriate targets and promote the onset of axonal regeneration. 
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The current consensus in the field is that a 20 Hz stimulus frequency 
delivered for 30 minutes to 1 hour will be sufficient to promote functional recovery 
in the clinic. First, this frequency is physiologically relevant to the normal slow 
firing patterns of motoneurons. As discussed, this ES protocol was shown to be 
optimal in vitro, and has had success in vivo in both rodents and humans 
following PNI. The ES protocol will most likely have to be altered depending on 
the type of nerve (i.e., motor, sensory, or mixed) and severity of injury. In 
conclusion, these data support the use of ES as a strategy to improve functional 
recovery by promoting appropriate target reinnervation and enhancing axonal 
regeneration. 
 
ii. Gonadal steroids 
To date, numerous studies suggest gonadal steroids have profound 
neuroprotective and neuroregenerative effects (Chowen et al., 1992; Singer et 
al., 1996; Tanzer & Jones, 1997; Chen et al., 1999). For example, progesterone 
has been reported to have neuroprotective roles in a variety of experimental 
models, such as stroke, Alzheimer’s disease, and traumatic brain injury 
(Jayaraman et al., 2012; Si et al., 2013; Wali et al., 2013), as well as the 
promotion of functional recovery after spinal cord injury (Thomas et al., 1999). 
Our laboratory has shown previously that estrogen accelerates the rate of facial 
nerve regeneration following facial nerve crush injury (Tanzer & Jones, 1997) 
which is supported by a more recent study demonstrating that estrogen and 
selective estrogen receptor modulators stimulate sciatic nerve regeneration in 
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mouse models (McMurray et al., 2003). Emerging evidence supports the ability of 
androgens to enhance regenerative properties, increase muscle mass, and 
promote functional recovery following nerve injury, as described below (Kujawa 
et al., 1993; Brown et al., 1999; Sinha-Hikim et al., 2003). 
Currently, androgens have been used clinically to treat several disorders, 
including hypogonadism, muscle wasting in human immunodeficiency virus 
(HIV), and androgen deficiency making them a highly translational therapeutic 
intervention following nerve injury (Bhasin et al., 1996; Strawford et al., 1999; 
Arlt, 2006; Selice et al., 2013). It is well understood that androgens have trophic 
effects on the developing nervous system which may translate to its use as a 
therapy following PNI. Androgens are well known for their essential role in male 
reproductive control and development of male secondary sex characteristics, yet 
their function is widespread. During adulthood, androgens support sperm 
production, promote the enlargement of skeletal muscle, and inhibit fat deposition 
(Bhasin et al., 1996; Arner, 2005; Walker, 2010). In the mammalian CNS, 
androgens function to maintain synaptic connections and promote neurite 
outgrowth. For example, androgens are essential for postnatal dendritic growth 
(Goldstein et al., 1990), as well as maintenance of dendrites in adulthood (Kurz 
et al., 1986) in motoneurons located in the spinal nucleus of the 
bulbocavernosus. 
The primary and most recognized androgen is testosterone, although 
other less known androgens, such as dihydrotestosterone (DHT) and 
androstenedione, have equally important roles in development. Androgens, like 
33 
 
all gonadal steroid hormones, are derived from cholesterol and thus are similar in 
structure. The gonadal steroids are composed of a central skeleton containing 
three cyclohexane rings and one cyclopentane ring and a side chain that varies 
among the different gonadal steroid hormones. The Leydig cells of the testes are 
the primary site of testosterone production, but considerable levels of 
testosterone can also be found in the adrenal cortex. Testosterone is present in 
both females and males, albeit at different levels, and can be prescribed as an 
exogenous therapeutic if levels fall below normal physiological levels (Selice et 
al., 2013). 
Within the last half-century, we have begun to understand the cellular and 
molecular mechanisms of testosterone action on target tissues. Testosterone can 
act directly through its androgen receptor (AR) or through its aromatization to 
estrogen. In the direct or classical steroid pathway, free testosterone is 
transported to its target tissue where it easily crosses the cell membrane (Fig. 2). 
Upon entering the cell, testosterone acts as a ligand to the AR to which it binds, 
stimulating a conformational change in the receptor. In order for the 
ligand/receptor complex to translocate to the nucleus, it must dimerize. After the 
receptor complexes dimerize, they enter the nucleus and bind to DNA sites 
called hormone response elements. This binding has a direct effect on the level 
of transcription at that site ultimately leading to an increase or decrease in mRNA 
synthesis (Brann et al., 1995). Although the direct pathway is considered to be 
the primary mechanism by which testosterone mediates its effects, indirect or 





Fig. 2. Schematic of the proposed mechanism by which testosterone (T) 
alters regeneration-associated gene expression in motoneurons.  
Testosterone enters the cell where it is able to bind to its receptor, the androgen 
receptor (AR), and induce a conformational change. The ligand/receptor complex 
dimerizes with another ligand/receptor complex and translocates to the nuclues. 
After the receptor complexes dimerize, they enter the nucleus and bind to DNA 
sites called hormone response elements. This binding has a direct effect on 
transcription and translation of genes responsible for neuroprotection, the 
astrocytic response, and axon regeneration.   
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increased interest. In indirect mechanisms of action, testosterone binds to 
membrane or neurotransmitter receptors and rapidly exerts its effect through 
signaling pathways that do not directly involve an increase in genomic DNA 
(McEwen, 1991; Falkenstein et al., 2000; Watson & Gametchu, 2003). 
Androgens have been shown to act in a variety of tissues due to the 
widespread distribution of AR. Although AR are present in both males and 
females, males have a significantly higher concentration of AR (Yu & McGinnis, 
2001). Several areas within the brain contain AR, including the preoptic area, 
arcuate nucleus, amygdala, regions of the hippocampus, ventromedial and 
dorsomedial nucleus, and medial hypothalamic area (Simerly et al., 1990). AR 
are also distributed in lower motoneurons of the brainstem and spinal cord and 
can be observed outside the CNS in muscle tissue, nerves, and DRG (Breedlove 
& Arnold, 1981; Simerly et al., 1990; Jordan et al., 2002; Luo et al., 2008; Oki et 
al., 2013). These distinct locations of AR allow gonadal steroids to have selective 
actions at these sites. For example, the effects of gonadal steroids on neuron 
ultrastructure have been well studied in the ventromedial nucleus of rats. 
Estradiol treatment has been shown to increase rough endoplasmic reticulum 
stacks and dense-cored vesicles, which may reflect increased biosynthesis of a 
secretory product (Cohen & Pfaff, 1981). Our laboratory reported similar findings 
and detected alterations in the nucleolus, an increase in cell size, and changes in 
the nuclear shape from nonspherical to spherical (Jones et al., 1985). Moreover, 
our laboratory utilized in situ hybridization to show an increase in gene 
transcription in the hypothalamic neurons of rats within 30 minutes (Jones et al., 
36 
 
1990). This work is supported by more recent literature which suggests estradiol 
recruits protein synthesis machinery for local protein synthesis in dendrites of 
newly developing synapses (McCarthy & Milner, 2003). 
Several reports have investigated the neuroprotective role of heat shock 
proteins (HSP) in the motor neuron disease spinal and bulbar muscular atrophy 
and after injury to the optic, facial, and sciatic nerves (Kalmar et al., 2002; 
Katsuno et al., 2005; Tetzlaff et al., 2007; Nagashima et al., 2011; Wang et al., 
2013). HSP are stress-induced, molecular chaperones that are critical in 
maintaining correct assembly, folding, and intracellular transport of proteins. A 
characteristic of the heat shock response is a rapid upregulation of HSP and the 
folding of nonnative proteins after injury (Morimoto & Santoro, 1998). Recent 
literature suggests androgens may exert their neuroprotective effects by 
modulating HSP following injury. In 1990, Sanchez and colleagues established 
that unbound steroid receptors complex with HSP 90 and HSP 70 (Sanchez et 
al., 1990). It was later determined that HSP are bound to AR in the cytoplasm 
and are released in the presence of a synthetic androgen (Veldscholte et al., 
1992). This work is supported by more recent findings in our laboratory 
demonstrating that AR protein localizes to the nucleus following the 
administration of a form of testosterone, testosterone propionate (TP; Tetzlaff et 
al., 2007). Our laboratory also has shown that levels of hsp 70 mRNA and protein 
increase dramatically following facial nerve transection in hamsters and are 
significantly reduced after testosterone treatment (Jones et al., 2000; Tetzlaff et 
al., 2007). Additionally, our laboratory has reported testosterone significantly 
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augments the ribosomal response 18 hours after injury and shortens the interval 
between rRNA transcription and processing in the presence of gonadal steroids 
(Kinderman & Jones, 1993). From this work, it has been hypothesized that 
testosterone treatment may reduce the normal stress response to allow for a 
more rapid neuroregenerative response by making available pre-existing HSP 
70. 
It has been hypothesized that testosterone drives the regenerative 
response by altering expression of regeneration-associated genes, including 
bdnf, gap-43, neuritin, and βII-tubulin (Sharma et al., 2010a; Verhovshek et al., 
2010). Previous studies indicate that BDNF promotes axonal sprouting, 
motoneuron survival, and functional recovery after injury (Serpe et al., 2005; 
Sasaki et al., 2009). Moreover, GAP-43 is a crucial component of the presynaptic 
terminal and necessary in growth cone guidance (Shen et al., 2002). Conversely, 
tubulin has a rather different role in the regeneration process as it is the main 
component of microtubules and functions in maintaining cell structure and 
intracellular transport (Hoffman & Lasek, 1975). McQuarrie et al. found that if a 
lesion precedes peripheral nerve injury, known as a conditioning lesion, tubulin 
levels are increased in the axonal shaft and axonal outgrowth is accelerated 
(McQuarrie, 1986). Recently, we reported that administration of testosterone 
following injury causes a delayed (2-7 days post-axotomy) upregulation of 
several regeneration-associated genes, including bdnf, neuritin, and βII-tubulin 
mRNA in rat facial motoneurons (Sharma et al., 2010a), which is consistent with 
previous results from our laboratory (Jones & Oblinger, 1994; Jones et al., 1999; 
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Brown et al., 2001; Storer et al., 2002; DeLucia et al., 2007; Fargo et al., 2008). 
In contrast to our earlier results, we did not see an upregulation in gap-43 
following testosterone treatment (Jones et al., 1997a; Sharma et al., 2010a). 
Interestingly, from these studies we found testosterone had no effect on mRNA 
levels of a different subclass of tubulin, αI–tubulin. In accordance with existing 
literature, testosterone regulates the expression of BDNF in both spinal 
motoneurons and muscle, as well as the BDNF receptor, trkB, in spinal 
motoneurons (Osborne et al., 2007; Verhovshek et al., 2010; Verhovshek & 
Sengelaub, 2013). Since BDNF regulates AR expression in motoneurons after 
injury, it is likely that BDNF and AR augment one another and have a feed-
forward mechanism (Al-Shamma & Arnold, 1997; Yang & Arnold, 2000). 
Since gonadal steroids have been established to play a role in CNS 
plasticity, our laboratory investigated their effects on motoneurons after injury. 
After transection of the facial nerve, we saw an 81% reduction in the percent 
somal membrane covered by synaptic profiles and a 26% decrease in the 
average synaptic length of axosomatic synapses (Jones et al., 1997b). Exposure 
to TP immediately after nerve transection reduced both of these measurements 
to 48% and 16%, respectively. These results indicate that treatment of TP 
following axotomy attenuated the synaptic stripping that occurred 5 days after 
injury. In support of these data, we found axotomy alone increased glial fibrillary-
acidic protein (gfap) expression in the facial motor nucleus after facial nerve 
transection, which was attenuated with treatment of TP (Jones et al., 1997c; 
Coers et al., 2002). Taken together, these observations indicate TP attenuates 
39 
 
the initial response of motoneurons to injury allowing for an accelerated 
regeneration response and that is able to diminish the astrocytic response after 
axotomy. 
Seminal studies conducted in the early 1980’s, examined the effect of 
androgens on axonal regeneration. The first of several elegant papers published 
by the Yu laboratory investigated the effect of TP and DHT on axonal 
regeneration following transection of the hypoglossal nerve in female rats (Yu & 
Srinivasan, 1981). Their results demonstrated that as early as two weeks after 
transection axotomy of the right hypoglossal nerve there was a greater number of 
HRP-labeled neurons in the right hypoglossal nucleus of rats injected with TP or 
DHT compared to vehicle-injected rats. Similar results were observed at three 
weeks post-axotomy but not four weeks post-axotomy for TP treated animals 
compared to control animals. In contrast, the DHT treated animals showed fewer 
labeled HRP-labeled motoneurons three and four weeks post-axotomy compared 
to control animals. The following year, Yu observed that TP treatment following 
transection axotomy of the hypoglossal nerve also increased the number of HRP-
labeled neurons that reached the tongue in male rats compared to female rats 
(Amy Yu, 1982; Yu, 1982). Furthermore, similar results were observed with TP 
treatment following crush axotomy of the hypoglossal nerve (Yu & Yu, 1983). 
Taken together, these data suggest that TP promotes axonal regeneration, but it 
is unclear if TP shortens the time before sprout formation or accelerates the rate 
of axonal regeneration. 
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In 1989, a study conducted by Kujawa and colleagues examined the effect 
of TP on functional recovery following facial nerve crush injury in male hamsters 
(Kujawa et al., 1989). In addition to assessing functional recovery, they also 
tested varying doses and administration of TP, i.e., capsule implants vs. injection. 
From these experiments, they had several unique discoveries. First, functional 
recovery was accelerated in all groups treated with TP, albeit at different levels. 
Moreover, they found that increasing the dose and frequency of TP injections 
directly altered functional recovery; however, TP-filled Silastic capsules elicited 
the most enhanced effects on functional recovery. Lastly, there was no difference 
in functional recovery when comparing gonadally intact to gonadectomized male 
hamsters, suggesting endogenous levels of testosterone was not sufficient to 
enhance functional recovery. 
At this point in time, it was known that TP promoted axon regeneration 
from the observations reported by our laboratory and others; however, the 
mechanism by which TP elicited its effects was unknown. Several subsequent 
papers from our laboratory examined the effects of TP on regeneration rate 
following facial nerve injury. Using linear regression analysis, we determined that 
TP significantly increased regeneration rate after facial nerve injury in intact 
female hamsters by ~10% but had a more enhanced effect in males (~30%; 
Kujawa et al., 1991). Additionally, we confirmed our previous finding that 
endogenous testosterone was not sufficient to alter regeneration rate. To test 
whether these observations were AR dependent, we gave daily injections of 
flutamide, a known antiandrogen (Kujawa et al., 1995). In this study, we found 
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that flutamide completely abolished the ability of TP to enhance regeneration rate 
which suggests that TP acts through an AR dependent mechanism. Interestingly, 
we discovered that there is a critical interval of 6 hours after injury in which TP 
must be administered to significantly enhance regeneration and augment 
functional recovery (Kujawa & Jones, 1990; Tanzer & Jones, 2004). Although 
metabolites of testosterone, including  DHT and estradiol, increase the rate of 
regeneration following injury, the effect is not as pronounced as seen with TP 
treatment (Tanzer & Jones, 1997; Sharma et al., 2009). 
The evidence we have accumulated in the last few decades supporting 
the neurotherapeutic role of testosterone after facial nerve injury has been 
confirmed in other injury models. TP has been shown to accelerate functional 
recovery after sciatic nerve crush injury (Brown et al., 1999). In a similar model, 
Swallow and colleagues observed enhanced anatomical recovery with TP, but 
they did not see behavioral recovery following treatment with TP (Swallow et al., 
1999). It was later determined that this discrepancy stemmed from differences in 
administration of TP and provided further evidence that TP is most effective 
when delivered through subcutaneous capsule implants that elevate serum levels 
of TP to supraphysiological levels. Enhanced functional recovery with TP 
treatment also has been reported following recurrent laryngeal nerve crush injury 
and hypoglossal nerve injury (Yu & Srinivasan, 1981; Yu & Yu, 1983; Brown et 
al., 2013; Monaco et al., 2013). In summary, we and others have established that 
androgens significantly accelerate functional recovery if administered at a 
supraphysiological level and in the propionated form. 
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iii. Growth factors 
The utilization of growth factors to promote peripheral nerve regeneration 
has been investigated with limited success. Neurotrophin-3 (NT-3) has been 
observed to enhance neurite outgrowth in vitro (Avila et al., 1993); however, NT-
3 failed to enhance functional recovery after transection of either the lingual or 
sciatic nerves (Young et al., 2001; Robinson et al., 2004). Similarly, neither 
BDNF nor nerve growth factor (NGF) enhanced peripheral nerve regeneration 
after nerve transection in rats and was inferior compared to no treatment (Young 
et al., 2001; Boyd & Gordon, 2002). In contrast, glial cell-derived neurotrophic 
factor (GDNF) delivered by fibrin glue or collagen gel at the repair site has been 
demonstrated to enhance functional recovery and partially recover contractile 
muscle force, muscle mass, and the number of estimated motor units after nerve 
transection and repair (Chen et al., 2001; Wood et al., 2013), but the 
overexpression of GDNF impaired motor axon growth and target reinnervation 
(Tannemaat et al., 2008). In 2001, Yin and colleagues discovered that NT-4/5 
treatment delivered at the repair site in fibrin glue after sciatic nerve transection 
and repair significantly improved the number of regenerated axons, axon 
diameter, and myelin thickness (Yin et al., 2001). English et al. later 
demonstrated that NT-4/5 enhances the early reinnervation of the distal stump 
(English et al., 2005). 
The limited success of growth factors to lead to functional recovery is 
supported by modest changes in mRNA and protein levels following nerve injury. 
Omura and coworkers investigated the expression of several growth factors in 
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nerve and muscle after various types of PNI (Omura et al., 2005). Their results 
demonstrated that bdnf mRNA and protein levels increased with nerve 
transection in the sciatic nerve and soleus muscle as early as 7 days post-
axotomy. In addition, nt-3 mRNA and protein levels showed no difference in 
either the sciatic nerve or soleus muscle in any of the tested PNI, whereas nt-4/5 
mRNA decreased as early as 4 days post-axotomy after sciatic nerve 
transection. One mechanism by which GDNF could mediate its effects on 
enhancing peripheral nerve regeneration is through upregulating GAP-43 (Chen 
et al., 2001). In support of the results reported by Chen et al., Storer and 
colleagues discovered application of GDNF to the injury site following 
hemisection to the rubrospinal tract significantly upregulated gap-43 7 days post 
injury (Storer et al., 2003). Additionally, Storer et al. observed increases in βII-
tubulin 1 day post injury, whereas there was no effect of BDNF treatment on βII-
tubulin or gap-43. The aforementioned results suggest growth factors alone are 
less promising than other non-surgical options in improving functional recovery 
following PNI. 
 
iv. Exercise  
Over the past decade, literature describing the effect of exercise on axonal 
regeneration and functional recovery has increased considerably. Several reports 
demonstrate exercise positively impacts axonal regeneration and functional 
recovery of injured peripheral nerves by increasing axon elongation (Sabatier et 
al., 2008), enhancing functional recovery (Cobianchi et al., 2010), and increasing 
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muscle reinnervation (Udina et al., 2011). Moreover, treadmill training within the 
first two weeks following PNI promoted motor axon regeneration without 
disrupting regeneration specificity (English et al., 2009). Treadmill training 
programs significantly reduced neuropathic pain symptoms after chronic 
constriction injury of the sciatic nerve in rats and mice (Cobianchi et al., 2010; 
Chen et al., 2012). Recently, Wood and colleagues investigated sex differences 
in treadmill training in mice following transection injury with allograft repair of the 
common fibular nerve (Wood et al., 2012). Interestingly, Wood et al. discovered 
continuous treadmill training significantly enhanced axon regeneration in males, 
whereas in female’s interval training significantly enhanced axon regeneration. 
Some studies have begun to elucidate the mechanisms underlying the 
effect of exercise on axon regeneration. Gómez-Pinilla et al. established that 
exercise significantly increased bdnf mRNA and protein in lumbar motoneurons 
and the soleus muscle after 5 days of training in uninjured rats (Gómez-Pinilla et 
al., 2001), as well as mRNA levels of the BDNF receptor, trkB, in the lumbar 
spinal cord after 3 days of exercise (Gómez-Pinilla et al., 2002). In contrast, nt-3 
mRNA expression was initially downregulated in the spinal cord after 1 day of 
exercise training but was upregulated after 5 days of continuous exercise training 
in uninjured rats (Gómez-Pinilla et al., 2001). In the soleus muscle, Gómez-Pinilla 
and coworkers observed nt-3 mRNA levels to be significantly upregulated after 
both 1 and 5 days of exercise training. Additionally, Gómez-Pinilla observed that 
exercise significantly increased both mRNA and protein levels of gap-43 and the 
synaptic mediator synapsin 1 in lumbar spinal cord (Gómez-Pinilla et al., 2002). 
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Similarly, Molteni et al. reported increased neurite outgrowth of cultured lumbar 
DRG neurons from exercised animals which was associated with significantly 
higher levels of mRNA of the neurotrophins bdnf and nt-3, synapsin 1, and gap-
43 (Molteni et al., 2004). Interestingly, Wood and coworkers demonstrated that 
castration eliminated the ability of exercise training to enhance axon regeneration 
in male rats (Wood et al., 2012). Conversely, Wood et al. treated female rats with 
the aromatase inhibitor, anastrozole, to demonstrate that axon regeneration is 
significantly enhanced without increasing serum testosterone levels (Wood et al., 
2012). The results presented by Wood and colleagues suggest axon 
regeneration is enhanced in a sex-dependent manner. Similar findings were later 
confirmed in male and female rats utilizing the androgen receptor blocker 
flutamide (Thompson et al., 2013). Together, these results suggest exercise is a 
potential therapy which enhances axon regeneration of both sensory and motor 
neurons and that androgen signaling is likely involved. 
 
d. Therapeutic outcomes after PNI  
The basal lamina acts as a conduit for axon regeneration and is necessary 
for proper regeneration. In a crush injury axotomy, the basal lamina is left intact 
resulting in a quicker recovery than observed with transection. Furthermore, a 
faster recovery time after crush injury is undoubtedly due to lack of surgical 
intervention and a faster axonal regeneration rate, as described above 
(McQuarrie et al., 1977; Bittner et al., 2012). Despite an accelerated recovery 
seen with crush axotomy, problems can still arise after both crush axotomy and 
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transection. For example, injury to a mixed nerve can lead to axonal regeneration 
from the proximal stump to inappropriate distal pathways resulting in failed 
functional connections. Moreover, the presence of a nerve in the incorrect 
pathway could inhibit proper axons from entering appropriate, specific pathways. 
This conundrum has been largely investigated as a potential mechanism 
underlying poor functional recovery. In 1988, Brushart labeled sensory neurons 
and motoneurons and quantified the number of neurons that reinnervated 
sensory and motor branches of the rat femoral nerve after lesion and repair. 
Brushart further demonstrated that, when motoneurons are given equal access to 
either a motor or cutaneous pathway, they preferentially reinnervated the motor 
pathway to the quadriceps muscle (Brushart, 1988). Interestingly, this same 
outcome was apparent even if the repair was intentionally misaligned. Aberrant 
nerve regeneration of motor axons to incorrect muscle groups can lead to 
synkinesis which is a common characteristic seen in individuals with cranial 
nerve injuries (Bodénez et al., 2010). 
 
C. Rodent models of PNI 
Animal models offer a valuable therapeutic approach to investigate PNI. 
Unlike humans, rodents typically have full functional recovery from crush (Hetzler 
et al., 2008) but not transection injuries (Deumens et al., 2007). Our laboratory 
and others have explored the use of animal models of the following cranial 
nerves: optic nerve (II; Wu et al., 2014), oculomotor (III; Fernandez et al., 2003), 
trochlear (IV; Fukuoka et al., 1999), trigeminal (V; Okubo et al., 2013), abducens 
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(VI; Pásaro et al., 1985), facial (VII; Kujawa et al., 1989), vestibulocochlear (VIII; 
Shimamura et al., 2002), glossopharyngeal (IX; Geran & Travers, 2011), vagus 
(X; Halum et al., 2013; Monaco et al., 2013), and hypoglossal (XII; Murakami & 
Yoshida, 2012). Injury of the facial nerve is commonly associated with the human 
disorder Bell’s palsy, which is characterized by ipsilateral paralysis of the 
muscles of facial expression (Bodénez et al., 2010). Although the facial nerve 
has a “sensory root,” the neuronal cell bodies are anatomically separate from the 
motor root making facial nerve axotomy one of the most widely used animal 
models to study motoneuron degeneration and regeneration (Moran & Graeber, 
2004). Approximately two months following facial nerve injury, there is 
approximately a 40% motoneuron loss observed in adult mice (Serpe et al., 
2000) but virtually all motoneurons survive after axotomy in adult hamsters 
(LaVelle & LaVelle, 1984). A benefit to interspecies differences in motoneuron 
death allows one to easily study mechanisms of nerve regeneration following 
injury. Commonly utilized models of facial nerve injury include extratemporal 
transection and crush, intratemporal crush, and intracranial transection of the 
facial nerve, all of which are considered proximal nerve injury models (Mattsson 
et al., 1999; Jones et al., 2001; Sharma et al., 2009). Similar to the facial nerve, 
the recurrent laryngeal nerve is classified as a cranial nerve as it is a branch of 
the vagus nerve. The recurrent laryngeal nerve is commonly injured during 
thyroidectomy procedures, thus leading to unilateral vocal fold paralysis and a 
loss of sensation to the inferior portion of the larynx (Rosenthal et al., 2007). A 
benefit to utilizing animal models of recurrent laryngeal nerve injury is that 
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functional recovery is easily quantifiable; however, mechanism is difficult to study 
as the cell bodies of the recurrent laryngeal nerve are not easily accessible. 
In addition to using animal models of cranial nerve injuries, our laboratory 
and others have investigated animal models of spinal nerve injury, such as the 
median, ulnar, femoral, and sciatic nerves (Brown et al., 1999; Wang et al., 2008; 
Gordon et al., 2009). A benefit to utilizing animal models of spinal nerves is that 
they are characterized as mixed nerves and have both motor and sensory 
components, which is advantageous when studying preferential motor 
reinnervation and treatments that enhance specificity of axons to their 
appropriate targets. Due to its large size and accessibility in the rat, the sciatic 
nerve is an ideal spinal nerve to study PNI. Furthermore, the sciatic nerve is the 
longest nerve in the human and rodent body and can be utilized to explore 
treatment effects on proximal vs. distal injuries. Unlike cranial nerve injuries, 
there is virtually no motoneurons loss after spinal nerve injury in adult rodents 
which allows the motoneuron cell bodies to be easily studied after injury 
(Schmalbruch, 1984; Pollin et al., 1991). In addition, the timeline for functional 
recovery following sciatic nerve crush injury has been well documented (Forman 
& Berenberg, 1978; Alberghina et al., 1985; Brown et al., 1999; Lago & Navarro, 
2006); however, the functional recovery timeline after sciatic nerve transection is 
more variable (Hare et al., 1992; Ijkema‐Paassen et al., 2002; Hamilton et al., 
2011). Previously, we have reported work completed on a proximal, mid-thigh 
sciatic injury (Brown et al., 1999) and this dissertation investigates the effects of 
ES and TP on a distal-thigh sciatic injury. The strength of animal models of PNI 
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has allowed us and others to investigate treatment effects in motor vs. mixed 
nerves, cranial vs. spinal nerves, and proximal vs. distal injuries to provide insight 
on how to appropriately guide therapeutic intervention in clinical situations. 
 
D. Sciatic nerve injury and repair 
1. Clinical relevance 
Sciatica is observed in an estimated 40% of adults at some point 
throughout their lives, and is characterized as pain/weakness of the hip and 
lower extremity resulting from pathologies affecting the sciatic nerve. In this 
disorder, pain may extend from the gluteal region, down the posterior and lateral 
thigh and leg, and into the lateral aspect of the foot (Ergun & Lakadamyali, 2010). 
Individuals with sciatica may experience weakness to muscles in the posterior 
compartment of the thigh or all muscles of the leg and foot. This may result in the 
inability of patients to perform any one of the following actions: extend the thigh, 
flex the leg, plantarflex or dorsiflex the foot, flex or extend the toes, and invert or 
evert the foot. Typically, individuals with sciatica develop a distinguishing gait 
abnormality called footdrop. This is caused by a loss of motor innervation to the 
tibialis anterior muscle in the anterior leg, which leads to the inability to dorsiflex 
the foot. As a result, an individual with footdrop will alter their gait to prevent 





2. Anatomy of the human and rat sciatic nerve  
 The sciatic nerve is a major nerve of the sacral plexus and is the longest 
and largest nerve in the human and rodent body. Axons from spinal levels L4-S3 
come together to form the sciatic nerve and stay together in a common sheath 
before dividing into the tibial and common fibular divisions. These divisions 
remain together as the sciatic nerve exits the pelvis via the greater sciatic 
foramen and as it emerges at the inferior border of the piriformis muscle. The 
sciatic nerve travels down the posterior thigh deep to semitendinosus and long 
head of bicpes femoris where it supplies innervation to both of these muscles. At 
the superior border of the popliteal fossa, the sciatic nerve divides into two 
independent nerves the tibial and common fibular nerves, which innervate 
muscles of the leg and foot. The path of the tibial nerve runs vertically through 
the center of the fossa where it gives rise to the medial sural cutaneous nerve 
before continuing into the proximal leg and passing between the medial and 
lateral heads of the gastrocnemius muscle. In contrast, the common fibular nerve 
gives off a lateral sural cutaneous branch in the popliteal fossa region before 
passing superficial to the lateral head of the gastrocnemius muscle. The route of 
the common fibular nerve continues laterally around the neck of the fibula toward 
the lateral compartment followed by the anterior compartment of the leg. It 
passes through the fibularis longus muscle and further divides into the superifical 
and deep fibular nerves. The superficial fibular nerve supplies innervation to the 
lateral compartment leg muscles, while the deep fibular nerve supplies 
innervation to the anterior compartment leg muscles, including tibialis anterior 
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muscle, and muscles of the anterior foot. The medial and lateral sural cutaneous 
nerves join in the posterior leg to form the sural nerve and provide cutaneous 
innervation to the lateral foot (Kim et al., 2004; Ergun & Lakadamyali, 2010; 
Brushart, 2011). 
 
3. Etiology of sciatic nerve damage 
Despite an elaborate protective sheath, trauma, disease, and 
complications during surgery can lead to injury of the sciatic nerve. In a 
retrospective study completed by Kim and colleagues, injections were the leading 
cause of sciatic nerve injuries at the level of the buttocks, and gunshot wounds 
constituted roughly a third of all sciatic injuries reported at the level of the thigh 
(Kim et al., 2004). Other reported methods of injury include, but are not limited to: 
fracture or dislocation of the femur, hip arthroplasty, iatrogenic, laceration, 
compression, stretch injury, tumors of the sciatic nerve, piriformis syndrome, and 
pregnancy (Kline et al., 1998; Kim et al., 2004; Ergun & Lakadamyali, 2010). 
Clinical evaluation through neurological examination is the first step in 
determining the severity of sciatic nerve injury. Loss of motor and sensory 
function is quantified using electrophysiological methods, such as compound 
muscle action potentials, nerve conduction velocities, electromyography, and 
sensory nerve action potentials (Masakado et al., 2008; Derr et al., 2009). 
Additionally, radiological assessment with CT scans and MRI can be used to 
determine underlying traumatic injuries. 
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E. Combinatorial approaches 
For researchers to successfully improve functional recovery after PNI a 
combinatorial approach should be considered because it has the ability to target 
and activate multiple pathways and mechanisms. PEG has demonstrated 
promise alone and in conjunction with the antioxidants melatonin and methylene 
blue in vitro and in vivo (Stavisky et al., 2005; Britt et al., 2010; Spaeth et al., 
2012). Bittner et al. also have reported positive motor recovery with microsuture, 
hypotonic Ca2+, methylene blue, and PEG following complete transection of the 
sciatic nerve near that of sham controls (Bittner et al., 2012). In contrast, a more 
recent study suggested seeding Schwann cells that overexpress GDNF into an 
allograft, but failed to promote regeneration into the distal stump thus preventing 
functional regeneration (Santosa et al., 2013). 
Promising results have been observed utilizing the combinatorial 
treatment of ES and exercise following axotomy. Asensio-Pinilla and colleagues 
demonstrated a 1 hour, 20 Hz ES paradigm and treadmill running for 4 weeks 
significantly improved muscle reinnervation following sciatic nerve transection 
with repair compared to either treatment alone (Asensio-Pinilla et al., 2009). A 
more recent study suggested ES enhanced motor and sensory reinnervation, 
whereas the combination of ES and treadmill training decreased nociceptive 
responses to mechanical and thermal stimuli (Cobianchi et al., 2013). Taken 




As previously mentioned, ES and TP target different stages of the 
regeneration process: delay time before sprout formation occurs and 
regeneration rate, respectively (Kujawa et al., 1993; Sharma et al., 2009). The 
ability of these two treatments to target different aspects of the regeneration 
process and enhance functional recovery provides a logical rationale for 
combinatorial treatment application following PNI. In support of a combinatorial 
approach, Sharma and colleagues demonstrated that ES and TP together acted 
synergistically to accelerate recovery of the vibrissae movement in rats after a 
facial nerve crush injury (Sharma et al., 2010b), which supported an earlier study 
(Hetzler et al., 2008). Interestingly, the presence of the steroid prednisone, which 
is an anti-inflammatory utilized to decrease edema associated with nerve injury, 
had no additional benefit. Also, we have determined that ES and TP treatment 
after a facial nerve injury increases neuritin, pacap, and bdnf mRNA expression 
in rat in an additive manner (Sharma et al., 2010a). In contrast, the combination 
of ES and TP had no additional benefit in functional recovery than either ES or 
TP alone after injury to the recurrent laryngeal nerve (Monaco et al., 2013). This 
is likely due to the fact that the recurrent laryngeal nerve injury was a more distal 
injury when compared to the facial nerve injury model used in these studies. It 
remains to be determined whether these same effects occur after a spinal nerve 
injury, such as a sciatic nerve injury, and if ES and TP will have differential 
effects on proximal vs. distal sciatic nerve injuries. 
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*This literature review was modified from a forthcoming book chapter in the 
3rd edition of Sunderland's Nerves and Nerve Injuries: Chapter 81: Cellular 
Aspects of Nerve Injury and Regeneration published by Elsevier*  
Meadows RM, Sengelaub DR, and Jones KJ. Cellular Aspects of Nerve Injury 






CHAPTER 3: MATERIALS AND METHODS 
 
A. Animals and sciatic nerve injury paradigm  
All surgical procedures were reviewed and approved by the Indiana 
University School of Medicine Institutional Animal Care and Use Committee and 
were conducted in accordance with National Institute of Health guidelines. Adult 
male Wistar rats (175-199 g) were purchased from Harlan (Indianapolis, IN) and 
used for all experiments. All animals were maintained with a 12/12 h light/dark 
cycle with standard feed and water ad libitum. No animals displayed a ≥15% 
weight loss throughout the study. 7 animals were removed from the study due to 
autonomy. For behavioral tests, uninjured animals were used as baseline 
throughout the training and testing period. A total of 178 (Aim 1 – 145; Aim 2 – 
33) male Wistar rats were used in this study. 
Surgeries were completed in a sterile, aseptic environment. Rats were 
anesthetized with 3% isoflurane gas with 1.5 L/min oxygen. Surgical site was 
shaven and cleaned. An incision approximately 2 cm in length was made on the 
dorsal surface of the hip and the skin was retracted to expose the underlying 
musculature. Using blunt dissection, the heads of biceps femoris were separated 
to expose the sciatic nerve. The right sciatic nerve was crushed approximately 2 
mm proximal to its trifurcation with Dumont forceps (#3). Two successive 30-
second crushes from alternating directions were completed while leaving the 
epineurium intact. Visible loss of motor function in the right hind foot and loss of 
electrical muscle activity were used as confirmation to ensure a successful crush. 
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After injury (Ax), rats were divided into four experimental groups: 1) No treatment 
(Ax only), animals receiving axotomy, with implantation of blank capsules not 
containing testosterone propionate (TP), 2) Electrical Stimulation (Ax + ES), 
animals receiving axotomy and ES treatment, 3) Ax + TP, animals receiving 
axotomy and TP treatment, 4) Ax + ES + TP, animals receiving axotomy and ES 
and TP treatments. Animals receiving both ES and TP treatments, ES was 
administered followed by delivery of TP. After injury and treatment, the heads of 
biceps femoris were sutured together and the overlying skin closed with wound 
clips as well as coated with triple antibiotic ointment. Immediately after surgery, 
0.025 mg/kg of buprenorphine was administered. Wound clips were removed 7-
10 days post-axotomy. 
 
B. Thin film disk receiver implant 
Immediately prior to the sciatic nerve crush injury, a sterilized, thin disk 
receiver (RedRock Laboratories, St. Louis, MI) was implanted subcutaneously on 
the posterior surface of the rat. The circular receiver device was less than the 
size of a penny (3 mm x 18 mm) and was covered with a silastic coating to make 
it flexible and soft.  The receiver was attached to a silastic cuff (2 mm I.D., 8 mm 
length) by two, thin, aluminum chloride or platinum insulated multi-conductor 
wires (4-5 in).  The cuff was gently wrapped around the sciatic nerve, proximal to 
the injury site, and sutured shut.  The implant was used to elicit ES (see below) 
immediately after injury and to stimulate the nerve for electromyography (EMG) 
recordings. The device was remained in the animal for the length of the study.  
57 
 
C. Electrical stimulation (ES) 
 The Automated Functional Assessment Station (FASt; Red Rock 
Laboratories, St. Louis, MO, USA) was used to deliver ES to all animals receiving 
ES treatment. ES was delivered through either wire hooks or a nerve cuff. For 
animals that did not undergo behavioral tests, two aluminum chloride or platinum 
coated wires were bent into hooks and placed around the sciatic nerve just 
proximal to the injury site. The anode and cathode connector pins were attached 
to the leads of a continuous ES box (Red Rock Laboratories, St. Louis, MO, 
USA). For animals that underwent behavior analysis, a silastic cuff housing 
aluminum chloride or platinum electrodes was inserted around the nerve. The 
wires were connected to a subcutaneously implanted disk receiver. A wireless 
transducer with 10 settings, 1-10, was placed above the disk and turned to a pre-
determined setting known to elicit a right hind twitch. The transducer was 
connected to a continuous ES box. Immediately after axotomy, the continuous 
ES box was turned on and rats were stimulated at 20 Hz (200 µsec pulses, 1000 
µA amplitude) for a continuous 30 minutes. 
 
D. Hormone administration 
 TP was administered through subcutaneous capsule implants. The 
capsules were made out of silastic tubing (0.062 in. (1.57 mm) I.D. by 0.095 in 
(2.41 mm) O.D.) and were 16 mm in total length, 10 mm of which contained 
100% crystalline TP (Sigma-Aldrich, St. Louis, MO, USA). Wooden plugs sealed 
both ends of the capsule. As a control, animals receiving axotomy, but no 
58 
 
treatment were implanted with blank capsules. Capsules were equilibrated in 
physiological saline for 30-60 minutes prior to implantation. Immediately following 
injury or ES, a subcutaneous pocket was formed by making an incision on the 
dorsal surface of the animal between the scapulae. Two TP capsules were 
implanted in the pocket and the wound site was closed with wound clips. Wound 
clips were removed 7-10 days post-axotomy. Capsules were left in the animal for 
the length of the study.  
 
E. Molecular techniques  
1. Enzyme immunoassay 
Serum was separated from whole blood by spinning whole blood samples 
at 4°C for 15 minutes at 1000 x g. Serum samples were diluted with enzyme 
immunoassay (EIA) buffer and ran in triplicate. An EIA kit was utilized to confirm 
testosterone levels from rats according to the manufacturer’s instructions 
(Cayman Chemical, Ann Arbor, MI, USA).  
 
2. Quantitative real time PCR (qRT-PCR) 
Rats were euthanized with an intraperitoneal injection of ketamine (100 
mg/kg) and xylazine (10 mg/kg) followed by bilateral pneumothorax at 6 hours, 1, 
2, 7, and 21 days post-axotomy. The lumbar region of the spinal column was 
removed and the ends of the column were cleaned of bone debris. A 10 mL 
syringe containing ice-cold saline solution fitted with a blunt-ended needle (16 G) 
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was used to eject the spinal cord, from the caudal end, into a 100 mm size petri 
dish containing ice-cold saline solution. The spinal cord was placed ventral side 
up on a petri dish on top of dry ice and trimmed with a razor blade to isolate a   
1 cm section of the lumbar enlargement. The ventral and dorsal horns of the 
spinal cord were isolated by making a sagittal cut down the central sulcus, 
turning the two tissue pieces until the flat portion was facing up, and making a 
final sagittal cut to separate the ventral horns, lateral side of tissue half, from the 
dorsal horns, medial side of tissue half (Fig. 3). All four quadrants were kept at -
80⁰C. To use as a control, non-lumbar spinal cord was removed and kept at -
80⁰C. 
Spinal cord tissue was homogenized with Lysing Matrix D (MP 
Biochemical, Santa Ana, CA, USA) and lysis buffer (PureLink® RNA Mini Kit 
Cat# 12183025; Ambion, Carlsbad, CA, USA) containing 1% 2-mercaptoethanol 
(Gibco, Carlsbad, CA, USA) using a fast prep 24 homogoenizer (MP 
Biochemical). RNA was extracted from the homogenized tissue sample with 30 
µL of RNase-Free Water according to the manufactures instructions, with the 
exception of incubating the column for 10 minutes instead of 1 minute during the 
extraction step with RNase-Free Water (PureLink® RNA Mini Kit). DNA was 
removed from the RNA samples using the PureLink® DNase Set according to 
the manufactures instructions (Cat# 12185010; Invitrogen, Carlsbad, CA). 100 ng 
of RNA was converted to cDNA using SuperScript® VILO™ Master Mix 
according to manufactures instructions (Cat# 11755250; Invitrogen). Rat-specific 







Fig. 3: Image depicting the quadrant sectioning process of the lumbar 
portion of the spinal cord. 





Biosystems, Carlsbad, CA, USA; Table 1 and Table 2). qRT-PCR was carried 
out in triplicate using Taqman® Gene Expression Master Mix (Applied 
Biosystems). The cycling parameters were as follows: UDG optimization at 50°C  
for 2 minutes, AmpliTaq Gold activation at 95°C for 10 minutes, followed by 40 
cycles at 95°C for 15 seconds and combined annealing/extension at 60°C for 1 
minute. geNorm software was used to determine the most optimal reference 
genes for this study out of 8 candidate housekeeping genes (Table 1) (Bangaru 
et al., 2012). Relative mRNA expression levels acquired from PCR amplification 
were analyzed using the ΔCt method, as previously published by our laboratory 
(Haulcomb et al., 2014), against two housekeeping genes glyceraldehyde 3-
phosphate dehydrogenase (gapdh) and hypoxanthine phosphoribosyl 
transferase 1 (hprt1), which were determined using geNorm software (Bangaru et 
al., 2012). ΔCt is the difference between the threshold cycle level for the gene of 
interest and the threshold cycle for the housekeeping gene within each sample, 
which is calculated for the control and axotomized sides separately. The 
geometric Ct mean of both gapdh and hprt1 was used as the threshold cycle for 
the housekeeping gene. Relative mRNA expression is expressed as the relative 
quantity mRNA of either the injured or uninjured ventral horn of the lumbar spinal 
cord by 2−ΔCt ± the standard error of the mean (SEM). The average percent 
change mRNA expression was calculated using the the ΔΔCt method, as 
previously published by our laboratory (Fargo et al., 2008; Mesnard et al., 2010) 
against gapdh and hprt1. The ΔΔCt value was obtained by calculating the 














glucuronidase, beta gusb Rn00566655_m1 NM_017015.2 
glyceraldehyde-3-phosphate 
dehydrogenase 
gapdh Rn01775763_g1 NM_017008.3 
hypoxanthine 
phosphoribosyltransferase 1 
hprt1 Rn01527840_m1 NM_012583.2 
beta-2 microglobulin b2mg Rn00560865_m1 NM_012512.2 
polymerase (RNA) II (DNA directed) 
polypeptide A 
polr2a Rn01752026_m1 XM_002727723.1 
succinate dehydrogenase complex, 
subunit A, flavoprotein (Fp) 
sdha Rn00590475_m1 NM_130428.1 
ornithine decarboxylase antizyme 1 oazi Rn01408148_g1 NM_139081.1 
tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation 
 protein, zeta 
ywhaz Rn00755072_m1 NM_013011.3 
 


















αI–tubulin atat1 Rn00821045_g1 NM_022298.1 
βII-tubulin tubb2b Rn01435337_g1 NM_001013886.2 
Growth cone guidance 
43-kiloDalton growth-associated 
protein 
gap43 Rn01474579_m1 NM_017195.3 
collapsin response mediator protein 2 dpysl2 Rn01534654_m1 NM_001105717.2 
Growth factors and neurotrophic 
brain derived neurotrophic factor bdnf Rn02531967_s1 NM_012513.3 
glial cell derived neurotrophic factor gdnf Rn00569510_m1 NM_019139.1 
pituitary adenylate cyclase-activating 
peptide 
adcyap1 Rn00566438_m1 NM_016989.2 
Plasticity 
neuritin nrn1 Rn00584304_m1 NM_053346.1 
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expressed as the average percent change in mRNA expression, by (2−ΔΔCt − 1) × 
100, of the axotomized samples relative to the control samples ± SEM. Ct values 
of 39 or higher were excluded from analysis. Outliers were determined and  
removed utilizing Grubbs’ Test (Graph Pad, La Jolla, CA, USA). Primer 
efficiencies are noted in Table 3.      
 
F. Behavioral tests 
1. Automatic foot misplacement apparatus 
 The automatic foot misplacement apparatus consisted of a corridor with 
an arrival box at one end (Bioseb, Vitrolles cedex, France). The corridor was a 
flat ladder, with alternating rungs removed, on which the rat could move freely 
from one end toward the arrival box. Rats were trained to traverse the walkway 
five times per week for two consecutive weeks prior to injury. During the testing 
period, rats traversed the walkway up to three times per session until a run 
without rearing and minimal stopping was achieved. Baseline data was acquired 
7, 5, and 3 days before injury. Sciatic nerve crush injury always occurred on the 
first day of the week. Following injury, rats were tested at 2 and 4 days post-
axotomy or day 3 and 5 of the week, respectively. Testing continued in 
succession on day 1, 3, and 5 for each of the following 8 consecutive weeks. 
Data from the runs was gathered using the provided Locotronic software and is 







Gene Name Primer Efficiency 
αI–tubulin 1.935 
βII-tubulin 2.0065 
43-kiloDalton growth-associated protein 2.081 
collapsin response mediator protein 2 2.053 
brain derived neurotrophic factor 2.393 
glial cell derived neurotrophic factor 2.962 
pituitary adenylate cyclase-activating peptide 1.942 
neuritin 2.031 
glyceraldehyde-3-phosphate dehydrogenase 1.9695 
hypoxanthine phosphoribosyltransferase 1 1.979 
 




to altering the software settings, 6 rats did not start the test until 21 days post-
axotomy.   
 
2. Grip strength  
 Hind limb strength was measured using a grip strength test with a rod and 
bar apparatus attached to a senor. To complete the bar task, rats were held by 
their torso and allowed to grab the bar with their hind legs. After successful 
contact of both hind paws with the bar, the rat was gently pulled in a horizontal 
direction by the base of their tail until they released the bar. After each pull, the 
sensor was reset and the rat was allowed to grip the bar. This process was 
repeated five consecutive times and the results were recorded. The grid test was 
used as a second grip strength measure. Similar to the bar, animals were 
allowed to grab the grid with their hind paws. Once the rat successfully made 
contact with the grid with both hind paws, the rat was gently pulled by the tail in a 
parallel direction with the surface of the grid. After each grasp, the sensor was 
reset and five consecutive trials were recorded. Animals were tested on the first 
day of each week for 8 consecutive weeks. Baseline data was recorded exactly 
one week prior to injury and the morning of surgery day. Results for both the bar 
and grid were expressed as an average of the five trials and as the maximum 
grip strength within the five trials for each animal. Each group contained an n of 




3. CatWalk XT© apparatus 
 The CatWalk apparatus (Noldus Information Technology, Wageningen, 
The Netherlands) consists of an enclosed walkway (8 cm wide) on a glass plate, 
on which the rat could move freely from one end to the other. We made the 
following modifications to the existing apparatus: on the departure end of the 
apparatus, was a plexiglass ledge while at the arrival end was a cage in which 
the rat could enter after completing a run. Since the glass plate was larger than 
the enclosed walkway, the rat could leave the arrival cage and traverse the glass 
plate in the opposite direction to the departure plexiglass ledge. One passage 
from departure ledge down the runway back to the departure ledge will be 
referred to as 1 run.  
All data acquisition was completed in a dark and silent room. The following 
parameters were used during data acquisition: length of the runway was 
approximately 90 cm, camera gain was 19.02, and intensity threshold was 0.1. 
No food restrictions took place during the study. The behavioral training 
consisted of placing the animals in the arrival cage and coaxing them to loop in a 
unidirectional manner. Fruit Loops or Apple Jacks were placed along the path in 
order to encourage the animal to loop. Training occurred on days 1-5 for two 
consecutive weeks prior to injury at which time 5-20 runs were acquired per 
training session. Baseline data (10-20 runs per training session) was acquired 7, 
5, and 3 days prior to injury. During data acquisition, if the rats stopped or 
displayed uneven speed they were encouraged to move as previously published 
(Batka et al., 2014). The glass runway was cleaned with Sparkle™ glass cleaner 
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after the completion of all runs for a particular animal, or as needed to remove 
debris.   
Following sciatic nerve crush injury, rats were tested on a similar schedule to 
that described in the automatic foot misplacement apparatus section. Testing 
lasted for 8 consecutive weeks starting at 2 days post-axotomy and 10 runs were 
acquired during each testing session. Runs in which the animal displayed 
behavioral anomalies (i.e. constant sniffing, turning, rearing) in the middle of the 
run were wholly-discarded. Within runs chosen to be classified, partial footprints 
and rearing as entering or exiting the runway were not classified. Of the classified 
runs, only runs which met the following criteria set in the data acquisition profile 
were exported: 10 minimum consecutive steps per run, average speed range 
from 1.0-150.0 cm/second, maximum allowed speed variation of 55%, and fully 
classified runs. Of the exported runs, only runs with an ‘other statistics maximum 
variation’ of ≤ 60% were analyzed. All exported run statistics were combined for 
each animal to create trial statistics; trial statistics were analyzed and compared 
across groups at various time points. 
The following trial statistics have been shown to change following injury and 
were thus chosen for analysis: print length, print width, print area, swing, swing 
speed, stride length, step cycle, duty cycle, max contact max intensity, sciatic 
functional index (SFI), peroneal functional index (PFI), posterior tibial functional 
index (TFI), base of support (BOS), regularity index, and cadence (Bain et al., 
1989; Hamers et al., 2001; Vrinten & Hamers, 2003; Koopmans et al., 2005; 
Hendriks et al., 2006; Deumens et al., 2007; Bozkurt et al., 2008). Formulas for 
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SFI, TFI, and PFI can be found in Fig. 4. For explanations of each parameter, 
see Table 4. Each group contained an n of 4-6.  
 
3. Electromyography (EMG) recordings 
 All rats were anesthetized with isofluorane and the FASt (Red Rock 
Laboratories) was used for all EMG measurements. Before injury, baseline EMG 
values were determined, whereas functional recovery was monitored by taking 
recordings on day 1 and 5 of each week beginning immediately after injury for 8 
consecutive weeks. Cathodic, monophasic electrical impulses (5000 μA, 0 
second delay, 0.3 second burst width, 200 μs pulse duration, and 0 Hz) were 
generated using a single-channel isolated pulse stimulator (Model 2100, A-M 
Systems Inc., Carlsborg, WA, USA) and delivered to the sciatic nerve proximal to 
injury via a silastic cuff. Stimulation of the nerve occurred wirelessly by placing 
the transducer just above the subcutaneous disk implant. A total of 9 trials 
(settings 1-9 on the transducer) with an inter-trial delay of 10 seconds were 
acquired for each animal. Stimulus amplitude ranged from 5001-5009, which was 
equivalent to a voltage output of 0.408-8.16 V from the transducer. Recordings 
were taken from tibialis anterior and lateral head of gastrocnemius muscles by 
placing 30 G needles into the belly of each muscle. Anode and cathode 
connector pins were attached to the needle probes, while a ground connector pin 
was attached to a 25 G needle placed subcutaneously on the back of the animal. 
Measurements were achieved using custom data acquisition software  (RRL 
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Fig. 4: Formulas to calculate rat sciatic functional index (SFI), posterior 
tibial functional index (TFI), and peroneal functional index (PFI). 
PL is Manual Print Length, TS is Toe Spread, ITS is Intermediate Toe Spread, 
and the subscripts E and N indicate the Experimental and Normal contralateral 






CatWalk Parameter Definition 
Paw-related parameters 
Print length length (horizontal direction) of the complete print 
Print width the width (vertical direction) of the complete print 
Print area surface area of the complete print 
Swing 
duration in seconds of no contact of a paw with 
the glass plate 
Swing speed speed (cm/s) of the paw during Swing 
Stride length 
distance (cm) between successive placements of 
the same paw 
Step cycle 
time in seconds between two consecutive initial 
contacts of the same paw [Stand + Swing] 
Duty cycle expresses Stand as a percentage of Step Cycle 
Duty cycle = (Stand)/[(Stand) + (Swing)] * 100 
Max contact max intensity maximum intensity at max contact of a paw 
Non paw-related parameters 
Sciatic functional index  
(SFI) 
measure for the functional recovery of the sciatic 
nerve which innervates the hind paws 
Peroneal functional index 
(PFI) 
measure for the functional recovery of the 
peroneal nerve which innervates the hind paws 
Posterial tibial functional 
index (TFI) 
measure for the functional recovery of the tibial 
nerve which is a branch of the sciatic nerve 
Base of support (BOS) 
front paws 
average width between the front paws  
BOS hind paws average width between the hind paws 
Regularity Index 
expresses the number of normal step sequence 
patterns and total paw placements 
Cadence expressed in steps per second  
 




software (The Mathworks Inc., Natick, MA, USA) and is expressed as the EMG 
amplitude (mV) ± SEM. 3 animals were removed from EMG analysis due to 
malfunctioning wireless electrodes. Each group contained an n of 4-6 animals.   
 
G. Histological and histochemical processing 
Eight weeks or 56 days post-axotomy after injury, animals were 
anesthetized with isofluorane, and the right anterior tibialis muscle was exposed 
and injected with horseradish peroxidase conjugated to the cholera toxin B 
subunit (BHRP; 0.5 µl, 0.2%; List Biological, Inc.). BHRP labeling permits 
population-level quantitative analysis of motoneuron somal and dendritic 
morphologies (Kurz et al., 1986; Goldstein & Sengelaub, 1990). Forty-eight hours 
after BHRP injection, a period that ensures optimal labeling of motoneurons 
(Kurz et al., 1986; Goldstein & Sengelaub, 1990), animals were weighed, 
anesthetized with Ketamine/Xylazine (i.p.), and perfused intracardially with saline 
followed by cold fixative (4% paraformaldehyde). Tibialis Anterior and lateral 
head of gastrocnemius muscles were extracted and weighed. 
 
1. Motoneuron number and morphology   
The tibialis anterior muscle is innervated by motoneurons located in 
column 4 of the lateral motor column in the L3 spinal segment (Nicolopoulos‐
Stournaras & Iles, 1983). Following perfusion, the lumbar portion of the spinal 
cord of each animal was removed, postfixed 5 hours in 1% paraformaldehyde/ 
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1.25% glutaraldehyde, and then transferred to sucrose phosphate buffer (10% 
w/v, pH 7.4) overnight for cryoprotection. Spinal cords were then embedded in 
gelatin, frozen, and sectioned transversely at 40 µm; all sections were collected 
into four alternate series. One series was stained with thionin for use in cell 
counts. For visualization of BHRP, the three remaining series were immediately 
reacted using a modified tetramethylbenzidine protocol (Mesulam, 1982), 
mounted on gelatin-coated slides, and counterstained with thionin. 
 
2. Motoneuron counts  
To assess potential motoneuron loss after nerve crush, counts of 
motoneurons in the tibialis motor pool were performed. Motoneurons innervating 
the tibialis anterior muscles do not form a discrete nucleus, but instead are 
contained within the large continuous populations of motoneurons located within 
the lateral motor column. Thus, to identify the appropriate area within the lateral 
motor column for motoneuron counts in the unreacted series, we used a method 
similar to that of Little et al. (2009). Briefly, for each animal the range of sections 
in which motoneurons labeled with BHRP after injection into the tibialis anterior 
muscle were present in the reacted series was identified, and then motoneuron 
counts were performed in the appropriate matching sections in the unreacted 
series. For each animal, estimates of the total number of motoneurons in the left 
and right lateral motor columns were obtained using the optical disector method 
as previously described (Little et al., 2009). Counts were made using a video-
based morphometry system (Stereo Investigator; MBF Bioscience, Williston, VT, 
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USA) at 937.5X under brightfield illumination. Motoneurons are easily 
recognizable as large, darkly staining, multipolar cells. A counting frame (110 µm 
X 80 µm) was moved systematically throughout an area of each ventral horn 
(approximately 300 µm X 300 µm, defined by the actual distribution of BHRP-
labeled somata from all of the animals used in the study) in each section within 
the identified range. Only motoneurons in which there was a clear nucleus and 
nucleolus were counted, provided they did not contact the forbidden lines of the 
counting frame; motoneuron nucleoli were counted as they appeared while 
focusing through the z axis, and nucleoli in the first focal plane (i.e., "tops") were 
excluded to avoid double counting. The length of the dissector was 
approximately 16 µm, which was adequate for visualizing nucleoli in multiple 
focal planes. Motoneuron counts were derived from a mean of 15.0 sections 
spaced 480 µm apart and distributed uniformly through the entire rostrocaudal 
extent of the tibialis motoneuron pool range. This sampling scheme produced 
average estimated coefficients of error (CE) of 0.051 for normal animals and 
0.046 for crush animals. Cell counts for each animal were corrected for the 
proportion of sections sampled and reported as per side and as a ratio [(right 
side/left side) X 100]. 
Using similar methods, the number of BHRP-labeled motoneurons was 
assessed in all sections of the reacted series through the entire rostrocaudal 
extent of their distribution for all animals. Counts of labeled tibialis motoneurons 
were made under brightfield illumination, where somata could be visualized and 
cytoplasmic inclusion of BHRP reaction product confirmed. 
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3. Soma volume  
To assess potential changes in motoneuron morphology after nerve crush, 
soma volumes were measured. The volume of tibialis motoneuron somata was 
assessed in at least one set of alternate sections (160 µm apart) using the 
Nucleator method (Gundersen, 1988). A set of 4 rays emanating from a point 
randomly chosen within each BHRP-labeled motoneuron soma was drawn and 
oriented randomly. Soma volumes of an average of 27.3 motoneurons were 
measured for each animal using Stereo Investigator at a final magnification of 
780X. Average estimated coefficients of error (CEs) were 0.022 for normal 
animals and 0.028 for crush animals. Soma volumes within each animal were 
then averaged for statistical analysis. 
 
4. Dendritic length   
To assess potential changes in motoneuron morphology after nerve crush, 
dendritic lengths and distributions were measured. For each animal, dendritic 
lengths in a single representative set of alternate sections were measured under 
darkfield illumination. Beginning with the first section in which BHRP-labeled 
fibers were present, labeling through the entire rostrocaudal extent of the tibialis 
motoneuron dendritic field was assessed in every third section (480 µm apart) in 
three dimensions using a computer-based morphometry system (Neurolucida; 
MBF Bioscience, Williston, VT, USA) at a final magnification of 250X. No attempt 
was made to identify BHRP-labeled fibers as either dendrites or axons. Average 
dendritic length per labeled motoneuron was estimated by summing the 
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measured dendritic lengths of the series of sections, multiplying by three to 
correct for sampling, then dividing by the total number of labeled motoneurons in 
that series. This method does not attempt to assess the actual total dendritic 
length of labeled motoneurons (Kurz et al., 1991), but has been shown to be a 
sensitive and reliable indicator of changes in dendritic morphology in normal 
development (Goldstein & Sengelaub, 1990; Goldstein et al., 1993; Goldstein & 
Sengelaub, 1994), after changes in dendritic interactions (Goldstein et al., 1993), 
afferent input (Kalb, 1994; Hebbeler et al., 2002; Hebbeler & Sengelaub, 2003), 
and after injury (Little et al., 2009; Byers et al., 2012). 
 
5. Dendritic distribution 
To assess potential redistributions of dendrites across treatment groups, 
for each animal the composite dendritic arbor created in the length analysis was 
divided using a set of axes oriented radially around the center of the collective 
labeled somata. These axes divided the spinal cord into twelve bins of 30° each. 
The portion of each animal’s dendritic arbor per labeled motoneuron contained 
within each location was then determined. This method provides a sensitive 
measure of dendritic redistribution in response to changes in dendritic 
interactions (Goldstein et al., 1993), afferent input (Hebbeler et al., 2002; 





6. Dendritic extent   
The comparability of BHRP labeling across groups was assessed by 
quantifying both the rostrocaudal and the radial extent of tibialis motoneuron 
dendritic arbors. The rostrocaudal extent of the dendritic arbor was determined 
by recording the rostrocaudal distance spanned by tibialis motoneuron dendrites 
for each animal. The maximal radial extent of the arbor in the transverse plane 
was also measured for each animal, using the same radial axes and resultant 
30° bins used for the dendritic distribution analysis. For each bin, the linear 
distance between the center of the tibialis motor pool and the most distal BHRP-
filled process was measured. Radial dendritic extent is independent of overall 
dendritic length and reflects the maximal linear distance (in the transverse plane) 
of BHRP transport to the most distal dendritic processes. 
 
H. Statistical analysis 
All data were expressed as mean ± SEM. For molecular and behavioral 
analyses, all data were analyzed by t-tests or analyses of variance (one way, two 
way, or repeated measures as appropriate) followed by post hoc analyses using 
either Student-Newman-Keuls or Holm-Šidák with significance at P ≤ 0.05 
(SigmaPlot, version 12.3). 
For behavioral tests, animals were subjected to the tests in a randomized 
order. All statistical tests for the CatWalk behavioral test were performed at a 
two-sided 5% significant level using SAS, version 9.3 (SAS Institute, Cary, North 
Carolina, USA). Statistical significance was evaluated using linear mixed effects 
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models including an interaction term for time as a qualitative variable and 
treatment group. Each model included random intercepts and slopes for speed 
and weight for each animal. Post hoc pairwise multiple comparisons were 
performed within time points using the Holm-Šidák method when group 
differences were detected.  
For histological analyses, all data were analyzed by t-tests or analyses of 
variance (one way, two way, or repeated measures as appropriate) followed by 
post hoc analyses using Fisher’s least significant difference (LSD). 
 
I. Figure preparation 
Digital light micrographs were obtained using an MDS 290 digital camera 
system (Eastman Kodak Company, Rochester, NY, USA).  Brightness and 
contrast of these images were adjusted in Adobe Photoshop (Adobe Systems, 




CHAPTER 4: RESULTS 
 
A. Validation experiments 
1. Verification of sciatic nerve crush axotomy 
 We validated our model of sciatic nerve crush axotomy by measuring 
electromyography (EMG) activity of two muscles that are innervated by branches 
of the sciatic nerve — tibialis anterior (TA) and lateral head of gastrocnemius 
(LG). The EMG amplitudes of both the TA and LG muscles (22.89 ± 1.76 mV and 
18.21 ± 1.90 mV, respectively) were significantly reduced in the rats following 
axotomy (0.80 ± 0.13 mV and 0.98 ± 0.18 mV, respectively; P < 0.001; Fig. 5). 
Thus, we achieved successful crush axotomy of the sciatic nerve.   
 
2. Serum testosterone propionate (TP) levels are supraphysiological by 6 
hours post-axotomy 
We have reported previously in hamster and rat that testosterone 
propionate (TP) capsule implants significantly elevate serum levels of 
testosterone (Kujawa et al., 1989; Kinderman & Jones, 1993; Brown et al., 2001; 
Tanzer & Jones, 2004; Hetzler et al., 2008). Serum samples were obtained and 
tested for the presence of systemic TP at 6 hours, 1, 2, 7, and 21 days post-
axotomy to confirm TP diffused out of the Silastic capsules into the blood where it 
could exert its effects. Statistical analysis revealed an overall main effect 







Fig. 5: Validation of sciatic nerve crush axotomy. 
Data is represented as EMG amplitude (mV) ± SEM. A Student’s t-test was 
utilized for statistical analysis to compare EMG amplitude before axotomy (Ax) to 
after Ax for both tibialis anterior (TA) and lateral head of gastrocnemius (LG) 
muscles. * represents a significant difference between before Ax relative to after 




0.001) as well as an interaction between treatment x time (F12,69 = 6.60; P < 
0.001; Fig. 6). At 6 hours post-axotomy, systemic administration of TP in both the 
TP only (Ax + TP; 31.6 ± 3.8 ng/mL) and the combined treatment (Ax + ES + TP; 
21.8 ± 3.7 ng/mL) groups were significantly increased compared to injury alone 
(Ax only; 2.5 ± 1.8 ng/mL; P< 0.001) and electrical stimulation (ES) treatment 
(1.3 ± 0.8 ng/mL; P < 0.001).  TP-treated animals (15.6 ± 3.1 ng/mL) and animals 
treated with ES plus TP (17.1 ± 2.8 ng/mL) had significantly elevated levels of 
testosterone at 1 day post-axotomy compared to both injury alone (2.1 ± 0.7 
ng/mL; P < 0.001) and ES only animals (2.4 ± 0.8 ng/mL; P < 0.001). At 2 days 
post-axotomy, TP-treated animals (10.6 ± 1.4 ng/mL) and ES plus TP-treated 
animals (15.1 ± 1.7 ng/mL) had significantly elevated levels of testosterone 
relative to both injury alone (1.0 ± 0.3 ng/mL; P = 0.006 and P < 0.001, 
respectively) and ES-treated animals (1.3 ± 0.04 ng/mL; P = 0.007 and P < 
0.001, respectively). By 7 days post-axotomy, administration of TP alone was 
significantly higher than ES-treated animals (11.2 ± 0.7 ng/mL and 2.5 ± 0.7 
ng/mL, respectively; P = 0.026), but there was no significant increase relative to 
injury alone (3.7 ± 0.9 ng/mL) or the combined treatment (7.3 ± 2.7 ng/mL). At 21 
days post-axotomy, TP-treated animals (7.9 ± 1.0 ng/mL) had a significantly 
enhanced serum level of TP compared to injury alone (2.3 ± 0.4 ng/mL; P = 0.05) 
and ES only (2.7 ± 0.6 ng/mL; P = 0.031); however, the combined treatment (8.0 






Fig. 6: Serum TP levels post-axotomy. 
Shown is a time-course of the serum testosterone level at 6 hours, 1, 2, 7, and 
21 days post-axotomy (Ax). Control animals, which were axotomized but left 
untreated, and animals receiving Ax + ES are compared to animals receiving Ax 
+ TP and Ax + ES + TP. Data is represented as serum testosterone 
concentration (ng/mL) ± SEM. A two-way ANOVA (treatment x time) with a 
Student-Newman-Keuls multiple comparison post hoc test was utilized for 
statistical analysis among all experimental groups. * represents a significant 
difference between Ax + TP or Ax + ES + TP compared to Ax only, at P < 0.05.  
# represents a significant difference between Ax + TP or Ax + ES + TP relative to 




3. Expression of βII-tubulin mRNA increases with axotomy  
We have demonstrated previously that axotomy alone significantly 
increased the mRNA expression of βII-tubulin in facial and sciatic motoneurons 
(Jones & Oblinger, 1994; Brown et al., 2001); however, this data was obtained 
utilizing a sensitive technique, in situ hybridization, and localized βII-tubulin 
mRNA to the cell bodies of motoneurons. In the current study, mRNA was 
extracted from the injured and uninjured ventral horns of the lumbar spinal cord 
which contains several uninjured cell types, in addition to the cell bodies of the 
injured motoneurons. We examined βII-tubulin mRNA expression in two different 
sciatic nerve crush injury models — distal and proximal — to confirm the mRNA 
samples from the injured cells were not diluted by mRNA from uninjured cells. 
We found that there was an upregulation in βII-tubulin mRNA at 7 days post-
axotomy after both distal and proximal sciatic nerve crush injuries (Fig. 7). In 
addition, there was a statistically significant increase in the expression of βII-
tubulin mRNA with the proximal sciatic nerve crush, compared to the distal sciatic 
nerve crush (50.4 ± 15.0% and  13.2 ± 12.1%, respectively; P = 0.05; Fig. 7). 
Thus, we conclude that our method of sectioning the spinal cord allowed us to 
detect differences in gene expression. 
 
4. Contralateral effect of regeneration-associated gene expression 
Previously, we have reported changes in mRNA as a percent ratio of 
injured (axotomy) to uninjured (control) facial nuclei (Haulcomb et al., 2014). 






Fig. 7: Distal vs. proximal injury βII-tubulin mRNA expression. 
Shown is the average percent of mRNA expression of βII–tubulin in the 
axotomized ventral horn of the spinal cord (Ax) relative to the non-axotomized 
control (C) ventral horn of the spinal cord at 7 days post-axotomy. Two injury 
paradigms were examined: distal and proximal nerve injuries. Data is 
represented as average percent of βII–tubulin mRNA expression ± SEM. A 
Student’s t-test was utilized for statistical analysis to compare βII–tubulin mRNA 
following distal and proximal nerve injuries. * represents a significant difference 
between distal and proximal nerve injuries, at P = 0.05. For each experimental 




and left sides of the spinal cord (Kiernan & Rajakumar, 2013). Thus, we 
examined whether axotomy and/or treatment influenced levels of gene 
expression in the contralateral ventral horn of the spinal cord and whether the 
contralateral side could be utilized as an internal control for analysis of 
regeneration-associated gene expression. This dissertation analyzed the relative 
mRNA expression of several genes involved in the regeneration process over the 
time-course of 6 hours, 1, 2, 7, and 21 days post-axotomy (Table 2). 
 
a. Cytoskeleton genes: αI–tubulin and βII–tubulin 
Statistical analysis revealed an overall main effect for the relative mRNA 
expression of αI–tubulin between treatment groups (F3,101 = 8.05; P < 0.001), 
time(F4,101 = 3.78; P = 0.007), as well as an interaction between treatment x time 
(F12,101 = 4.42; P < 0.001; Fig. 8). Injury alone significantly decreased αI–tubulin 
expression at 1 day post-axotomy (13.594 ± 0.508) compared to 6 hours, 2, 7, 
and 21 days post-axotomy (19.755 ± 1.322, 18.339 ± 1.279, 17.903 ± 1.615, and 
17.912 ± 1.033, respectively; P < 0.05). Administration of ES did not alter αI–
tubulin mRNA levels at 6 hours, 1, 2, and 7 days post-axotomy (18.192 ± 1.578, 
17.068 ± 1.267, 16.014 ± 1.835, and 19.447 ± 1.210, respectively), but αI–tubulin 
mRNA was significantly downregulated at the later time-point of 21 days post-
axotomy with ES treatment (13.270 ± 1.137) relative to both 6 hours and 7 days 
post-axotomy (P < 0.05; Fig. 8A). In contrast to treatment with ES, systemic 
treatment of TP alone did not alter αI–tubulin mRNA across the time-course of 6 




Fig. 8: Contralateral αI–tubulin mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of αI–tubulin in 
the uninjured ventral horn at 6 hours, 1, 2, 7, and 21 days post-axotomy (Ax). 
Control animals, which were axotomized but left untreated, are compared to 
axotomized animals receiving only ES (A), only TP (B), or the combination of 
both ES and TP (C). (D) Represents the comparison between ES, TP, and the 
combination of ES and TP. Data is represented as relative αI–tubulin mRNA 
expression ± SEM. A two-way ANOVA (treatment x time) with a Student-
Newman-Keuls multiple comparison post hoc test was utilized for statistical 
analysis among all experimental groups. * represents a significant difference 
between ES, TP, or ES and TP compared to axotomy alone, at P < 0.05.             
# represents a significant difference between ES, TP, or ES and TP, at P < 0.05. 




15.903 ± 0.972, 17.818 ± 0.878, and 17.274 ± 1.443, respectively; Fig. 8B). The 
combined treatment maintained levels of αI–tubulin mRNA from 6 hours to 1 day 
post-axotomy (12.980 ± 0.937 and 16.062 ± 0.971, respectively) before peaking 
at a significant level at 2 days post-axotomy (19.444 ± 0.949; P ≤ 0.05; Fig. 8C). 
The combination of ES and TP significantly downregulated the relative mRNA 
expression of αI–tubulin by 7 and 21 days post-axotomy (12.387 ± 1.077 and 
9.607 ± 1.178, respectively; P < 0.001) relative to 2 days post-axotomy. Only at 
the latest time-point of 21 days post-axotomy did ES of the sciatic nerve elicit a 
significant decrease in the expression of αI–tubulin relative to axotomy alone (P < 
0.05; Fig. 8A). In contrast, treatment with TP did not alter αI–tubulin mRNA 
relative to axotomy alone at any time-point (Fig. 8B). The combined treatment 
group significantly downregulated the expression of αI–tubulin at 6 hours, 7, and 
21 days post-axotomy compared to all other groups (P < 0.05; Fig. 8C and Fig. 
8D, respectively).  
We found an overall main effect in the relative mRNA expression of βII–
tubulin between treatment groups (F3,100 = 4.00; P = 0.010), time (F4,101 = 13.95; 
P < 0.001), as well as an interaction between treatment x time (F12,100 = 3.48; P < 
0.001; Fig. 9). Axotomy alone significantly enhanced the relative expression of 
βII–tubulin mRNA at 7 days post-axotomy (0.949 ± 0.117) relative to 6 hours and 
1 day post-axotomy (0.626 ± 0.021 and 0.596 ± 0.087, respectively; P < 0.05), 
but not to 2 and 21 days post-axotomy (0.720 ± 0.031 and 1.013 ± 0.132, 
respectively; Fig. 9). Similar to injury alone, ES of the sciatic nerve significantly 




Fig. 9: Contralateral βII–tubulin mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of βII–tubulin in 
the uninjured ventral horn at 6 hours, 1, 2, 7, and 21 days post-axotomy (Ax). 
Control animals, which were axotomized but left untreated, are compared to 
axotomized animals receiving only ES (A), only TP (B), or the combination of 
both ES and TP (C). (D) Represents the comparison between ES, TP, and the 
combination of ES and TP. Data is represented as relative βII–tubulin mRNA 
expression ± SEM. A two-way ANOVA (treatment x time) with a Student-
Newman-Keuls multiple comparison post hoc test was utilized for statistical 
analysis among all experimental groups. * represents a significant difference 
between ES, TP, or ES and TP compared to axotomy alone, at P < 0.05.             
# represents a significant difference between ES, TP, or ES and TP, at P < 0.05. 
For each experimental group, n = 5-7 animals/time-point.     
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compared to 6 hours, 1, 2, and 21 days post-axotomy (0.620 ± 0.073, 0.827 ± 
0.081, 0.851 ± 0.129, and 0.747 ± 0.039, respectively; P < 0.05; Fig. 9A). TP-
treated animals demonstrated a significant, steady increase in relative mRNA 
expression of βII–tubulin at the early time-points of 6 hours, 1, and 2 days post-
axotomy (0.450 ± 0.056, 0.731 ± 0.058, and 0.817 ± 0.100, respectively; P < 
0.05) until it peaked at 7 days post-axotomy (1.045 ± 0.095) relative to 6 hours 
and 1 day post-axotomy (P < 0.05; Fig. 9B). At the latest time-point of 21 days 
post-axotomy (0.986 ± 0.100), βII–tubulin remained significantly upregulated with 
TP treatment compared to 6 hours post-axotomy (P < 0.001). Administration of 
ES and TP demonstrated a significant increase in βII–tubulin mRNA expression 
from 6 hours to 1 day post-axotomy (0.416 ± 0.041 and 0.752 ± 0.058, 
respectively; P < 0.05; Fig. 9C). βII–tubulin levels remained significantly elevated 
in animals treated with both ES and TP at 2 and 7 days post-axotomy (0.965 ± 
0.093 and 0.739 ± 0.091, respectively; P < 0.05) before significantly decreasing 
at 21 days post-axotomy (0.421 ± 0.056; P < 0.05). No differences in βII–tubulin 
mRNA expression, with respect to injury alone, were observed in ES- or TP-
treated animals (Fig. 9A and Fig. 9B, respectively). The combined treatment of 
ES plus TP demonstrated a significantly lower βII–tubulin expression at 7 days 
post-axotomy compared to either treatment alone (P < 0.05; Fig. 9D). At the 
latest time-point of 21 days post-axotomy, ES and TP demonstrated a significant 





b. Axonal growth genes: gap-43 and crmp2 
When investigating the relative mRNA expression of 43-kiloDalton growth-
associated protein (gap-43) in the contralateral ventral horn we observed a main 
effect of post-operative time (F4,99 = 4.14; P = 0.004) and an interaction between 
treatment x time (F12,99 = 2.53; P = 0.006; Fig. 10); although, there was no overall 
effect between treatment groups (F3,99 = 0.91; P = 0.44; Fig. 10). Axotomy alone 
did not alter the relative level of gap-43 expression throughout the time course of 
6 hours, 1, 2, 7, or 21 days post-axotomy (0.313 ± 0.019, 0.363 ± 0.030, 0.377 ± 
0.030, 0.304 ± 0.026, and 0.365 ± 0.045, respectively; Fig. 10). In animals 
receiving ES treatment, the value of gap-43 mRNA expression remained steady 
at 6 hours, 1, 2, and 7 days post-axotomy (0.321 ± 0.045, 0.323 ± 0.039, 0.352 ± 
0.042, and 0.388 ± 0.050, respectively), but significantly declined at the latest 
time-point of 21 days post-axotomy (0.237 ± 0.017; P < 0.05; Fig. 10A). Similar 
to axotomy alone, administration of TP had no effect on the relative mRNA 
expression of gap-43 at 6 hours, 1, 2, 7, or 21 days post-axotomy (0.388 ± 0.040, 
0.290 ± 0.028, 0.357 ± 0.022, 0.386 ± 0.036, and 0.321 ± 0.023, respectively; 
Fig. 10B). Unlike animals treated with TP, treatment with the combination of ES 
plus TP significantly upregulated the mRNA expression of gap-43 at 1 and 2 
days post-axotomy compared to 6 hours-axotomy (0.364 ± 0.054, 0.462 ± 0.075, 
and 0.217 ± 0.024, respectively; P < 0.05; Fig. 10C). The combination treatment 
demonstrated a significant decrease in gap-43 mRNA at both 7 and 21 days 
post-axotomy (0.315 ± 0.041 and 0.213 ± 0.018, respectively) relative to 2 days 




Fig. 10: Contralateral gap-43 mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of 43-kiloDalton 
growth-associated protein (gap-43) in the uninjured ventral horn at 6 hours, 1, 2, 
7, and 21 days post-axotomy (Ax). Control animals, which were axotomized but 
left untreated, are compared to axotomized animals receiving only ES (A), only 
TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between ES, TP, and the combination of ES and TP. Data is 
represented as relative gap-43 mRNA expression ± SEM. A two-way ANOVA 
(treatment x time) with a Student-Newman-Keuls multiple comparison post hoc 
test was utilized for statistical analysis among all experimental groups.                 
* represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES, 





expression was significantly lower at 21 days post-axotomy compared to injury 
alone (P = 0.05; Fig. 10A). Unlike ES-treated animals, TP-treated animals were 
similar to axotomized, untreated animals at all time-points (Fig. 10B). In contrast 
to TP treatment, the combination treatment of ES and TP was significantly 
downregulated at 6 hours post-axotomy compared to TP-treated animals and at 
21 days post-axotomy relative to axotomy alone (P ≤ 0.05; Fig. 10D and Fig. 
10C, respectively).  
Overall, we observed a main effect between treatment groups (F3,100 = 
6.68; P < 0.001), time (F4,100 = 5.40; P < 0.001), as well as an interaction 
between treatment x time (F12,100 = 4.47; P < 0.001; Fig. 11) when examining the 
relative mRNA expression of collapsin response mediator protein 2 (crmp2).  In 
axotomized, untreated animals there was a significant decline in crmp2 mRNA 
expression at 1 day post-axotomy compared to 6 hours post-axotomy (1.134 ± 
0.050 and 1.556 ± 0.077, respectively; P < 0.05; Fig. 11). By 2 days post-
axotomy (1.553 ± 0.136), crmp2 levels returned to levels similar to that of 6 hours 
post-axotomy (P < 0.05) where they were maintained throughout the rest of the 
time-course of 7 and 21 days post-axotomy (1.425 ± 0.107 and 1.520 ± 0.060, 
respectively). Treatment with ES did not alter crmp2 expression at the earlier 
time-points of 6 hours, 1, 2, and 7 days post-axotomy (1.518 ± 0.140, 1.355 ± 
0.093, 1.310 ± 0.147, and 1.516 ± 0.107, respectively), but did significantly 
downregulate crmp2 expression at 21 days post-axotomy (1.061 ± 0.114) relative 
to 6 hours and 7 days post-axotomy (P < 0.05; Fig. 11A). In contrast to treatment 




Fig. 11: Contralateral crmp2 mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of collapsin 
response mediator protein 2 (crmp2) in the uninjured ventral horn at 6 hours, 1, 
2, 7, and 21 days post-axotomy (Ax). Control animals, which were axotomized 
but left untreated, are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between ES, TP, and the combination of ES and TP. Data is 
represented as relative crmp2 mRNA expression ± SEM. A two-way ANOVA 
(treatment x time) with a Student-Newman-Keuls multiple comparison post hoc 
test was utilized for statistical analysis among all experimental groups.                   
* represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES, 





crmp2 throughout the entire time-course of 6 hours, 1, 2, 7, and 21 days (1.478 ± 
0.065, 1.326 ± 0.138, 1.368 ± 0.083, 1.404 ± 0.042, and 1.389 ± 0.109, 
respectively; Fig. 11B). The combination of ES and TP significantly elevated 
crmp2 levels at 2 days post-axotomy compared to 6 hours and 1, 7, and 21 days 
post-axotomy (1.709 ± 0.097, 1.082 ± 0.070, 1.255 ± 0.066, 1.040 ± 0.108, and 
0.787 ± 0.095, respectively; P < 0.05; Fig. 11C). Crmp2 expression was similar 
between systemic TP treatment compared to axotomy alone throughout the 
entire time-course (Fig. 11B); however, animals treated with ES demonstrated a 
significant decrease in crmp2 mRNA at the latest time-point of 21 days post-
axotomy compared to injury alone and TP-treated animals (P < 0.05; Fig. 11A 
and Fig. 11D, respectively). Animals treated with the combination of ES and TP 
demonstrated a significant downregulation in the mRNA expression of crmp2 at 6 
hours and 7 days post-axotomy compared to all groups (P < 0.05) and at 21 days 
post-axotomy relative to axotomy alone and TP treatment (P < 0.001; Fig. 11D). 
In contrast, the combination treatment significantly elevated crmp2 mRNA 
expression at 2 days post-axotomy compared to either treatment alone (P < 0.05; 
Fig. 11D). 
 
c. Growth factor and neurotrophic genes: bdnf, gdnf, and pacap 
We found an overall main effect in the relative mRNA expression of brain 
derived neurotrophic factor (bdnf) between treatment groups (F3,98 = 10.09; P < 
0.001), time (F4,98 = 4.29; P = 0.003), as well as an interaction between treatment 




Fig. 12: Contralateral bdnf mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of brain derived 
neurotrophic factor (bdnf) in the uninjured ventral horn at 6 hours, 1, 2, 7, and 21 
days post-axotomy (Ax). Control animals, which were axotomized but left 
untreated, are compared to axotomized animals receiving only ES (A), only TP 
(B), or the combination of both ES and TP (C). (D) Represents the comparison 
between ES, TP, and the combination of ES and TP. Data is represented as 
relative bdnf mRNA expression ± SEM. A two-way ANOVA (treatment x time) 
with a Student-Newman-Keuls multiple comparison post hoc test was utilized for 
statistical analysis among all experimental groups. * represents a significant 
difference between ES, TP, or ES and TP compared to axotomy alone, at           
P < 0.05. # represents a significant difference between ES, TP, or ES and TP, at 




hours, 1, 2, 7, and 21 days post-axotomy was not altered by axotomy alone 
(0.00185 ± 0.00017, 0.00192 ± 0.00015, 0.00151 ± 0.000007, 0.00162 ± 
0.00019, and 0.00241 ± 0.00026, respectively; Fig. 12). In contrast to axotomy 
alone, ES of the sciatic nerve significantly upregulated bdnf expression at 7 days 
post-axotomy compared to 6 hours, 1, 2, and 21 days post-axotomy (0.00260 ± 
0.00037, 0.00156 ± 0.00025, 0.00130 ± 0.00011, 0.00179 ± 0.00024, and 
0.00121 ± 0.00014, respectively; Fig. 12A). We observed a significant 
downregulation in the relative mRNA expression of bdnf in TP-treated animals at 
1 day post-axotomy compared to 6 hours post-axotomy (0.00156 ± 0.00022 and 
0.00271 ± 0.00014, respectively; P < 0.05; Fig. 12B). With TP treatment, bdnf 
levels were maintained at 2 days post-axotomy (0.00223 ± 0.00024) but peaked 
to a significant level at 7 days post-axotomy (0.00296 ± 0.00047) compared to 1 
day post-axotomy (P < 0.001) and the latest time-point of 21 days post-axotomy 
(0.00209 ± 0.00030; P < 0.05). Similar to axotomized animals, bdnf expression in 
animals treated with the combination of ES and TP remained unaltered 
throughout the entire time-course of 6 hours, 1, 2, 7, and 21 days post-axotomy 
(0.00139 ± 0.00017, 0.00144 ± 0.00019, 0.00184 ± 0.00018, 0.00173 ± 0.00018, 
and 0.00119 ± 0.00021, respectively; Fig. 12C). In animals treated with ES there 
was a significant upregulation in bdnf expression at 7 days post-axotomy relative 
to injury alone (P < 0.05; Fig. 12A). In contrast, a significant downregulation in 
bdnf expression was observed at 21 days post-axotomy compared to injury alone 
and TP-treated animals (P < 0.05; Fig. 12D). Administration of TP significantly 
increased bdnf levels at 6 hours post-axotomy compared to all other groups (P < 
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0.05) and at 7 days post-axotomy relative to injury alone and the combination 
treatment (P < 0.05; Fig. 12B and Fig. 12D). Animals treated with the 
combination of ES plus TP demonstrated a significant downregulation in bdnf 
mRNA expression at 21 days post-axotomy compared to injury alone and TP-
treated animals (P < 0.05; Fig. 12C and Fig. 12D, respectively). 
The expression of glial cell derived neurotrophic factor (gdnf) mRNA 
following axotomy led to a main effect of treatment group (F3,96 = 4.77; P = 
0.004); although, there was no overall effect of post-operative time (F4,96 = 1.96; 
P = 0.107) or interaction between group x post-operative time (F12,96 = 0.760; P = 
0.690; Fig. 13). There was a significant difference in gdnf expression in the 
combined treatment group compared to injury alone and either treatment alone 
(P < 0.05).  
Evaluation of the relative mRNA expression of pituitary adenylate cyclase-
activating peptide (pacap) after axotomy revealed a main effect of post-operative 
time (F4,94 = 2.68; P = 0.036) and treatment x time (F12,94 = 2.074; P = 0.026) but 
not treatment (F3,94 = 2.361; P = 0.076; Fig. 14). The time-course of pacap 
expression at 6 hours, 1, 2, 7, and 21 days post-axotomy was not altered with 
axotomy (0.0225 ± 0.0027, 0.0424 ± 0.0087, 0.0281 ± 0.0074, 0.0268 ± 0.0062, 
and 0.0251 ± 0.0031, respectively; Fig. 14), treatment with ES (0.0307 ± 0.0079, 
0.0227 ± 0.0009, 00.0266 ± 0.0006, 0.0305 ± 0.0046, and 0.0136 ± 0.0013, 
respectively; Fig. 14A), or the combined treatment (0.0164 ± 0.0022, 0.0212 ± 
0.0012, 0.0239 ± 0.0030, 0.0342 ± 0.0052, and 0.0156 ± 0.0014, respectively; 




Fig. 13: Contralateral gdnf mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of glial cell 
derived neurotrophic factor (gdnf) in the uninjured ventral horn at 6 hours, 1, 2, 7, 
and 21 days post-axotomy (Ax). Control animals, which were axotomized but left 
untreated, are compared to axotomized animals receiving only ES (A), only TP 
(B), or the combination of both ES and TP (C). (D) Represents the comparison 
between ES, TP, and the combination of ES and TP. Data is represented as 
relative gdnf mRNA expression ± SEM. A two-way ANOVA (treatment x time) 
with a Student-Newman-Keuls multiple comparison post hoc test was utilized for 
statistical analysis among all experimental groups. * represents a significant 
difference between ES, TP, or ES and TP compared to axotomy alone, at           
P < 0.05. # represents a significant difference between ES, TP, or ES and TP, at 




Fig. 14: Contralateral pacap mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of pituitary 
adenylate cyclase-activating peptide (pacap) in the uninjured ventral horn at 6 
hours, 1, 2, 7, and 21 days post-axotomy (Ax). Control animals, which were 
axotomized but left untreated, are compared to axotomized animals receiving 
only ES (A), only TP (B), or the combination of both ES and TP (C). (D) 
Represents the comparison between ES, TP, and the combination of ES and TP. 
Data is represented as relative pacap mRNA expression ± SEM. A two-way 
ANOVA (treatment x time) with a Student-Newman-Keuls multiple comparison 
post hoc test was utilized for statistical analysis among all experimental groups.                 
* represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES, 





expression at 1, 2, and 21 days post-axotomy relative to 6 hours post-axotomy 
(0.0211 ± 0.0043, 0.0277 ± 0.0039, 0.0236 ± 0.0055, and 0.0468 ± 0.0105, 
respectively; P < 0.05) but pacap expression at 6 hours post-axotomy was similar 
to 7 days post-axotomy (0.0345 ± 0.0102; Fig. 14B). ES treatment alone 
significantly downregulated pacap mRNA expression compared to injury alone (P 
< 0.05; Fig. 14A). Relative mRNA expression of pacap was significantly higher at 
6 hours post-axotomy in TP-treated animals compared to all other groups (P < 
0.05; Fig. 14B). At 2 days post-axotomy, TP treatment significantly 
downregulated pacap mRNA compared to axotomy alone (P < 0.05). Similar to 
TP treatment, the combined treatment also significantly downregulated pacap 
mRNA at 1 day post-axotomy compared to axotomy alone (P < 0.05; Fig. 14C).       
 
d. Plasticity gene: neuritin 
The extended time course did not reveal any differences between 
treatment groups after axotomy for neuritin (F3,100 = 1.18; P = 0.320) or an 
interaction between treatment x post-operative time (F12,100 = 0.99; P = 0.466; 
Fig. 15). However, analysis did reveal a main effect of post-operative time (F4,100 







Fig. 15: Contralateral neuritin mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of neuritin in the 
uninjured ventral horn at 6 hours, 1, 2, 7, and 21 days post-axotomy (Ax). Control 
animals, which were axotomized but left untreated, are compared to axotomized 
animals receiving only ES (A), only TP (B), or the combination of both ES and TP 
(C). (D) Represents the comparison between ES, TP, and the combination of ES 
and TP. Data is represented as relative neuritin mRNA expression ± SEM. A two-
way ANOVA (treatment x time) with a Student-Newman-Keuls multiple 
comparison post hoc test was utilized for statistical analysis among all 
experimental groups. * represents a significant difference between ES, TP, or ES 
and TP compared to axotomy alone, at P < 0.05. # represents a significant 
difference between ES, TP, or ES and TP, at P < 0.05. For each experimental 





In this study, we characterized the molecular effects of ES and TP on the 
expression of 8 genes associated with axonal regeneration on the contralateral 
side of the lumbar ventral horn following sciatic nerve crush axotomy. We found 
the expression of 3 out of 8 regeneration-associated genes was altered following 
axotomy. Moreover, our results indicate that ES and/or TP treatment modified the 
expression of 6 out of 8 genes following axotomy. Our results demonstrate that 
ES and TP alter gene expression in very distinct patterns when administered 
alone, and have a combined suppressive effect when administered together 
(Table 5). We have categorized the genes into three groups: (1) the individual 
treatments altered expression relative to axotomy alone (i.e. differential), (2) the 
combined treatment altered expression relative to both of the individual 
treatments (i.e. additive), (3) treatment did not alter gene expression (i.e. no 
effect; Table 6). In summary, ES and TP differentially altered the expression of 
gap-43, bdnf, and pacap, whereas the combination of both ES and TP exhibited 
an additive downregulation in the expression of αI-tubulin, βII-tubulin, and crmp2. 














ES    
gap-43 - - ↓ 
crmp2 - - ↓ 
bdnf - ↑ ↓ 
pacap ↓ - - 
TP    
bdnf ↑ ↑ - 
pacap ↑ , ↓ - - 
ES + TP    
αI–tubulin ↓ ↓ ↓ 
βII–tubulin - - ↓ 
gap-43 - - ↓ 
crmp2 ↓ ↓ ↓ 
bdnf - - ↓ 
pacap ↓ - - 
 










Change in Expression Sciatic Nerve Crush Injury 
Differential gap-43, bdnf, and pacap 
Additive αI-tubulin, βII-tubulin, and crmp2 
No change gdnf and neuritin 
 






B. Effects of ES and TP on regeneration-associated gene expression 
Since we found a significant change in mRNA expression with either 
treatment and/or time in 6 out of 8 genes, we did not use the contralateral side as 
an internal control. Therefore, all data is expressed as the relative mRNA 
expression from the ipsilateral ventral horn of the lumbar spinal cord. 
Experiments were carried out over the time-course of 6 hours, 1, 2, 7, and 21 
days post-axotomy.  
 
a. Cytoskeleton genes: αI–tubulin and βII–tubulin 
Microtubules are comprised of two members of the tubulin family, αI–
tubulin and βII–tubulin. In order for the axon to elongate, the cytoskeletal 
architecture must remodel. These subunits provide cytoskeleton support and 
have been demonstrated to increase following injury (Jones & Oblinger, 1994; 
Brown et al., 2001; Sharma et al., 2010a). In addition, αI–tubulin and βII–tubulin 
are differentially regulated by ES and TP following cranial and spinal nerve injury 
(Brown et al., 2001; Al-Majed et al., 2004; Sharma et al., 2010a). Although it is 
known that ES elevates αI–tubulin and that TP elevates βII–tubulin following 
spinal nerve injury, it remains to be determined whether the combination of ES 
and TP has an additive effect on tubulin expression.  
A two-way ANOVA for the relative mRNA expression of ipsilateral ventral 
horn αI–tubulin revealed no differences across time (F3,101 = 2.02; P = 0.116) or 
between treatment groups (F4,101 = 1.81; P = 0.134; Fig. 16). In contrast, 
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statistical analysis revealed a significant interaction between treatment x time 
(F12,101 = 3.67; P < 0.001; Fig. 16). Axotomy alone significantly decreased αI–
tubulin expression at 1 day post-axotomy relative to 6 hours post-axotomy 
(14.758 ± 0.536 and 21.922 ± 2.002, respectively; P < 0.05; Fig. 16). For the 
remaining time-points of 2, 7, and 21 days post-axotomy αI–tubulin levels were 
maintained in axotomized animals (18.902 ± 2.874, 21.189 ± 2.458, and 18.489 ± 
1.953, respectively). ES of the sciatic nerve maintained αI–tubulin mRNA values 
at 6 hours, 1, 2, and 7 days post-axotomy (20.627 ± 2.352, 17.080 ± 1.185, 
18.219 ± 1.587, and 22.629 ± 2.127, respectively; Fig. 16A); however, a 
significant decline in αI–tubulin mRNA was observed at the latest time-point of 21 
days post-axotomy (15.488 ± 1.413) compared to 7 days post-axotomy (P < 0.05; 
Fig. 16A). Unlike that observed with axotomy alone and ES treatment, αI–tubulin 
mRNA expression was unaffected by TP treatment at 6 hours, 1, 2, 7, and 21 
days post-axotomy (18.797 ± 2.471, 17.784 ± 1.747, 20.385 ± 1.052, 18.757 ± 
2.358, and 22.813 ± 0.956, respectively; Fig. 16B). There was a transient 
upregulation of αI–tubulin with the combination treatment of ES and TP at 1 and 
2 days post-axotomy relative to 6 hours post-axotomy (21.985 ± 1.665, 21.401 ± 
1.778, and 13.848 ± 0.388, respectively; P < 0.05; Fig. 16C). Levels of αI–tubulin 
started to decline in animals treated with ES and TP at 7 and 21 days post-
axotomy (16.727 ± 1.115 and 11.170 ± 1.295, respectively) but were only 
significantly lower at the latest time-point relative to 1 and 2 days post-axotomy 




Fig. 16: Ipsilateral αI–tubulin mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of αI–tubulin in 
the injured ventral horn at 6 hours, 1, 2, 7, and 21 days post-axotomy (Ax). 
Control (C) animals, which were axotomized but left untreated, are compared to 
axotomized animals receiving only ES (A), only TP (B), or the combination of 
both ES and TP (C). (D) Represents the comparison between ES, TP, and the 
combination of ES and TP. Data is represented as relative αI–tubulin mRNA 
expression ± SEM. A two-way ANOVA (treatment x time) with a Student-
Newman-Keuls multiple comparison post hoc test was utilized for statistical 
analysis among all experimental groups. * represents a significant difference 
between ES, TP, or ES and TP compared to axotomy alone, at P < 0.05.             
# represents a significant difference between ES, TP, or ES and TP, at P < 0.05. 




throughout the studied time-course compared to axotomy alone (Fig. 16A and 
Fig. 16B, respectively). In contrast, the combined treatment significantly 
downregulated αI–tubulin at 6 hours post-axotomy relative to axotomy alone and 
ES treatment (P < 0.05; Fig. 16C and Fig. 16D, respectively). At 1 day post-
axotomy, the combined treatment of ES plus TP significantly elevated αI–tubulin 
expression relative to axotomy alone (P < 0.05; Fig. 16C). By 21 days post-
axotomy, αI–tubulin levels were significantly lower in animals that received the 
combined treatment relative to axotomy alone and TP treatment (P < 0.05; Fig. 
Fig. 16C and Fig. 16D, respectively). 
In the current study, the extended time course of the relative mRNA 
expression of βII–tubulin revealed a main effect of time (F4,100 = 11.81; P < 0.001) 
and treatment x time (F12,100 = 2.76; P = 0.003), but there was no statistical 
interaction between treatment groups (F3,100 = 1.43; P = 0.240; Fig. 17). In 
axotomized, untreated animals βII–tubulin expression was maintained at 6 hours, 
1, 2, and 21 days post-axotomy (0.723 ± 0.061, 0.587 ± 0.060, 0.778 ± 0.125, 
and 0.827 ± 0.087, respectively) but peaked at 7 days post-axotomy (1.052 ± 
0.134) relative to 1 day post-axotomy (P < 0.05; Fig. 17). Treatment with ES 
significantly upregulated βII–tubulin expression at 7 days post-axotomy relative to 
6 hours, 1, 2, and 21 days post-axotomy (1.181 ± 0.135, 0.697 ± 0.074, 0.751 ± 
0.022, 0.758 ± 0.074, and 0.710 ± 0.073, respectively; P < 0.05; Fig. 17A). 
Systemic administration of TP sustained βII–tubulin levels at the earlier time-
points of 6 hours, 1, and 2 days post-axotomy (0.518 ± 0.081, 0.687 ± 0.062, and 




Fig. 17: Ipsilateral βII–tubulin mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of βII–tubulin in 
the injured ventral horn at 6 hours, 1, 2, 7, and 21 days post-axotomy (Ax). 
Control (C) animals, which were axotomized but left untreated, are compared to 
axotomized animals receiving only ES (A), only TP (B), or the combination of 
both ES and TP (C). (D) Represents the comparison between ES, TP, and the 
combination of ES and TP. Data is represented as relative βII–tubulin mRNA 
expression ± SEM. A two-way ANOVA (treatment x time) with a Student-
Newman-Keuls multiple comparison post hoc test was utilized for statistical 
analysis among all experimental groups. * represents a significant difference 
between ES, TP, or ES and TP compared to axotomy alone, at P < 0.05.             
# represents a significant difference between ES, TP, or ES and TP, at P < 0.05. 




0.177 and 0.985 ± 0.051), βII–tubulin expression was significantly elevated 
relative to 6 hours post-axotomy in TP-treated animals (P < 0.05). The 
combination treatment of ES and TP significantly elevated relative βII–tubulin 
mRNA expression at 1, 2, and 7 days post-axotomy compared to 6 hours post- 
axotomy (0.896 ± 0.110, 0.904 ± 0.092, 0.877 ± 0.091, and 0.440 ± 0.012, 
respectively; P < 0.05; Fig. 17C). At 21 days post-axotomy (0.422 ± 0.064), 
administration of both ES and TP together downregulated levels of βII–tubulin to 
levels similar to that observed at 6 hours post-axotomy (P < 0.05). Statistical 
analysis revealed no differences between animals treated with either ES or TP 
relative to axotomized, untreated animals (Fig. 17A and Fig. 17B, respectively). 
In contrast, the combination treatment significantly downregulated βII–tubulin 
compared to all other groups at 21 days post-axtomy (P < 0.05; Fig. 17D).   
 
b. Axonal growth genes: gap-43 and crmp2 
Following injury, assembly of the growth cone is essential for axon 
elongation and synaptogenesis. Both gap-43 and crmp2 are present in the 
growth cone and are important in axonal growth, whereas gap-43 is important in 
growth cone guidance (Aigner et al., 1995; Fukata et al., 2002). Molecular 
studies further demonstrate that gap-43 increases and is regulated by ES and TP 
following injury (Tetzlaff et al., 1991; Al-Majed et al., 2004; Sharma et al., 2010a). 
However, it is unknown whether ES and TP regulate the expression of crmp2 
after nerve injury. 
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 Overall, we observed a main effect with time (F4,101 = 10.42; P < 0.001) 
and treatment x time (F12,101 = 2.05; P = 0.027; Fig. 18); although, there was no 
effect of time (F3,101 = 1.71; P = 0.169; Fig. 18) when examining the relative 
mRNA expression of gap-43. In axotomized animals, there was a peak in gap-43 
expression at 7 days post-axotomy relative to 6 hours, 1, and 2 days post-
axotomy (0.598 ± 0.094, 0.352 ± 0.035, 0.235 ± 0.023, and 0.326 ± 0.035, 
respectively; P < 0.05) but not to 21 days post-axotomy (0.457 ± 0.060; Fig. 18). 
ES of the sciatic nerve significantly upregulated gap-43 expression at 7 days 
post-axotomy compared to 6 hours, 1, 2, and 21 days post-axotomy (0.649 ± 
0.125, 0.308 ± 0.032, 0.348 ± 0.022, 0.442 ± 0.074, and 0.436 ± 0.108, 
respectively; P < 0.05; Fig. 18A). In contrast, animals treated with TP 
demonstrated no significant difference throughout the time-course of 6 hours, 1, 
2, 7, and 21 days post-axotomy (0.334 ± 0.021, 0.302 ± 0.010, 0.444 ± 0.029, 
0.433 ± 0.063, and 0.492 ± 0.036, respectively; Fig. 18B). The combination of 
ES and TP had no effect on gap-43 expression at the earlier time-points of 6 
hours, 1, and 2 days post-axotomy (0.227 ± 0.008, 0.403 ± 0.048, and 0.414 ± 
0.048, respectively; Fig. 18C). At 7 days post-axotomy (0.467 ± 0.057) relative 
levels of gap-43 mRNA peaked relative to 6 hours post-axotomy (P < 0.05), but 
this effect was absent by 21 days post-axotomy (0.261 ± 0.037). ES-treated 
animals demonstrated a significantly upregulated gap-43 expression at 7 days 
post-axotomy compared to TP-treated animals (P < 0.05; Fig. 18D). The 





Fig. 18: Ipsilateral gap-43 mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of 43-kiloDalton 
growth-associated protein (gap-43) in the injured ventral horn at 6 hours, 1, 2, 7, 
and 21 days post-axotomy (Ax). Control (C) animals, which were axotomized but 
left untreated, are compared to axotomized animals receiving only ES (A), only 
TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between ES, TP, and the combination of ES and TP. Data is 
represented as relative gap-43 mRNA expression ± SEM. A two-way ANOVA 
(treatment x time) with a Student-Newman-Keuls multiple comparison post hoc 
test was utilized for statistical analysis among all experimental groups.                 
* represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES, 
TP, or ES and TP, at P < 0.05.  For each experimental group, n = 6-7 




latest time-point of 21 days post-axotomy compared to all other groups (P < 0.05; 
Fig. 18D). 
Statistical analysis did not reveal a main effect of treatment group (F3,101 = 
1.80; P = 0.153) or an effect of post-operative time (F4,101 = 1.31; P = 0.273) but 
did reveal an interaction between treatment x post-operative time (F12,101 = 3.19; 
P < 0.001; Fig. 19). Axotomy alone significantly decreased crmp2 expression at 
1 day post-axotomy relative to 6 hours post-axotomy (1.193 ± 0.062 and 1.932 ± 
0.233; P < 0.05) but levels were maintained throughout the rest of the time- 
course at 2, 7, and 21 days post-axotomy (1.504 ± 0.258, 1.714 ± 0.171, and 
1.548 ± 0.150, respectively; Fig. 19). No significant differences in crmp2 mRNA 
were observed at 6 hours, 1, 2, 7, or 21 days post-axotomy in animals treated 
with either ES (1.842 ± 0.211, 1.480 ± 0.122, 1.536 ± 0.141, 1.815 ± 0.179, and 
1.389 ± 0.166, respectively; Fig. 19A) or TP (1.474 ± 0.251, 1.498 ± 0.156, 1.704 
± 0.092, 1.533 ± 0.192, and 1.916 ± 0.053, respectively; Fig. 19B). The 
combination treatment of ES plus TP maintained crmp2 mRNA expression at 6 
hours, 1, 2, and 7 days post-axotomy (1.259 ± 0.048, 1.738 ± 0.109, 1.781 ± 
0.132, and 1.398 ± 0.113, respectively) but downregulated crmp2 expression at 
the later time-point of 21 days post-axotomy (0.908 ± 0.117) relative to 1 and 2 
day post-axotomy (P < 0.05; Fig. 19C). In the combined treatment group, a 
downregulation in crmp2 expression was observed at 6 hours relative to axotomy 
alone and ES treatment (P < 0.05) and 21 days post-axotomy relative to all 





Fig. 19: Ipsilateral crmp2 mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of collapsin 
response mediator protein 2 (crmp2) in the injured ventral horn at 6 hours, 1, 2, 
7, and 21 days post-axotomy (Ax). Control (C) animals, which were axotomized 
but left untreated, are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between ES, TP, and the combination of ES and TP. Data is 
represented as relative crmp2 mRNA expression ± SEM. A two-way ANOVA 
(treatment x time) with a Student-Newman-Keuls multiple comparison post hoc 
test was utilized for statistical analysis among all experimental groups.                 
* represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES, 
TP, or ES and TP, at P < 0.05.   For each experimental group, n = 6-7 




c. Growth factor and neurotrophic genes: bdnf, gdnf, and pacap 
Neurotrophic factors, such as BDNF and GDNF, promote neurite 
outgrowth and survival of motoneurons following axotomy (Yan et al., 1992; 
Novikov et al., 1997; Boyd & Gordon, 2003). PACAP is a multifunctional peptide 
and is important in the regeneration process (Armstrong et al., 2008). Similar to 
BDNF and GDNF, PACAP has been demonstrated to promote neurite outgrowth 
and motoneuron survival (Chen & Tzeng, 2005; Suarez et al., 2006). We and 
others have demonstrated previously that ES and TP differentially regulate the 
expression of bdnf and pacap following facial or femoral nerve axotomy (Al-
Majed et al., 2000a; Sharma et al., 2010a); although, it has yet to be determined 
whether the combination of ES and TP alter bdnf and pacap expression following 
sciatic nerve axotomy. ES in combination with exercise has been reported to 
increase the expression of gdnf (Cobianchi et al., 2013). However, it is unknown 
whether ES with administration of systemic TP alter the expression of gdnf 
following sciatic nerve injury.     
Statistical analysis revealed a main effect of treatment (F3,97 = 5.93; P < 
0.001) and an interaction between treatment x time (F12,97 = 3.26; P < 0.001) but 
no effect was observed for time (F4,97 = 1.31; P = 0.272; Fig. 20) with respect to 
bdnf mRNA expression in the ipsilateral ventral horn of the spinal cord. Injury 
alone moderately decreased the expression of bdnf at 1 day post-axotomy 
relative to 6 hours post-axotomy (0.00163 ± 0.00017 and 0.00259 ± 0.00054, 
respectively; P < 0.05; Fig. 20). By 2 days post-axotomy (0.00169 ± 0.00017), a 




Fig. 20: Ipsilateral bdnf mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of brain derived 
neurotrophic factor (bdnf) in the injured ventral horn at 6 hours, 1, 2, 7, and 21 
days post-axotomy (Ax). Control (C) animals, which were axotomized but left 
untreated, are compared to axotomized animals receiving only ES (A), only TP 
(B), or the combination of both ES and TP (C). (D) Represents the comparison 
between ES, TP, and the combination of ES and TP. Data is represented as 
relative bdnf mRNA expression ± SEM. A two-way ANOVA (treatment x time) 
with a Student-Newman-Keuls multiple comparison post hoc test was utilized for 
statistical analysis among all experimental groups. * represents a significant 
difference between ES, TP, or ES and TP compared to axotomy alone, at           
P < 0.05. # represents a significant difference between ES, TP, or ES and TP, at 




axotomy (P < 0.05). Bdnf expression values started to increase by 7 days post-
axotomy (0.00269 ± 0.00017) and peaked at 21 days post-axotomy (0.00291 ± 
0.00039) to a level that was significantly different relative to 1 and 2 days post-
axotomy (P < 0.05; Fig. 20). In contrast to axotomy alone, ES did not alter bdnf 
expression at 6 hours, 1, 2, 7, or 21 days post-axotomy (0.00234 ± 0.00035, 
0.00227 ± 0.00024, 0.00194 ± 0.00042, 0.00301 ± 0.00025, and 0.00179 ± 
0.00030, respectively; Fig. 20A). TP treatment significantly elevated bdnf 
expression at 2 days post-axotomy relative to 1 and 7 days post-axotomy 
(0.00371 ± 0.00076, 0.00219 ± 0.00029, and 0.00246 ± 0.00041, respectively) 
but had no effect at 6 hours and 21 days post-axotomy (0.00310 ± 0.00032 and 
0.00298 ± 0.00075, respectively; Fig. 20B). Similar to ES treatment, the 
combination treatment revealed no differences in bdnf expression at 6 hours, 1, 
2, 7, or 21 days post-axotomy (0.00195 ± 0.00011, 0.00247 ± 0.00027, 0.00242 
± 0.00026, 0.00223 ± 0.00029, and 0.00363 ± 0.00015, respectively; Fig. 20C). 
At the latest time-point of 21 days post-axotomy, there was a significant 
downregulation in bdnf mRNA in animals treated with ES relative to axotomy 
alone (P < 0.05; Fig. 20A). Systemic treatment with TP significantly elevated 
bdnf expression at 2 days post-axotomy compared to all groups tested (P < 0.05; 
Fig. 20B and Fig. 20D). There was a significant downregulation in bdnf mRNA at 
21 days post-axotomy relative to axotomy alone and TP treatment (P < 0.05; Fig. 
20C and Fig. 20D).  
In the current study, the extended time course of the relative mRNA 
expression of gdnf did not reveal a main effect of treatment (F3,97 = 0.92; P = 
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0.437) or time (F4,97 = 2.41; P = 0.055) but did reveal a statistical interaction 
between treatment x time (F12,97 = 2.48; P = 0.007; Fig. 21). No differences were 
observed in the relative mRNA expression of gdnf at 6 hours, 1, 2, 7 and 21 days 
post-axotomy in animals that received axotomy alone (0.000484 ± 0.00008, 
0.000297 ± 0.000041, 0.000421 ± 0.000068, 0.000428 ± 0.000072, and 
0.000430 ± 0.000069, respectively; Fig. 21) or axotomy and TP treatment 
(0.000484 ± 0.000010, 0.000351 ± 0.000032, 0.000469 ± 0.000048, 0.000480 ± 
0.000078, and 0.000486 ± 0.000095, respectively; Fig. 21B). Animals treated 
with ES demonstrated similar levels of gdnf expression at 6 hours and 1 day 
post-axotomy before peaking at 2 days post-axotomy (0.000565 ± 0.000111, 
0.000386 ± 0.000054, and 0.000764 ± 0.000256, respectively) compared to 1 
day post-axotomy (P < 0.05; Fig. 21A). Relative mRNA expression of gdnf 
declined at 7 days post-axotomy and reached a significant low at 21 days-post 
axotomy (0.000496 ± 0.000083 and 0.000213 ± 0.000053, respectively) relative 
to 6 hours and 2 days post-axotomy (P < 0.05; Fig. 21A). The combination 
treatment significantly peaked gdnf expression at 1 day post-axotomy relative to 
6 hours, 7, and 21 days post-axotomy (0.000667 ± 0.000063, 0.000372 ± 
0.000055, 0.000323 ± 0.000041, and 0.0002005 ± 0.000056, respectively; P < 
0.05), but gdnf expression was similar to 2 days post-axotomy (0.000444 ± 
0.000033; Fig. 21C). Treatment with ES only was significantly different than all 
groups at 2 days post-axotomy (P < 0.05; Fig. 21D) but similar at all other tested 
time-points. In contrast, TP treatment did not alter gdnf expression at any time-




Fig. 21: Ipsilateral gdnf mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of glial cell 
derived neurotrophic factor (gdnf) in the injured ventral horn at 6 hours, 1, 2, 7, 
and 21 days post-axotomy (Ax). Control (C) animals, which were axotomized but 
left untreated, are compared to axotomized animals receiving only ES (A), only 
TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between ES, TP, and the combination of ES and TP. Data is 
represented as relative gdnf mRNA expression ± SEM. A two-way ANOVA 
(treatment x time) with a Student-Newman-Keuls multiple comparison post hoc 
test was utilized for statistical analysis among all experimental groups.                 
* represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES, 
TP, or ES and TP, at P < 0.05. For each experimental group, n = 5-6 




significantly elevated levels of gdnf at 1 day post-axotomy relative to all other 
groups tested (P < 0.05) but was similar at all other time-points (Fig. 21D).      
When investigating the relative mRNA expression of pacap in the 
ipsilateral ventral horn we observed a main effect of post-operative time (F4,99 = 
7.30; P < 0.001) 0.006; Fig. 22); although, there was no overall effect between 
treatment groups (F3,99 = 1.80; P = 0.152) or treatment x time (F12,99 = 0.79; P = 
0.663; Fig. 22).  
 
d. Plasticity gene: neuritin 
Neuritin was first identified as a candidate plasticity-related gene but since 
has been shown to promote neurite outgrowth and dendritic arborization (Naeve 
et al., 1997; Javaherian & Cline, 2005; Marron et al., 2005). Previously, our 
laboratory has demonstrated that axotomy with either ES or TP increase neuritin 
levels following facial nerve injury (Fargo et al., 2008; Sharma et al., 2010a). It 
remains to be determined whether ES and TP alter neuritin expression following 
sciatic nerve injury.   
The extended time course did not reveal any differences between 
treatment groups after axotomy for neuritin (F3,101 = 0.532; P = 0.662) or an 
interaction between treatment x post-operative time (F12,101 = 1.20; P = 0.296; 
Fig. 23). However, analysis did reveal a main effect of post-operative time (F4,101 





Fig. 22: Ipsilateral pacap mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of pituitary 
adenylate cyclase-activating peptide (pacap)in the injured ventral horn at 6 
hours, 1, 2, 7, and 21 days post-axotomy (Ax). Control (C) animals, which were 
axotomized but left untreated, are compared to axotomized animals receiving 
only ES (A), only TP (B), or the combination of both ES and TP (C). (D) 
Represents the comparison between ES, TP, and the combination of ES and TP. 
Data is represented as relative pacap mRNA expression ± SEM. A two-way 
ANOVA (treatment x time) with a Student-Newman-Keuls multiple comparison 
post hoc test was utilized for statistical analysis among all experimental groups.  
* represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES, 
TP, or ES and TP, at P < 0.05. For each experimental group, n = 5-6 





Fig. 23: Ipsilateral neuritin mRNA expression. 
Shown is a time-course of the relative mRNA expression levels of neuritin in the 
injured ventral horn at 6 hours, 1, 2, 7, and 21 days post-axotomy (Ax). Control 
(C) animals, which were axotomized but left untreated, are compared to 
axotomized animals receiving only ES (A), only TP (B), or the combination of 
both ES and TP (C). (D) Represents the comparison between ES, TP, and the 
combination of ES and TP. Data is represented as relative neuritin mRNA 
expression ± SEM. A two-way ANOVA (treatment x time) with a Student-
Newman-Keuls multiple comparison post hoc test was utilized for statistical 
analysis among all experimental groups. * represents a significant difference 
between ES, TP, or ES and TP compared to axotomy alone, at P < 0.05.             
# represents a significant difference between ES, TP, or ES and TP, at P < 0.05.    





We characterized the molecular effects of ES and TP on the expression of 
8 regeneration-associated genes on the ipsilateral side of the lumbar ventral horn 
following sciatic nerve crush axotomy. Similar to our results from the contralateral 
analysis, we found that the expression of 3 out of 8 regeneration-associated 
genes was altered ipsilateral to injury. These genes include αI-tubulin, crmp2, 
and gap-43. Furthermore, our results indicate that ES and/or TP treatment 
altered the expression of 6 out of 8 genes following axotomy. Our results 
demonstrate that ES and TP alter gene expression in very distinct patterns when 
administered alone and have a combined suppressive effect when administered 
together (Table 7). In summary, ES and TP separately altered the expression of 
bdnf, whereas the combination of both ES and TP suppressed the expression of 
αI-tubulin, βII-tubulin, gap-43, crmp2, and gdnf in an additive manner (Table 8). In 
















bdnf - - ↓ 
gdnf ↑ - - 
TP    
bdnf ↑  - - 
ES + TP    
αI-tubulin ↓ , ↑ - ↓ 
βII-tubulin - - ↓ 
gap-43 - - ↓ 
crmp2 ↓ - ↓ 
bdnf - - ↓ 
gdnf ↑ - - 
 






















pacap, bdnf, and 
neuritin 
αI-tubulin, βII-tubulin, gap-43, 
gdnf and crmp2 
No change - pacap and neuritin 
 
Table 8: Comparison of the effects of ES and TP on gene expression after 
facial vs. sciatic nerve crush injuries.  
*Facial nerve crush injury gene expression summarized from Sharma et al. (2010a).  
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C. Effects of ES and TP on functional recovery 
The following assessments were used to test functional recovery following 
sciatic nerve axotomy: rear foot falls (automatic foot misplacement apparatus), 
grip strength, gait analysis (CatWalk XT©), and EMG recordings. Testing of the 
automatic foot misplacement and CatWalk XT© apparatuses was completed on 
day 0 (3 days before injury), 2, 4, 7, 9, 11, 14, 16, 18, 21, 23, 25, 28, 30, 32, 35, 
37, 39, 42, 44, 46, 49, 51, 53, and 56 days post-axotomy. Grip strength was 
tested before axotomy (0) and weekly for 8 weeks. EMG recordings were taken 
before axotomy and at 53 days post-axotomy.  
A two-way repeated measures ANOVA revealed a significant difference in 
animal weight across time (F27,509 = 355.54; P < 0.001) and an interaction 
between treatment group x time (F81,509 = 3.22; P < 0.001) but no effect was 
observed between treatment groups (F3,509 = 1.9; P = 0.162; Fig. 24). Analysis 
revealed that animals treated with ES had a significantly higher weight than TP 
only treated animals from 32 days post-axotomy through 46 days post-axotomy 
(P < 0.05; Fig. 24). Since there was an effect of treatment on weight and since 
speed alters several gait parameters (Batka et al., 2014), we included weight and 
speed as dependent factors for all CatWalk XT© analysis.  
 
1. Automatic foot misplacement apparatus 
A two-way repeated measures ANOVA revealed a significant difference in 





Fig. 24: Effect of ES and TP on animal body weight. 
Shown is a time-course of the effect of ES and TP on animal body weight post-
axotomy (Ax). Uninjured animals (solid line) represent a longitudinal baseline 
throughout the study. Control animals, which were axotomized but left untreated 
(Ax only), are compared to axotomized animals receiving only ES (A), only TP 
(B), or the combination of both ES and TP (C). (D) Represents the comparison 
between the combination of ES and TP relative to both ES and TP alone. Data is 
represented as weight (g) ± SEM. Statistical significance was evaluated using 
linear mixed effects models. Each model included random intercepts and slopes 
for speed and weight for each animal. Post hoc pairwise multiple comparisons 
were performed within time points using the Holm-Šidák method when group 
differences were detected. * represents a significant difference between ES, TP, 
or ES and TP compared to axotomy alone, at P < 0.05. # represents a significant 
difference between ES and TP relative to both ES and TP alone, at P < 0.05. For 




interaction between treatment group x time (F96,429 = 1.52; P = 0.003) but no 
effect was observed between treatment groups (F4,429 = 2.27; P = 0.092; Fig. 25). 
At 2 days post-axotomy, all injured animals had a significantly higher number of 
rear foot fall errors relative to uninjured animals (P < 0.001; Fig. 25). However, 
axotomized, untreated animals by 4 days post-axotomy were similar to control, 
unaxotomized animals. Due to the fast recovery time of 2 days post-axotomy for 
injured, untreated animals with this particular motor test, treatment effects could 
not be determined.       
 
2. Grip strength 
a. Bar apparatus 
Overall, we observed a main effect with time (F8,170 = 66.25; P < 0.001) 
and between treatment groups (F4,170 = 2.74; P = 0.05; Fig. 26); although, there 
was no interaction observed between treatment x time (F32,170 = 1.26; P = 0.177; 
Fig. 26) when examining the mean force for the bar grip strength test. Additional 
analysis to determine the presence of a treatment effect was not completed since 
there was no statistical difference between treatment x time.  
 
b. Grid apparatus 
A two-way repeated measures ANOVA for mean force for the grid grip 
strength test revealed no difference between treatment groups (F4,170 = 1.91; P = 




Fig. 25: Effect of ES and TP on the number of rear leg errors. 
Shown is a time-course of the effect of ES and TP on the number of rear leg 
errors post-axotomy (Ax). Uninjured animals (solid line) represent a longitudinal 
baseline throughout the study. Control animals, which were axotomized but left 
untreated (Ax only), are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between the combination of ES and TP relative to both ES and TP 
alone. Data is represented as the number of rear leg erros ± SEM. Statistical 
significance was evaluated using linear mixed effects models. Each model 
included random intercepts and slopes for speed and weight for each animal. 
Post hoc pairwise multiple comparisons were performed within time points using 
the Holm-Šidák method when group differences were detected. * represents a 
significant difference between ES, TP, or ES and TP compared to axotomy 
alone, at P < 0.05. # represents a significant difference between ES and TP 
relative to both ES and TP alone, at P < 0.05. For each experimental group, n = 





Fig. 26: Effect of ES and TP on hind paw grip strength utilizing the bar 
apparatus. 
Shown is a time-course of the effect of ES and TP on hind paw grip strength 
utilizing the bar apparatus post-axotomy (Ax). Uninjured animals (solid line) 
represent a longitudinal baseline throughout the study. Control animals, which 
were axotomized but left untreated (Ax only), are compared to axotomized 
animals receiving only ES (A), only TP (B), or the combination of both ES and TP 
(C). (D) Represents the comparison between the combination of ES and TP 
relative to both ES and TP alone. Data is represented as force (g) ± SEM. 
Statistical significance was evaluated using linear mixed effects models. Each 
model included random intercepts and slopes for speed and weight for each 
animal. Post hoc pairwise multiple comparisons were performed within time 
points using the Holm-Šidák method when group differences were detected.        
* represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES and 
TP relative to both ES and TP alone, at P < 0.05. For each experimental group,  





Fig. 27: Effect of ES and TP on hind paw grip strength utilizing the grid 
apparatus. 
Shown is a time-course of the effect of ES and TP on hind paw grip strength 
utilizing the grid apparatus post-axotomy (Ax). Uninjured animals (solid line) 
represent a longitudinal baseline throughout the study. Control animals, which 
were axotomized but left untreated (Ax only), are compared to axotomized 
animals receiving only ES (A), only TP (B), or the combination of both ES and TP 
(C). (D) Represents the comparison between the combination of ES and TP 
relative to both ES and TP alone. Data is represented as force (g) ± SEM. 
Statistical significance was evaluated using linear mixed effects models. Each 
model included random intercepts and slopes for speed and weight for each 
animal. Post hoc pairwise multiple comparisons were performed within time 
points using the Holm-Šidák method when group differences were detected.        
* represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES and 
TP relative to both ES and TP alone, at P < 0.05. For each experimental group,  




across time (F8,170 = 119.90; P < 0.001) and an interaction between treatment x 
time (F32,170 = 2.33; P < 0.001; Fig. 27). At 1 week post-axotomy, all axotomized 
groups had a significantly lower grip strength force relative to uninjured, 
untreated animals (No Ax: 393.8 ± 46.6 g; Ax only: 195.0 ± 24.1 g; ES: 245.0 ± 
26.5 g; TP: 205.2 ± 22.3 g; ES + TP: 177.7 ± 23.9 g ; P < 0.05; Fig. 27A-D). By 2 
weeks post-axotomy, the combined treatment group was similar to the No Ax and 
Ax only groups (246.1 ± 27.2 g, 367.8 ± 63.8 g, and 187.3 ± 14.9 g, respectively; 
Fig. 27C), but was similar to either treatment alone (ES: 211.8 ± 20.1 g; TP: 
220.4 ± 25.0 g; Fig. 27D). 
 
3. CatWalk XT© apparatus 
A detailed list of analyzed CatWalk parameters with definitions can be 
found in Table 4. 
 
a. Paw-related parameters  
i. TP increases print length. 
We found an overall main effect in the right hind (RH) print length between 
treatment groups (F4,5767 = 13.80; P < 0.0001), time (F26,5767 = 69.77; P < 0.0001), 
as well as an interaction between treatment x time (F104,5767 = 10.54; P < 0.0001; 
Fig. 28). Print length was significantly decreased in injured, untreated animals at 
2 days post-axotomy relative to uninjured control animals (0.25 ± 0.14 cm and 




Fig. 28: Effect of ES and TP on RH print length. 
Shown is a time-course of the effect of ES and TP on right hind (RH) print length 
post-axotomy (Ax). Uninjured animals (solid line) represent a longitudinal 
baseline throughout the study. Control animals, which were axotomized but left 
untreated (Ax only), are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between the combination of ES and TP relative to both ES and TP 
alone. Data is represented as RH print length (cm) ± SEM. Statistical significance 
was evaluated using linear mixed effects models. Each model included random 
intercepts and slopes for speed and weight for each animal. Post hoc pairwise 
multiple comparisons were performed within time points using the Holm-Šidák 
method when group differences were detected. * represents a significant 
difference between ES, TP, or ES and TP compared to axotomy alone, at           
P < 0.05. # represents a significant difference between ES and TP relative to 
both ES and TP alone, at P < 0.05. For each experimental group, n = 5-6 




length for axotomized animals returned to control levels (1.86 ± 0.11 cm and 1.99 
± 0.16 cm, respectively; Fig. 28). At 23 days post-axotomy, print length of 
axotomized animals significantly decreased relative to uninured animals and 
remained steady for the remainder of the time-course (P < 0.05; Fig. 28). 
Animals treated with ES demonstrated no consistent significant pattern for print 
length across all time-points relative to that observed in uninjured animals (Fig. 
28A). In contrast, animals treated with TP demonstrated a significantly higher 
print length as early as 4 days post-axotomy relative to injured, untreated animals 
(P < 0.05; Fig. 28B) until 9 days post-axotomy. From 25 to 39 days post-
axotomy, TP-treated animals demonstrated a significantly elevated print length 
relative to axotomy alone (P < 0.05; Fig. 28B). The combinatorial treatment 
significantly elevated print length at the earlier time-points of 2, 4, 7, and 9 days 
post-axotomy relative to axotomy alone (P < 0.05; Fig. 28C), but demonstrated 
no consistent difference compared to axotomized animals throughout the rest of 
the time-course. Animals treated with ES and TP demonstrated no 
supplementary effect relative to either treatment alone throughout the time-
course (Fig. 28D).            
 
ii. TP increases print width. 
Overall, we observed a main effect in the RH print width between 
treatment groups (F4,5767 = 15.34; P < 0.0001), time (F26,5767 = 115.02; P < 
0.0001), as well as an interaction between treatment x time (F104,5767 = 18.41; P < 




Fig. 29: Effect of ES and TP on RH print width. 
Shown is a time-course of the effect of ES and TP on right hind (RH) print width 
post-axotomy (Ax). Uninjured animals (solid line) represent a longitudinal 
baseline throughout the study. Control animals, which were axotomized but left 
untreated (Ax only), are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between the combination of ES and TP relative to both ES and TP 
alone. Data is represented as RH print width (cm) ± SEM. Statistical significance 
was evaluated using linear mixed effects models. Each model included random 
intercepts and slopes for speed and weight for each animal. Post hoc pairwise 
multiple comparisons were performed within time points using the Holm-Šidák 
method when group differences were detected. * represents a significant 
difference between ES, TP, or ES and TP compared to axotomy alone, at           
P < 0.05. # represents a significant difference between ES and TP relative to 
both ES and TP alone, at P < 0.05. For each experimental group, n = 5-6 
animals/time-point.    
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in injured, untreated animals relative to uninjured control animals (0.35 ± 0.08 cm 
and 1.85 ± 0.09 cm, respectively; P < 0.001; Fig. 29) and never returned to that 
observed in uninjured animals. Animals treated with ES demonstrated no 
consistent significant pattern for print width until 46 days post-axotomy at which 
point levels were significantly elevated relative to that observed in uninjured 
animals (P < 0.05; Fig. 29A). In contrast, animals treated with TP demonstrated 
a significantly higher print width at 4 and 7 days post-axotomy relative to injured, 
untreated animals (TP: 0.95 ± 0.06 cm and 1.09 ± 0.06 cm, respectively; Ax only: 
0.58 ± 0.07 cm and 0.72 ± 0.07 cm, respectively; P < 0.001; Fig. 29B). Similarly, 
TP-treated animals demonstrated a significantly elevated print width beginning at 
16 days post-axotomy for the remainder of the time-course relative to axotomy 
alone (P < 0.001). The combinatorial treatment significantly elevated print width 
at the earlier time-points of 2, 4, 7, and 9 days post-axotomy relative to axotomy 
alone (P < 0.05). At 35 days post-axotomy, animals treated with ES and TP 
exhibited a consistent significant elevation relative to axotomy alone that was 
present through 56 days post-axotomy (P < 0.05; Fig. 29C). The combinatorial 
treatment had no supplementary benefit to either treatment alone (Fig. 29D). 
 
iii. TP increases print area. 
When investigating the effect of treatment on RH print area we observed a 
main effect between treatment groups (F4,5767 = 12.64; P < 0.0001), time (F26,5767 
= 76.29; P < 0.0001), as well as an interaction between treatment x time (F104,5767 




Fig. 30: Effect of ES and TP on RH print area. 
Shown is a time-course of the effect of ES and TP on right hind (RH) print area 
post-axotomy (Ax). Uninjured animals (solid line) represent a longitudinal 
baseline throughout the study. Control animals, which were axotomized but left 
untreated (Ax only), are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between the combination of ES and TP relative to both ES and TP 
alone. Data is represented as RH print area (cm2) ± SEM. Statistical significance 
was evaluated using linear mixed effects models. Each model included random 
intercepts and slopes for speed and weight for each animal. Post hoc pairwise 
multiple comparisons were performed within time points using the Holm-Šidák 
method when group differences were detected. * represents a significant 
difference between ES, TP, or ES and TP compared to axotomy alone, at           
P < 0.05. # represents a significant difference between ES and TP relative to 
both ES and TP alone, at P < 0.05. For each experimental group, n = 5-6 
animals/time-point.    
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untreated animals at 2 days post-axotomy and never returned to levels observed 
in that of uninjured control animals (-0.04 ± 0.13 cm2 and 1.93 ± 0.15 cm2, 
respectively; P < 0.001; Fig. 30). Animals treated with ES demonstrated no 
consistent significant pattern throughout the observed time-course (Fig. 30A). In 
contrast, animals treated with TP demonstrated a significantly higher print area at 
21 days post-axotomy until 42 days post-axotomy relative to injured, untreated 
animals (P < 0.05; Fig. 30B). Similar to ES-treated animals, animals treated with 
ES plus TP demonstrated no consistent difference in print area relative to 
animals receiving axotomy alone (Fig. 30C). The combinatorial treatment had no 
supplementary benefit to either treatment alone (Fig. 30D). 
 
iv. ES only and TP only increase swing 
Statistical analysis revealed a main effect between treatment groups 
(F4,5730 = 10.36; P < 0.0001), time (F26,5730 = 67.00; P < 0.0001), as well as an 
interaction between treatment x time (F104,5730 = 9.11; P < 0.0001; Fig. 31) with 
respect to RH swing. Swing was significantly increased in injured, untreated 
animals at 2 days post-axotomy relative to uninjured control animals (0.31 ± 
0.010 s and 0.10 ± 0.007 s, respectively; P < 0.001; Fig. 31). At 30 days post-
axotomy, swing of axotomized animals returned to values similar to that of 
uninjured animals (0.14 ± .006 s and 0.11 ± 0.008 s, respectively) where they 
were maintained for the remainder of the time-course. ES of the sciatic nerve 
significantly decreased swing as early as 2 days post-axotomy relative to injury 




Fig. 31: Effect of ES and TP on RH swing. 
Shown is a time-course of the effect of ES and TP on right hind (RH) swing post-
axotomy (Ax). Uninjured animals (solid line) represent a longitudinal baseline 
throughout the study. Control animals, which were axotomized but left untreated 
(Ax only), are compared to axotomized animals receiving only ES (A), only TP 
(B), or the combination of both ES and TP (C). (D) Represents the comparison 
between the combination of ES and TP relative to both ES and TP alone. Data is 
represented as RH swing (s) ± SEM. Statistical significance was evaluated using 
linear mixed effects models. Each model included random intercepts and slopes 
for speed and weight for each animal. Post hoc pairwise multiple comparisons 
were performed within time points using the Holm-Šidák method when group 
differences were detected. * represents a significant difference between ES, TP, 
or ES and TP compared to axotomy alone, at P < 0.05. # represents a significant 
difference between ES and TP relative to both ES and TP alone, at P < 0.05. For 
each experimental group, n = 5-6 animals/time-point.    
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that of injury alone by 9 days post-axotomy. Animals receiving systemic TP 
demonstrated a significant decrease in swing at 2 and 4 days post-axotomy (0.20 
± .008 s, 0.15 ± .007 s, respectively) relative to injured, untreated animals (P < 
0.05; Fig. 31B). There was no consistent difference in swing of animals that 
received reatment with the combination of ES plus TP compared to axotomy 
alone throughout the time-course (Fig. 31C). Therefore, ES and TP had no 
supplementary effect in swing relative to either treatment alone (Fig. 31D). 
 
v. TP increases swing speed 
Overall, we observed a main effect between treatment groups (F4,5730 = 
11.07; P < 0.0001), time (F26,5730 = 186.18; P < 0.0001), as well as an interaction 
between treatment x time (F104,5730 = 18.89; P < 0.0001; Fig. 32) with respect to 
RH swing speed. Axotomy alone significantly decreased swing speed at 2 days 
post-axotomy relative to uninjured animals (94.8 ± 4.5 cm/s and 170.0 ± 4.0 
cm/s, respectively; P < 0.001; Fig. 32) where it was maintained until 42 days 
post-axotomy. Animals treated with ES only had similar swing speed throughout 
the observed time-course compared to axotomized animals (Fig. 32A). In 
contrast, TP-treated animals demonstrated a significantly higher swing speed 
between 14 and 28 days post-axotomy relative to axotomized, untreated animals 
albeit this trend was not consistent (P < 0.05; Fig. 32B). Similar to treatment with 
ES, the combination of ES and TP did not consistently alter swing speed relative 




Fig. 32: Effect of ES and TP on RH swing speed. 
Shown is a time-course of the effect of ES and TP on right hind (RH) swing 
speed post-axotomy (Ax). Uninjured animals (solid line) represent a longitudinal 
baseline throughout the study. Control animals, which were axotomized but left 
untreated (Ax only), are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between the combination of ES and TP relative to both ES and TP 
alone. Data is represented as RH swing speed (cm/s) ± SEM. Statistical 
significance was evaluated using linear mixed effects models. Each model 
included random intercepts and slopes for speed and weight for each animal. 
Post hoc pairwise multiple comparisons were performed within time points using 
the Holm-Šidák method when group differences were detected. * represents a 
significant difference between ES, TP, or ES and TP compared to axotomy 
alone, at P < 0.05. # represents a significant difference between ES and TP 
relative to both ES and TP alone, at P < 0.05. For each experimental group,        
n = 5-6 animals/time-point.    
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no supplementary effect in swing speed compared to either treatment alone (Fig. 
32D).  
 
vi. ES only and TP only decrease stride length 
Evaluation of RH stride length did not reveal a main effect of treatment 
group (F4,5730 = 1.62; P = 0.1651) but did reveal an effect of post-operative time 
(F26,5730 = 8.14; P < 0.0001) and an interaction between treatment x post-
operative time (F104,5730 = 2.89; P < 0.0001; Fig. 33). Injury alone significantly 
increased stride length at 2 days post-axotomy relative to uninjured animals (20.8 
± 0.6 cm and 17.3 ± 0.5 cm, respectively; P < 0.001; Fig. 33) but was similar for 
the remainder of the observed time-course. In contrast, ES-treated animals 
demonstrated a significant decrease in stride length at 2 days post-axotomy 
animals (13.7 ± 0.5 cm) compared to axotomy alone (P < 0.001; Fig. 33A) but 
was similar to axotomy alone at all other time-points. Similar to ES-treated 
animals, systemic treatment of TP significantly decreased stride length only at 2 
days post-axotomy (15.9 ± 0.5 cm) relative to injury alone (P < 0.001; Fig. 33B). 
Animals treated with both ES and systemic TP demonstrated a significant 
increase in stride length only at 4 days post-axotomy relative to axotomy alone 
(18.2 ± 0.4 cm and 16.2 ± 0.5 cm, respectively; P < 0.05; Fig. 33C). The 
combination of ES plus TP had no additional benefit to either treatment alone 





Fig. 33: Effect of ES and TP on RH stride length. 
Shown is a time-course of the effect of ES and TP on right hind (RH) stride 
length post-axotomy (Ax). Uninjured animals (solid line) represent a longitudinal 
baseline throughout the study. Control animals, which were axotomized but left 
untreated (Ax only), are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between the combination of ES and TP relative to both ES and TP 
alone. Data is represented as RH stride length (cm) ± SEM. Statistical 
significance was evaluated using linear mixed effects models. Each model 
included random intercepts and slopes for speed and weight for each animal. 
Post hoc pairwise multiple comparisons were performed within time points using 
the Holm-Šidák method when group differences were detected. * represents a 
significant difference between ES, TP, or ES and TP compared to axotomy 
alone, at P < 0.05. # represents a significant difference between ES and TP 
relative to both ES and TP alone, at P < 0.05. For each experimental group,        
n = 5-6 animals/time-point.    
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vii. ES only and TP only decrease step cycle 
In the current study, the extended time course of RH step cycle revealed a 
main effect between treatment groups (F4,5730 = 4.09; P = 0.0026), time (F26,5730 = 
6.83; P < 0.0001), as well as an interaction between treatment x time (F104,5730 = 
4.15; P < 0.0001; Fig. 34). Injury alone significantly increased step cycle at 2 
days post-axotomy relative to uninjured animals (0.32 ± 0.01 s and 0.23 ± 0.008 
s, respectively; P < 0.001; Fig. 34) but was similar for the remainder of the 
observed time-course. In contrast, ES-treated animals demonstrated a significant 
decrease in step cycle at 2 days post-axotomy (0.17 ± 0.01 s) compared to 
axotomy alone (P < 0.001; Fig. 34A) but was similar to axotomy alone at all other 
time-points. Similar to ES-treated animals, systemic treatment of TP significantly 
decreased step cycle only at 2 days post-axotomy (0.20 ± 0.008 s) relative to 
injury alone (P < 0.001; Fig. 34B). Animals treated with both ES and systemic TP 
demonstrated a significant increase in step cycle only at 4 days post-axotomy 
relative to axotomy alone (0.25 ± 0.007 s and 0.21 ± 0.007 s, respectively; P < 
0.001; Fig. 34C). The combination of ES plus TP had no additional benefit to 
either treatment alone throughout the time-course (Fig. 34D). 
 
viii. TP increases duty cycle 
Statistical analysis revealed a main effect between treatment groups 
(F4,5730 = 14.39; P < 0.0001), time (F26,5730 = 345.63; P < 0.0001), as well as an 




Fig. 34: Effect of ES and TP on RH step cycle. 
Shown is a time-course of the effect of ES and TP on right hind (RH) step cycle 
post-axotomy (Ax). Uninjured animals (solid line) represent a longitudinal 
baseline throughout the study. Control animals, which were axotomized but left 
untreated (Ax only), are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between the combination of ES and TP relative to both ES and TP 
alone. Data is represented as RH step cycle (s) ± SEM. Statistical significance 
was evaluated using linear mixed effects models. Each model included random 
intercepts and slopes for speed and weight for each animal. Post hoc pairwise 
multiple comparisons were performed within time points using the Holm-Šidák 
method when group differences were detected. * represents a significant 
difference between ES, TP, or ES and TP compared to axotomy alone, at           
P < 0.05. # represents a significant difference between ES and TP relative to 
both ES and TP alone, at P < 0.05. For each experimental group, n = 5-6 




Fig. 35: Effect of ES and TP on RH duty cycle. 
Shown is a time-course of the effect of ES and TP on right hind (RH) duty cycle 
post-axotomy (Ax). Uninjured animals (solid line) represent a longitudinal 
baseline throughout the study. Control animals, which were axotomized but left 
untreated (Ax only), are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between the combination of ES and TP relative to both ES and TP 
alone. Data is represented as RH duty cycle (%) ± SEM. Statistical significance 
was evaluated using linear mixed effects models. Each model included random 
intercepts and slopes for speed and weight for each animal. Post hoc pairwise 
multiple comparisons were performed within time points using the Holm-Šidák 
method when group differences were detected. * represents a significant 
difference between ES, TP, or ES and TP compared to axotomy alone, at           
P < 0.05. # represents a significant difference between ES and TP relative to 
both ES and TP alone, at P < 0.05. For each experimental group, n = 5-6 
animals/time-point.    
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respect to RH duty cycle. Duty cycle significantly decreased in injured, untreated 
animals at 2 days post-axotomy relative to uninjured control animals (8.9 ± 2.0% 
and 55.2 ± 2.0%, respectively; P < 0.001; Fig. 35). At 42 days post-axotomy, 
duty cycle of axotomized animals returned to values similar to that of uninjured 
animals and was maintained for the remaining time-points. ES of the sciatic 
nerve significantly increased duty cycle at 2 and 7 days post-axotomy relative to 
injury alone (P < 0.001; Fig. 35A) but was similar at all other time-points. Animals 
receiving systemic TP demonstrated a significant increase in duty cycle at 4, 7, 9, 
and 11 days post-axotomy relative to injured, untreated animals (P < 0.05; Fig. 
35B). Similar to TP treatment, treatment with the combination of ES plus TP 
significantly increased duty cycle at 4, 7, 9, and 11 days post-axotomy compared 
to axotomy alone throughout the time-course (P < 0.05; Fig. 35C). However, the 
combination of ES and TP had no supplementary effect in duty cycle relative to 
either treatment alone (Fig. 35D). 
 
ix. ES and TP increase max contact max intensity mean 
When investigating the effect of treatment on RH max contact max 
intensity mean we observed a main effect between treatment groups (F4,5767 = 
7.48; P < 0.0001), time (F26,5767 = 109.30; P < 0.0001), as well as an interaction 
between treatment x time (F104,5767 = 16.13; P < 0.0001; Fig. 36). Max contact 
max intensity mean was significantly decreased in injured, untreated animals at 2 
days post-axotomy relative to uninjured control animals (53.7 ± 10.1 and 206.4 ± 




Fig. 36: Effect of ES and TP on RH max contact max intensity mean. 
Shown is a time-course of the effect of ES and TP on RH max contact max 
intensity mean post-axotomy (Ax). Uninjured animals (solid line) represent a 
longitudinal baseline throughout the study. Control animals, which were 
axotomized but left untreated (Ax only), are compared to axotomized animals 
receiving only ES (A), only TP (B), or the combination of both ES and TP (C). (D) 
Represents the comparison between the combination of ES and TP relative to 
both ES and TP alone. Data is represented as intensity (arbitrary units) ± SEM. 
Statistical significance was evaluated using linear mixed effects models. Each 
model included random intercepts and slopes for speed and weight for each 
animal. Post hoc pairwise multiple comparisons were performed within time 
points using the Holm-Šidák method when group differences were detected. * 
represents a significant difference between ES, TP, or ES and TP compared to 
axotomy alone, at P < 0.05. # represents a significant difference between ES and 
TP relative to both ES and TP alone, at P < 0.05. For each experimental group, n 
= 5-6 animals/time-point.     
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uninjured animals, with the exception of 42 days post-axotomy. Animals treated 
with ES demonstrated a significantly elevated max contact max intensity mean at 
some of the later time-points between 28 and 42 days post-axotomy, but this 
effect was not consistently maintained (P < 0.05; Fig. 36A). In contrast, animals 
treated with TP demonstrated a significantly higher max contact max intensity 
mean as early as 4 days post-axotomy relative to axotmy alone that lasted for 
several weeks (P < 0.05; Fig. 36B). Animals treated with ES plus TP 
demonstrated a significant increase in max contact max intensity mean 4 days 
post-axotomy relative to animals receiving axotomy alone (P < 0.05; Fig. 36C) 
that lasted until 11 days post-axotomy. This effect returned at the later time-point 
of 25 days post-axotomy, but was not consistently maintained. The combinatorial 
treatment significantly increased max contact max intensity mean at 7 days post-
axotomy relative to either treatment alone (P < 0.05; Fig. 36D) but was similar at 
all other time-points. 
 
b. Non paw-related parameters 
i. ES only and TP only significantly increase SFI 
Evaluation of sciatic functional index (SFI) score did not reveal a main 
effect of treatment group (F3,1429 = 0.91; P = 0.4336) but did reveal an effect of 
post-operative time (F7,1429 = 106.44; P < 0.0001) and an interaction between 
treatment x post-operative time (F21,1429 = 3.91; P < 0.0001; Fig. 37). Axotomized 




Fig. 37: Effect of ES and TP on SFI. 
Shown is a time-course of the effect of ES and TP on SFI score post-axotomy 
(Ax). Control animals, which were axotomized but left untreated (Ax only), are 
compared to axotomized animals receiving only ES (A), only TP (B), or the 
combination of both ES and TP (C). (D) Represents the comparison between the 
combination of ES and TP relative to both ES and TP alone. Data is represented 
as SFI score ± SEM. Statistical significance was evaluated using linear mixed 
effects models. Each model included random intercepts and slopes for speed 
and weight for each animal. Post hoc pairwise multiple comparisons were 
performed within time points using the Holm-Šidák method when group 
differences were detected. * represents a significant difference between ES, TP, 
or ES and TP compared to axotomy alone, at P < 0.05. # represents a significant 
difference between ES and TP relative to both ES and TP alone, at P < 0.05. For 




(Fig. 37). ES treatment significantly elevated SFI levels only at 7 weeks post-
axotomy relative to axotomy alone (-17.4 ±  3.6 and -33.2 ±  3.9; P < 0.05; Fig. 
37A). TP-treated animals demonstrated a significant increase in SFI only at 5 
weeks post-axotomy relative to axotomy alone (-25.2 ±  2.8 and -40.8 ± 3.5; P < 
0.05; Fig. 37B). The combinatorial treatment had no effect on PFI relative to 
axotomy alone (Fig. 37C). Analysis revealed the combination treatment of ES 
plus TP did not have any supplementary benefit to either treatment alone (Fig. 
37D). 
 
ii. ES only and TP only significantly increase PFI 
Overall, we observed a main effect of treatment group (F3,1429 = 2.68; P = 
0.0459), time (F7,1429 = 47.32; P < 0.0001) as well as an interaction between 
treatment x post-operative time (F21,1429 = 8.17; P < 0.0001; Fig. 38) with respect 
to peroneal functional index (PFI) score. Axotomy alone demonstrated a recovery 
in PFI over the extended 8 week time-course (Fig. 38). ES treatment significantly 
elevated SFI levels at the later time-points of 5, 6, and 7 weeks post-axotomy (P 
< 0.05) relative to axotomy alone (Ax + ES: -43.6 ± 10.5, -21.2 ± 11.3, and -8.7 ± 
11.5; Ax only: -97.8 ± 12.8, -73.4 ±  12.7, and -65.0 ±  13.1;  P < 0.05; Fig. 38A). 
TP-treated animals demonstrated a significant increase in SFI at 1, 5, and 6 
weeks post-axotomy (-99.2 ± 14.5, -40.1 ± 10.6, and -32.3 ± 10.6) relative to 
axotomy alone (Ax only at 1 week post-axotomy: -184.3 ± 19.2; P < 0.05; Fig. 
38B). The combinatorial treatment had no effect on PFI relative to axotomy alone 




Fig. 38: Effect of ES and TP on PFI. 
Shown is a time-course of the effect of ES and TP on PFI score post-axotomy 
(Ax). Control animals, which were axotomized but left untreated (Ax only), are 
compared to axotomized animals receiving only ES (A), only TP (B), or the 
combination of both ES and TP (C). (D) Represents the comparison between the 
combination of ES and TP relative to both ES and TP alone. Data is represented 
as PFI score ± SEM. Statistical significance was evaluated using linear mixed 
effects models. Each model included random intercepts and slopes for speed 
and weight for each animal. Post hoc pairwise multiple comparisons were 
performed within time points using the Holm-Šidák method when group 
differences were detected. * represents a significant difference between ES, TP, 
or ES and TP compared to axotomy alone, at P < 0.05. # represents a significant 
difference between ES and TP relative to both ES and TP alone, at P < 0.05. For 
each experimental group, n = 5-6 animals/time-point.  
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TP was significantly lower at 5 weeks post-axotomy (-85.9 ± 13.4) relative to 
either treatment alone (P < 0.05; Fig. 38D).   
 
iii. ES only and TP only significantly increase TFI 
Overall, we did not observe a main effect between treatment groups 
(F3,1429 = 1.73; P = 0.1591; Fig. 39); however, analysis revealed an effect with 
time (F7,1429 = 143.74; P < 0.0001) and an interaction between treatment x post-
operative time (F21,1429 = 86.74; P < 0.0001; Fig. 39) with respect to posterior 
tibial functional index (TFI) score. Axotomy alone demonstrated a recovery in TFI 
over the extended time-course of 1, 2, 3, 4, 5, 6, 7, and 8 weeks post-axotomy 
(Fig. 39). At 5 and 7 weeks post axotomy, treatment with either ES (-33.4 ± 3.3 
and -18.3 ± 3.8, respectively; Fig. 39A) or TP (-25.9 ± 3.0 and -22.2 ± 3.4, 
respectively; Fig. 39B) significantly elevated TFI score relative to injury alone (-
45.3 ± 3.6 and -35.5 ± 4.0, respectively, P < 0.05). In contrast, ES + TP animals 
were similar to axotomy alone at all observed time-points (Fig. 39C). At 4 weeks 
post-axotomy, the combination treatment of ES and TP (-39.7 ± 3.7) 
demonstrated a significantly lower TFI score than either treatment alone (P < 
0.05; Fig. 39D). 
 
iv. TP decreases BOS of front paws 
We found an overall main effect between treatment groups (F4,5863 = 3.00; 




Fig. 39: Effect of ES and TP on TFI. 
Shown is a time-course of the effect of ES and TP on TFI score post-axotomy 
(Ax). Control animals, which were axotomized but left untreated (Ax only), are 
compared to axotomized animals receiving only ES (A), only TP (B), or the 
combination of both ES and TP (C). (D) Represents the comparison between the 
combination of ES and TP relative to both ES and TP alone. Data is represented 
as TFI score ± SEM. Statistical significance was evaluated using linear mixed 
effects models. Each model included random intercepts and slopes for speed 
and weight for each animal. Post hoc pairwise multiple comparisons were 
performed within time points using the Holm-Šidák method when group 
differences were detected. * represents a significant difference between ES, TP, 
or ES and TP compared to axotomy alone, at P < 0.05. # represents a significant 
difference between ES and TP relative to both ES and TP alone, at P < 0.05. For 




treatment x time (F104,5863 = 3.12; P < 0.0001; Fig. 40) with respect to the base of 
support (BOS) of the front paws. Although the BOS of the front paws was 
significantly elevated at 2 days post-axotomy in axotomized animals relative to 
uninjured animals (2.18 ± 0.10 cm and 1.70 ± 0.15 cm, respectively) this effect 
was not consistent across all time-points (P < 0.05; Fig. 40). The BOS of the 
front paws of ES-treated animals was significantly lower at 21 and 23 days post-
axotomy (1.67 ± 0.09 cm and 1.65 ± 0.10 cm, respectively) relative to axotomy 
alone (2.09 ± 0.10 cm and 2.06 ± 0.10 cm) but was similar at all other time-points 
(P < 0.05; Fig. 40A). In TP-treated animals, the BOS of the front paws was 
significantly decreased at multiple time-points between 7 and 14 days post-
axotomy and 21 and 28 days post-axotomy relative to axotomy alone (P < 0.05; 
Fig. 40B). The combination of ES plus TP significantly decreased BOS of the 
front paws at 2 days post-axotomy, but this effect was not consistent across time 
(P < 0.05; Fig. 40C). In addition, the combination of both ES and TP 
demonstrated no additional benefit to either treatment alone throughout the time-
course (Fig. 40D). 
 
v. Treatment does not affect BOS of hind paws     
We observed an overall main effect between treatment groups (F4,5767 = 
4.55; P = 0.0011), time (F26,5767 = 137.50; P < 0.0001), as well as an interaction 
between treatment x time (F104,5767 = 12.71; P < 0.0001; Fig. 41) with respect to 
the BOS of the hind paws. The BOS of the hind paws was significantly increased 




Fig. 40: Effect of ES and TP on BOS of the front paws. 
Shown is a time-course of the effect of ES and TP on BOS of the front paws 
post-axotomy (Ax). Uninjured animals (solid line) represent a longitudinal 
baseline throughout the study. Control animals, which were axotomized but left 
untreated (Ax only), are compared to axotomized animals receiving only ES (A), 
only TP (B), or the combination of both ES and TP (C). (D) Represents the 
comparison between the combination of ES and TP relative to both ES and TP 
alone. Data is represented as BOS of the front paws (cm) ± SEM. Statistical 
significance was evaluated using linear mixed effects models. Each model 
included random intercepts and slopes for speed and weight for each animal. 
Post hoc pairwise multiple comparisons were performed within time points using 
the Holm-Šidák method when group differences were detected. * represents a 
significant difference between ES, TP, or ES and TP compared to axotomy 
alone, at P < 0.05. # represents a significant difference between ES and TP 
relative to both ES and TP alone, at P < 0.05. For each experimental group,        





Fig. 41: Effect of ES and TP on BOS of the hind paws. 
Shown is a time-course of the effect of ES and TP on BOS of the hind paws post-
axotomy (Ax). Uninjured animals (solid line) represent a longitudinal baseline 
throughout the study. Control animals, which were axotomized but left untreated 
(Ax only), are compared to axotomized animals receiving only ES (A), only TP 
(B), or the combination of both ES and TP (C). (D) Represents the comparison 
between the combination of ES and TP relative to both ES and TP alone. Data is 
represented as BOS of the hind paws (cm) ± SEM. Statistical significance was 
evaluated using linear mixed effects models. Each model included random 
intercepts and slopes for speed and weight for each animal. Post hoc pairwise 
multiple comparisons were performed within time points using the Holm-Šidák 
method when group differences were detected. * represents a significant 
difference between ES, TP, or ES and TP compared to axotomy alone, at           
P < 0.05. # represents a significant difference between ES and TP relative to 
both ES and TP alone, at P < 0.05. For each experimental group, n = 5-6 
animals/time-point.    
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control animals (2.84 ± 0.14 cm and 2.09 ± 0.24 cm, respectively; P < 0.05; Fig. 
41) and was maintained throughout the remaining time-course. The BOS of the 
hind paws of ES-treated animals demonstrated no consistent difference relative 
to injury alone (Fig. 41A). In TP-treated animals, the BOS of the hind paws was 
similar to axotomy alone throughtout the time-course (Fig. 41B). The 
combination of ES plus TP significantly increased BOS of the hind paws between 
21 and 28 days post-axotomy (P < 0.05; Fig. 41C). Similarly, the BOS of the hind 
paws in ES and TP treated animals was significantly elevated shortly after 42 
days post-axotomy throughout the remaining time-points relative to injury alone 
(P < 0.05) with the exception of 49 days post-axotomy. In contrast, the 
combination of both ES and TP demonstrated no additional benefit to either 
treatment alone throughout the time-course (Fig. 41D). 
 
vi. TP increases regularity index 
Evaluation of the regularity index revealed an overall main effect between 
treatment groups (F4,5863 = 2.98; P = 0.0181), time (F26,5863 = 149.18; P < 0.0001), 
as well as an interaction between treatment x time (F104,5863 = 12.20; P < 0.0001; 
Fig. 42). Axotomy alone significantly decreased the regularity index at 2 days 
post-axotomy relative to uninjured animals (31.3 ± 2.1% and 99.6 ± 2.1%, 
respectively, P < 0.001) and returned to levels similar to that observed in 
uninjured animals at 11 days post-axotomy (Fig. 42). At the earlier time-points of 
2 and 4 days post-axotomy, ES of the sciatic nerve (40.2 ± 2.0% and 90.8 ± 




Fig. 42: Effect of ES and TP on regularity index. 
Shown is a time-course of the effect of ES and TP on regularity index post-
axotomy (Ax). Uninjured animals (solid line) represent a longitudinal baseline 
throughout the study. Control animals, which were axotomized but left untreated 
(Ax only), are compared to axotomized animals receiving only ES (A), only TP 
(B), or the combination of both ES and TP (C). (D) Represents the comparison 
between the combination of ES and TP relative to both ES and TP alone. Data is 
represented as regularity index (%) ± SEM. Statistical significance was evaluated 
using linear mixed effects models. Each model included random intercepts and 
slopes for speed and weight for each animal. Post hoc pairwise multiple 
comparisons were performed within time points using the Holm-Šidák method 
when group differences were detected. * represents a significant difference 
between ES, TP, or ES and TP compared to axotomy alone, at P < 0.05.             
# represents a significant difference between ES and TP relative to both ES and 




alone (P < 0.05; Fig. 42A). Similarly, TP treatment demonstrated a significant 
elevation at 2, 4, 7, and 9 days post-axtomy (59.6 ± 2.0%, 96.1 ± 1.9%, 101.0 ± 
1.8%, and 100.8 ± 1.7%, respectively) relative to axotomy alone (P < 0.05; Fig. 
42B). At 2, 7, and 9 days post-axotomy, the combination of ES and TP (43.7 ± 
1.9%, 98.9 ± 1.7%, and 96.1 ± 1.8%, respectively) significantly elevated the 
regularity index relative to axotomy alone (P < 0.05; Fig. 42C). The combinatorial 
treatment of ES and TP did not demonstrate a supplementary effect in regularity 
index relative to either treatment alone (Fig. 42D). 
 
vii. Treatment does not affect cadence 
The extended time course did not reveal any differences between treatment 
groups (F4,5863 = 1.23; P = 0.2958) but did reveal a significant effect between time 
(F26,5863 = 21.69; P < 0.0001) as well as an interaction between treatment x time 
(F104,5863 = 3.94; P < 0.0001; Fig. 43). Axotomy alone demonstrated a brief and 
delayed significant increase in the cadence from 11 through 21 days post-
axotomy relative to uninjured animals (P ≤ 0.05; Fig. 43). Treatment with ES 
(Fig. 43A), TP (Fig. 43B), or the combination of ES and TP (Fig. 43C) 
demonstrated no consistent difference across time relative to axotomy alone. 
Thus, the combination of ES and TP showed no supplementary benefit relative to 





Fig. 43: Effect of ES and TP on cadence. 
Shown is a time-course of the effect of ES and TP on cadence post-axotomy 
(Ax). Uninjured animals (solid line) represent a longitudinal baseline throughout 
the study. Control animals, which were axotomized but left untreated (Ax only), 
are compared to axotomized animals receiving only ES (A), only TP (B), or the 
combination of both ES and TP (C). (D) Represents the comparison between the 
combination of ES and TP relative to both ES and TP alone. Data is represented 
as cadence (steps/sec) ± SEM. Statistical significance was evaluated using linear 
mixed effects models. Each model included random intercepts and slopes for 
speed and weight for each animal. Post hoc pairwise multiple comparisons were 
performed within time points using the Holm-Šidák method when group 
differences were detected. * represents a significant difference between ES, TP, 
or ES and TP compared to axotomy alone, at P < 0.05. # represents a significant 
difference between ES and TP relative to both ES and TP alone, at P < 0.05. For 




4. EMG recordings 
Overall, we observed a main effect with time (F1,16 = 4.72; P = 0.05; Fig. 
44); although there was no difference between treatment groups (F3,16 = 1.08; P 
= 0.385) or an interaction observed between treatment x time (F3,16 = 0.20; P = 
0.895; Fig. 44) when examining the EMG amplitude of the tibialis anterior 
muscle. Additional analysis to determine the presence of a treatment effect was 







Fig. 44: Effect of ES and TP on tibialis anterior EMG amplitude. 
Shown is the effect of ES and TP on electromyography (EMG) amplitude post-
axotomy (Ax). EMG amplitudes of animals that were axotomized but left 
untreated (Ax only) and axotomized animals receiving only ES, only TP, or the 
combination of both ES and TP are compared to their respective EMG amplitude 
before Ax. Bars represent means ± SEM. For graphical purposes, the EMG 
amplitudes before axotomy for all treatment groups were averaged together.       





In this study, we characterized the effects of ES and TP on functional 
recovery following sciatic nerve crush axotomy. We found that animals treated 
with systemic TP exhibited the greatest recovery then either treatment with ES 
only or the combination of both ES and TP. Moreover, our results indicate that 
treatment with only ES improved many gait parameters but not to the same 
extent as treatment with only TP. Our results demonstrate that ES and TP 
together significantly improved one parameter, max contact max intensity, 




D. Effects of ES and TP on dendritic morphology 
1. Axotomy and treatment do not alter motoneuron counts 
In normal animals, the number of motoneurons within the identified tibialis 
range averaged 125.83 (± 13.01, Mean ± SEM) on the left side and 134.91 (± 
17.62) on the right side (right/left ratio X 100 = 116.65 ± 21.06). Nerve crush with 
or without subsequent treatment had no effect on the number (F(4,25) = 0.74, ns) 
or ratio (F(4,25) = 0.56, ns) of tibialis motoneurons (Ax only left, 153.14 ± 16.03, 
right, 150.29 ± 23.07, right/left ratio = 98.33± 11.76; Ax + ES left, 179.91 ± 19.55, 
right, 155.46 ± 26.41, right/left ratio = 86.44 ± 11.52; Ax + TP left, 154.20 ± 
15.80, right, 137.54 ± 17.81, right/left ratio = 97.38 ± 18.45; Ax + ES + TP left, 
144.24 ± 22.81, right, 156.48 ± 27.04, right/left ratio = 112.72 ± 15.43; Fig. 45). 
 
2. Motoneuron morphometry 
Injection of BHRP into the right anterior tibialis successfully labeled 
ipsilateral motoneurons in all groups (Fig. 46). Labeled motoneurons were 
located in the lateral motor column in the L3 spinal segment (Nicolopoulos‐
Stournaras & Iles, 1983). Dendritic arbors were strictly unilateral, with extensive 
ramification along the ventrolateral edges of the gray matter and in the lateral 
funiculus, as well as throughout the ventral horn. An average of 35.56 ± 3.34 
motoneurons per animal were labeled with BHRP, and did not differ by group 




Fig. 45: Effect of ES and TP on number of tibialis anterior motoneurons.  
Shown are the number of tibialis anterior motoneurons of normal controls (No Ax) 
and axotomized animals (Ax only) that were either treated with ES, TP, or ES + 
TP. (A) Location of tibialis anterior motoneurons in column 4 of the lateral motor 
column in the L3 spinal segment. (B) Image of tibialis anterior motoneurons. (C) 
Number of contralateral and ipsilateral tibialis anterior motoneurons at 58 days 
post-axotomy. (D) Number of tibialis anterior motoneurons as a percent ratio of 
ipsilateral/contralateral side. Bar heights represent means ± SEM.  







Fig. 46: Darkfield digital micrographs and somata composites 
demonstrating the effect of ES and TP on the dendritic arbor of tibialis 
anterior motoneurons.  
Shown are darkfield digital micrographs of transverse hemisections through the 
lumbar spinal cord and corresponding computer-generated composites of labeled 
somata and processes after BHRP injection into the right tibialis anterior muscle. 
Composites of BHRP-labeling were selected as representative of the respective 




a. Axotomy and treatment do not alter soma volume   
In normal animals, tibialis motoneuron somata were typical in size 
(24985.63 ± 1946.05 μm3), and did not differ from those of Ax only (22143.52 ± 
2507.01 μm3), Ax+ES (24107.88 ± 1176.06 μm3), Ax + TP  
 (25849.02 ± 2268.86 μm3), or Ax + ES + TP (29511.34 ± 2470.25 μm3) animals 
(F(4,25) = 1.49, ns; Fig. 47). 
 
b. TP attenuates axotomy-induced dendritic hypertrophy 
Following nerve crush, tibialis motoneurons underwent marked dendritic 
hypertrophy. Dendritic length increased by 174.57% (11741.62 ± 1931.11 µm in 
Ax only animals compared to 4276.42 ± 928.54 µm for normal animals, LSD, P < 
0.05; overall test for the effect of group on arbor per cell F(4,22) = 5.15, P < 0.05; 
Fig. 48). Treatment with ES or ES + TP had no effect on dendritic hypertrophy: 
dendritic lengths in Ax + ES animals (11233.80 ± 2449.38 μm) and Ax + ES + TP 
(13345.94 ± 2449.38 μm) were 162.69% and 212.08% (respectively) longer than 
those of normal animals (LSDs P < 0.05), and did not differ from each other 
(LSD, ns). In contrast, treatment with TP attenuated crush-induced hypertrophy: 
dendritic lengths in Ax+TP animals (8385.91 ± 1686.28 μm) were 96.10% longer 
than those of normal animals but this difference did not reach statistical 
significance (LSD, ns). Dendritic length per bin was nonuniform across radial 









Fig. 47: Effect of ES and TP on soma volume. 
Shown is the cross-sectional soma areas of tibialis anterior motoneurons of 
normal controls (No Ax) and axotomized animals (Ax only) that were either 
treated with ES, TP, or ES + TP. Bar heights represent means ± SEM  








Fig. 48: Effect of ES and TP on dendritic arbor. 
Shown is the dendritic lengths of tibialis anterior motoneurons of normal controls 
(No Ax) and axotomized animals (Ax only) that were either treated with ES, TP, 
or ES + TP. Bar heights represent means ± SEM. * indicates significantly 





location (F(11,242) = 41.51, P < 0.05; Fig. 49). Consistent with the results of the 
arbor per cell analysis, there was also a significant effect of group (F(4,242) = 5.17, 
P < 0.05). Increases in dendritic length occurred throughout the radial distribution 
in Ax only animals compared to that of normal animals (an average of 275.91%; 
F(1,110) = 14.46, P < 0.05). Similar increases in length throughout the radial 
distribution of the dendritic arbor were present in animals treated with ES 
(averaging 271.18%) or ES + TP (326.87%) (Fs(1,110) > 15.30, Ps < 0.05). 
Consistent with the attenuation in crush-induced dendritic hypertrophy seen after 
TP treatment, smaller but statistically significant (F(1,110) = 5.27, P < 0.05) 
increases in length throughout the radial distribution of the dendritic arbor were 
present in Ax + TP animals (averaging 198.12%). 
 
c. TP attenuates axotomy-induced dendritic extent 
Consistent with the nonuniform dendritic distribution of tibialis 
motoneurons apparent in Fig. 49, radial dendritic extent differed across bins (Fig. 
50), and repeated-measures ANOVA revealed a significant effect of location 
(F(11,242) = 69.83, P < 0.05). Radial dendritic extent also differed across groups 
(F(4,242) = 8.73, P < 0.05). Increases in dendritic extent occurred throughout the 
radial distribution in Ax only animals compared to that of normal animals (an 
average of 159.59%; F(1,110) = 20.12, P < 0.05). Similar increases in extent 
throughout the radial distribution of the dendritic arbor were present in animals 







Fig. 49: Effect of ES and TP on dendritic arbor across radial bins. 
Top: Drawing of gray matter divided into radial sectors for measure of tibialis 
anterior motoneuron dendritic distribution. 
Bottom: Shown is the length per radial bin of tibialis anterior motoneurons of 
normal controls (No Ax) and axotomized animals (Ax only) that were either 
treated with ES, TP, or ES + TP. For graphical purposes, dendritic length 
measures have been collapsed into 6 bins of 60° each. Bar heights represent 







Fig. 50: Effect of ES and TP on dendritic extent. 
Top: Drawing of gray matter divided into radial sectors for measure of tibialis 
anterior motoneuron radial dendritic extent. 
Bottom: Shown is the radial extents of tibialis anterior motoneurons of normal 
controls (No Ax) and axotomized animals (Ax only) that were either treated with 
ES, TP, or ES + TP. For graphical purposes, dendritic length measures have 
been collapsed into 6 bins of 60° each. Bar heights represent means ± SEM. * 




(Fs(1,110) > 6.65, Ps < 0.05). Rostrocaudal dendritic extent also differed across 
groups (F(4,22) = 3.72, P < 0.05; Fig. 51), spanning 2605.70 ± 147.00 µm in 
normal animals, and increasing to 4000.00 ± 572.40 µm in Ax + ES animals, and 
4128.00 ± 478.4 µm in Ax+ES+TP animals (LSDs, Ps < 0.05). Rostrocaudal 
extent in Ax only (3424.00 ± 164.7 µm) and Ax + TP (3328.00 ± 163.2 µm) 
animals did not differ from that of normal animals (LSDs, ns).  
 
6. Summary       
In this study, we characterized the effects of ES and TP on motoneuron 
morphology following sciatic nerve crush axotomy. We found that crush axotomy 
and treatment did not alter the number of tibialis motoneurons. Interestingly, our 
results indicate crush axotomy leads to hypertrophy of the dendritic arbor of 






   
 
Fig. 51: Effect of ES and TP on rostrocaudal extent of the dendritic arbor. 
Shown is the rostrocaudal extent of tibialis anterior motoneurons of normal 
controls (No Ax) and axotomized animals (Ax only) that were either treated with 
ES, TP, or ES + TP. Bar heights represent means ± SEM  




CHAPTER 5: DISCUSSION 
 
It is well-established that functional recovery is suboptimal following 
peripheral nerve injury (PNI), especially with transection injuries, with full 
functional recovery seen in approximately 50% of individuals (Kallio & Vastamäki, 
1993). The use of electrical stimulation (ES), gonadal steroids, growth factors, 
and exercise as therapies following axotomy have had great success in rodents, 
but few have shown promise in a clinical setting (Gordon et al., 2010). It is likely 
that the greatest success in achieving full functional recovery will come from the 
use of a combinatorial approach that has the potential to stimulate multiple 
targets and pathways. Several objectives must be accomplished to have 
successful regeneration and complete functional recovery: 1)  maintaining the 
internal neuronal growth state, 2) increasing regeneration-associated genes to 
promote axon elongation across the injury site, 3) removing inhibitory debris to 
promote a permissive environment, 4) increasing axonal regeneration by 
decreasing the time before sprout formation and/or accelerating regeneration 
rate, 5) increasing regeneration specificity, and 6) maintaining viable and intact 
target end-organs. Many of the aforementioned treatments target one or more of 
these goals, although two treatments show more promise than the others. Both 
ES and testosterone propionate (TP) address several of the goals listed above. 
ES decreases the time before sprout formation and increases regeneration 
specificity (Brushart, 1988; Sharma et al., 2009). On the other hand, TP 
maintains the internal growth state and target end-organs while also enhancing 
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axonal regeneration rate (Kujawa et al., 1993; Tetzlaff et al., 2007; Verhovshek et 
al., 2010; Verhovshek & Sengelaub, 2013). Together, ES and TP increase 
regeneration-associated gene expression (Jones et al., 1999; Al-Majed et al., 
2000a; Fargo et al., 2008; Sharma et al., 2010a). From a translational 
perspective, ES has demonstrated therapeutic potential in the clinic following 
axotomy (Gordon et al., 2010) and TP is currently utilized in the clinic to treat 
other disorders, thus making it an easily translational therapy for treatment of 
PNI. The results presented in the preceding chapter have provided insight into 
the mechanisms by which ES and TP promote functional recovery following 
sciatic nerve crush injury. Following is a discussion of some of those key results 
and their impact on the current literature.  
 
A. Validation Experiments 
As previously discussed, functional recovery following nerve injury is 
dependent upon several factors: type and location of injury, age of individual, and 
regeneration distance to target (Birch & Raji, 1991; Perry et al., 1992; Fu & 
Gordon, 1995a, 1995b). In the current study, we demonstrated that there is a 
significant increase in βII-tubulin mRNA expression with proximal sciatic nerve 
crush injury relative to a distal sciatic nerve crush axotomy; findings which have 
been previously documented (Fernandes et al., 1999). Therefore, we can 
conclude that the strength of the motoneuron response following injury is in direct 
proportion to the proximity of injury to the cell body.  
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The peripheral nervous system exhibits a high degree of symmetry with 
side-to-side integration particularly extensive in the spinal cord. Some animal PNI 
models, such as the facial nerve injury model, have historically utilized the 
contralateral side as an internal control for analysis, such as normalizing gene 
expression data (Haulcomb et al., 2014). However, numerous examples of 
unilateral injury have been reported to produce bilateral effects, including 
alterations in gene expression and nociceptive response (McGregor et al., 1984; 
Sugimoto et al., 1990; Booth & Brown, 1993; Koltzenburg et al., 1999; Pettersson 
et al., 2004). In contrast to motor nuclei in the brainstem, the spinal cord is 
anatomically predisposed to exhibit contralateral effects to unilateral nerve injury 
(Kiernan & Rajakumar, 2013).      
In the literature, there are contradictory data on whether nerve injury can 
lead to a contralateral effect in gene expression in the spinal cord (Booth & 
Brown, 1993; Fernandes et al., 1999; Pettersson et al., 2004). The current study 
revealed alterations in the expression of αI-tubulin, βII-tubulin, and collapsin 
response mediator protein 2 (crmp2) with axotomy alone. Some studies have 
reported altered mRNA levels of pituitary adenylate cyclase-activating peptide 
(pacap) and 43-kiloDalton growth-associated protein (gap-43) in intact 
motoneurons contralateral to a sciatic nerve lesion (Booth & Brown, 1993; 
Pettersson et al., 2004). Similar to our findings, Pettersson and colleagues did 
not detect a change in pacap expression on the contralateral side with a distal 
sciatic nerve injury (level of mid-thigh), but did observe a slight increase in pacap 
expression after a proximal sciatic nerve injury (Pettersson et al., 2004). Given 
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the discrepancy in the literature and our current results, we did not use the 
contralateral side as an internal control.  
 
B. ES and TP differentially alter regeneration-associated gene expression 
It is well-established that motoneurons undergo a robust response to 
axotomy and shift from a state of maintenance to growth/repair (Lieberman, 
1971). This morphological shift is critical for motoneurons to regenerate and 
characterized by several changes in the somata, including chromatolysis, 
swelling, and an upregulation of genes critical for neuronal recovery and repair 
(regeneration-associated genes; Lieberman, 1971). In the current study, we 
analyzed the effects of ES and TP on axotomy-induced expression of the 
following regeneration-associated genes: αI-tubulin, βII-tubulin, gap-43, crmp2, 
brain derived neurotrophic factor (bdnf), glial cell derived neurotrophic factor 
(gdnf), pacap, and neuritin.       
Over the extended post-axotomy time-course, we observed an increase in 
gap-43 mRNA expression at 7 days post-axotomy. Previous studies from our 
laboratory and others support the upregulation of gap-43 mRNA following 
axotomy (Tetzlaff et al., 1991; Jones et al., 1997a; Sharma et al., 2010a). In 
addition, we observed a downregulation in the expression of αI-tubulin and crmp2 
after axotomy that contradicts what has been previously reported (Pasterkamp et 
al., 1998; Sharma et al., 2010a), and which could be attributed to differences in 
the molecular response of cranial versus spinal neurons. Initially, it was 
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surprising that we did not observe significant changes in the expression of βII-
tubulin, bdnf, and pacap with axotomy alone, as all of these genes have been 
reported to increase after facial or sciatic nerve axotomy (Brown et al., 1999; 
Zhou et al., 1999; Pettersson et al., 2004; Sharma et al., 2010a; Haulcomb et al., 
2014). However, these contradictory findings could be due to differences in 
tissue source and extraction methodologies (i.e. motoneuron cell body vs. entire 
ventral horn) and also the lesion site. Similar to previous studies, we found no 
axotomy-induced increase in neuritin mRNA (Höke et al., 2000; Fargo et al., 
2008; Sharma et al., 2010a).    
Several groups have reported an increase in gdnf expression after 
axotomy in the DRG, dorsal horn, and sciatic nerve (Höke et al., 2000; Dong et 
al., 2005; Cobianchi et al., 2013). In contrast, resultant low gdnf expression within 
the whole spinal cord has been documented following axotomy (Cobianchi et al., 
2013), which is in agreement with our current results. ES has been demonstrated 
to increase gdnf expression in the DRG, but not the ventral horn, at 1 and 3 days 
following sciatic nerve injury (Cobianchi et al., 2013). Similarly, we did not detect 
a change in gdnf expression at 1 day post-axotomy. Although we discovered ES-
treated animals displayed a significant increase in ventral horn gdnf expression 
at 2 days post-axotomy, this discrepancy is most likely due to temporal 
differences.  
We also reported ES treatment has no effect on early bdnf expression. In 
contrast, Cobianchi et al. published an increase in bdnf ventral horn expression 
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following axotomy and ES treatment (Cobianchi et al., 2013); however, their 
analysis was relative to sham animals and not to injured animals.    
An earlier study from our laboratory concluded that one 30 minute session 
of low frequency ES (20 Hz) was just as effective as daily, 30 minute ES at the 
same low frequency (Foecking et al., 2012). Therefore, for the current study we 
used one 30 minute session of low frequency ES (20 Hz). It is possible that a 
longer stimulation session or multiple sessions would lead to more robust 
increases in regeneration-associated gene expression following sciatic nerve 
crush injury (Sharma et al., 2010a).  
Previously, our laboratory reported that systemic TP treatment enhanced 
bdnf mRNA after facial nerve injury at 7 days post-axotomy (Sharma et al., 
2010a). Similarly, we observed an upregulation in bdnf expression with systemic 
TP treatment but at an earlier time-point of 2 days post-axotomy. Most likely, the 
temporal delay observed by Sharma et al. is due to the fact they utilized a 
proximal nerve injury model and thus more time was necessary for nerve 
degeneration. In addition, they examined a mostly pure motoneuron population 
and could detect smaller changes in mRNA expression.   
To our knowledge, we are the first to investigate the combined effects of 
ES and TP on the expression of both gdnf and crmp2 after sciatic nerve injury. 
Our results indicate that together ES and TP together act in an additive manner 
to elevate gdnf levels 1 day post-axotomy. Cobianchi et al. found that ES in 
combination with treadmill exercise led to a synergistic increase in gdnf ventral 
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horn expression following sciatic nerve axotomy (Cobianchi et al., 2013). It is 
possible that multiple pathways need to be activated to achieve substantial 
elevation in gdnf expression, which could explain the greater effect on gdnf 
expression with the combinatorial treatment of ES and TP rather than with ES 
alone. Moreover, we observed an early and late decrease in mRNA expression 
of crmp2 in response to ES and TP treatment. Similar to gap-43, crmp2 is 
important in axonal growth and shows a decreased expression level at a late 
time-point similar to that of gap-43. Decreased expression of both gap-43 and 
crmp2 could indicate a decrease in axonal outgrowth, resulting in a slower rate of 
axon regeneration.  
The work by Sharma et al. effectively described the differential and 
combinatorial effects of ES and TP on regeneration-associated gene expression 
after facial nerve axotomy (Sharma et al., 2010a). For ease of discussion, a 
comparison of the previous study by Sharma et al. and the current study is 
summarized in Table 8. Sharma and colleagues demonstrated that ES and TP 
differentially altered the expression of αI-tubulin, βII-tubulin, and gap-43, whereas 
the combination of ES and TP increased the expression of bdnf, neuritin, and 
pacap. Interestingly, our results with a different injury model, crush injury to the 
sciatic nerve, contrasted significantly with those reported by Sharma and 
coworkers. ES has been reported to enhance αI-tubulin, gap-43, and pacap 
mRNA expression (Al-Majed et al., 2004; Sharma et al., 2010a). In addition, 
findings from our laboratory have established that TP enhances βII-tubulin 
expression following facial and sciatic nerve axotomy (Jones & Oblinger, 1994; 
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Jones et al., 1999; Brown et al., 2001; Storer et al., 2002; Sharma et al., 2010a). 
Yet, in the current study, we did not observe any changes in αI-tubulin or βII-
tubulin expression with ES or systemic TP treatment alone, but a combinatorial 
treatment of ES and TP resulted in early increases in αI-tubulin expression and 
late downregulation in both αI-tubulin and βII-tubulin. Furthermore, in the current 
study we did not find an altered expression of gap-43 with either ES or TP 
treatment alone (Jones et al., 1997a; Al-Majed et al., 2004; Sharma et al., 2010a) 
but did observe a decrease in gap-43 levels after concerted administration of ES 
and TP. Previously, Sharma et al. found the expression levels of bdnf were 
unchanged by the individual treatments of ES or TP but were elevated after 
treatment with both ES and TP following facial nerve axotomy (Sharma et al., 
2010a). In contrast to their findings, results from our current study indicate that 
administering TP led to an early increase, while ES treatment led to a late 
downregulation in bdnf expression. Sharma and colleagues report that when ES 
and TP were administered together, ES led to an early increase in neuritin mRNA 
whereas TP elevated neuritin levels in a delayed fashion. Most notably, the 
current study revealed no change in the expression of neuritin after sciatic nerve 
crush axotomy. In the facial nerve axotomy model, treatment with the 
combination of ES and TP elevated the expression of pacap in a synergistic 
manner and demonstrated the most robust change out of all of the regeneration-
associated genes that were examined in the study (Sharma et al., 2010a). 
Interestingly, treatment did not alter pacap expression in the sciatic nerve injury 
model used in the current study.  
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The numerous findings our study which contradict what has been reported 
in other PNI models raise several interesting questions that should be considered 
when guiding future investigations for therapeutic strategies and whether ES 
and/or TP are beneficial treatments following PNI. First, the remarkable 
dichotomy in differential and combinatorial effects observed between the facial 
and sciatic nerve injuries supports the theory that cranial and spinal 
motoneurons, respectively, molecularly respond differently to treatment following 
PNI. Second, our results support the idea that gene expression levels in direct 
proportion to injury distance from the motoneuron cell body. In our model of distal 
sciatic nerve crush injury, we observed smaller changes in expression compared 
to what has been reported by others using a proximal nerve crush injury model 
(Fernandes et al., 1999; Pettersson et al., 2004; Sharma et al., 2010a). 
Furthermore, our results demonstrate ES and TP alone lead to an early increase 
in expression of regeneration-associated genes; however, when ES and TP are 
administered in combination they elicit a late suppressive effect in regeneration-
associated gene expression. These results agree with a rapid regenerating 
response at the level of the motoneuron cell body accompanied by rapid 
functional recovery, which will be discussed in more detail below. Lastly, the type 
of injury should be considered when choosing the best therapeutic strategy. 
Although our experiments were restricted to crush axotomy, a more severe 
transection injury may respond differently to ES and/or TP treatment. The latter 




C. TP improves functional recovery following sciatic nerve crush axotomy 
Rodent gait analysis has been long utilized as a method to assess 
therapeutic efficacy and extrapolate to humans (Medinaceli & Wyatt, 1988). 
Moreover, rodent locomotion has been examined in the context of treatment 
efficacy on several disease and injury models, including Parkinson’s disease, 
amyotrophic lateral sclerosis, and PNI (Deumens et al., 2007; Hampton & 
Amende, 2009; Westin et al., 2012).The CatWalk gait analysis system is an 
automated unforced gait analysis method and has been utilized to measure 
functional recovery following sciatic nerve crush and transection injuries 
(Deumens et al., 2007; Bozkurt et al., 2008). From these studies, it was 
discovered that sciatic nerve injury altered several gait parameters, including but 
not limited to print length, print width, print area, swing, swing speed, step cycle, 
duty cycle, max contact max intensity mean, sciatic functional index (SFI), 
peroneal functional index (PFI), posterior tibial functional index (TFI), and base of 
support (BOS) of the hind paws. Although CatWalk examines 162 gait 
parameters, we limited our analysis to clinically relevant parameters, such as 
those described above with the addition of stride length, BOS of the front paws, 
and cadence. It should be noted, for all paw related parameters only the right 
hind (RH) paw was analyzed.   
In addition to gait analysis, other behavioral assessments have been 
utilized to examine functional recovery after nerve injury, such as grip strength 
and electromyography (EMG) recordings (Galtrey & Fawcett, 2007; Hamilton et 
al., 2011). Both grip strength and EMG measurements correlate with nerve 
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reinnervation to intrinsic muscles of the paws. We adapted these methods to 
measure functional recovery of the hind limbs following sciatic nerve axotomy.  
For assessment of the effects of ES and TP on functional recovery, we 
employed a variety of behavioral tests, including automatic foot misplacement, 
grip strength, CaWalk©, and EMG recordings. Below, I will discuss our findings in 
context with the current literature and our original hypothesis. 
The foot misplacement apparatus tests the ability of the rat to use all four 
paws in a coordinated manner. An increase in the number of rear leg errors 
indicates a decrease in coordinated movement. Although all axotomized groups 
demonstrated a significant increase in the number of rear leg errors 2 days post-
axotomy, few rear legs errors were observed for the remaining time-course. 
These data suggest axotomized animals quickly adapted to the behavioral test 
and altered their gait. Likewise, axotomized animals exhibited a significant 
decrease in grip strength relative to uninjured animals. Although no significant 
treatment effect was observed, ES had the strongest effect in returning grip 
strength levels to those of uninjured animals.  
The time-line for functional recovery following a sciatic nerve crush injury 
has been well documented (Forman & Berenberg, 1978; Alberghina et al., 1985; 
Brown et al., 1999; Lago & Navarro, 2006). Based on our results, axotomoized 
animals returned to levels of uninjured animals in all of the behavioral parameters 
analyzed, including EMG activity, with the exception of BOS hind paws, print 
length, print width, and print area. These findings suggest that, in the absence of 
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treatment, animals still exhibit deficits at 8 weeks post-axotomy, which 
substantiates the need for therapeutic intervention to achieve full functional 
recovery.   
Print length and print width are used to calculate the total area of the paw 
that is in contact with the glass floor (print area). A larger print area indicates that 
a larger portion of the foot is in contact with the glass floor. A decrease in print 
length, print width, and print area has been reported following sciatic nerve 
transection and crush (Deumens et al., 2007; Bozkurt et al., 2008). Systemic TP 
treatment beginning immediately after injury resulted in the most pronounced 
improvement throughout the time-course for print length, print width, and thus 
print area, compared to either treatment with only ES or the combination of ES 
and TP following axotomy. An increase in all three of these parameters indicates 
reinnervation of the calf and foot muscles (de Medinaceli et al., 1982; Brown et 
al., 1999). The abililty of TP treatment to improve print length, print width, and 
print area better than ES treatment or the combination of ES and TP, suggests 
TP treatment alone can accelerate regeneration of the sciatic nerve (Brown et al., 
1999). 
Stride length is the distance between two successive placements of the 
same paw, in this case the RH paw. Axotomy has been shown to have no effect 
on stride length when examined as early as 3 days post-axotomy (Deumens et 
al., 2007). We observed a significant increase in stride length with injury at 2 
days post-axotomy. In line with previous findings, this effect diminished by 4 days 
post-axotomy (Deumens et al., 2007). Interestingly, treatment with either ES or 
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TP alone significantly decreased stride length relative to the combination of ES 
and TP. This suggests that ES and TP individually can decrease the distance 
between two consecutive placements of the RH paw. Despite the paw being 
placed more frequently, there was no significant difference in cadence among 
any of the groups. 
Swing has been reported to increase with axotomy and is defined as the 
duration in seconds of no contact of the RH paw with the glass plate (Vrinten & 
Hamers, 2003; Deumens et al., 2007; Bozkurt et al., 2008). Similarly, we 
observed an increase in swing following crush injury to the sciatic nerve. 
Individually, ES and TP decreased swing by 2 days post-axotomy relative to no 
treatment. However, the combination of both ES and TP had no supplementary 
benefit. These data suggest ES and TP individually decrease the amount of time 
the RH paw is in the air between consecutive placements of that paw.  
Stand is defined as the duration of time the RH paw is in contact with the 
glass plate. Step cycle is defined as the time in seconds between two 
consecutive initial contacts of the same paw and can be calculated as the sum of 
both stand and swing. Given that minor differences were observed across 
treatment groups in swing, it is not surprising we did not detect substantial 
treatment differences with step cycle.  
Duty cycle expresses stand as a percentage of step cycle. In the current 
study, duty cycle significantly increased within the first 2 weeks post-axotomy 
across all treatment groups. Since small treatment effects were detected with 
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step cycle, the treatment effect observed with duty cycle is mostly attributed to an 
increase in stand or the time the RH paw was placed on the glass. In contrast to 
our results, Bozkurt and colleagues report a decrease in duty cycle following 
sciatic nerve crush injury (Bozkurt et al., 2008). It should be noted that their data 
is reported as a percent ratio of ipsilateral to contralateral hind paws and the 
current study did not examine the duty cycle of the contralateral hind paw. Taken 
together, these data suggest that either ES or TP treatment alone is beneficial in 
improving gait parameters following injury.        
Swing speed takes into account both stride length and swing and is the 
speed of the RH paw during swing. Since there were no substantial differences 
among treatment groups in stride length, swing, or cadence, it was surprising to 
us that TP-treated animals exhibited significant increases in swing speed 
between the second and fourth weeks post-axotomy. One explanation for these 
differences is that TP-treated animals had a shorter swing, albeit not significant, 
during the second and fourth weeks post-axotomy. Furthermore, a decrease in 
swing would lead to an increase in swing speed. Our results contradict what has 
been reported previously by Bozkurt et al. (2008); however, it should be noted 
their data is expressed a ratio of the ipsilateral to contralateral hind paw and the 
current study did not examine swing speed of the contralateral hind paw. 
In 1988, Bain et al. modified formulas to calculate functional recovery of 
the sciatic nerve and its branches (Bain et al., 1989). The formulas proposed by 
Bain et al. are the basis for calculation of SFI, PFI, and TFI with the CatWalk 
system (Fig. 4). A decrease in SFI, PFI, or TFI indicates a deficit in the injured 
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hind paw and the inability of the rat to correctly spread their toes. Regardless of 
treatment, animals showed early improvement in SFI, PFI, and TFI. ES of the 
sciatic nerve significantly improved SFI, PFI, and TFI during the later phases of 
recovery, an observation reported by others (Gigo-Benato et al., 2010; Zhang et 
al., 2013). Although we observed improvements with ES at slightly later time-
points than what has been previously published, these differences are most likely 
due to differences in location of injury and duration of ES treatment. TP-treated 
animals exhibited PFI recovery relatively early and all three parameters were 
significantly improved in later recovery phases (Brown et al., 1999).  In contrast, 
the combination of ES plus TP did not enhance the benefits of individual 
treatments only. Together, these data suggest with a distal sciatic nerve injury, 
either treatment alone is sufficient to improve functional recovery; however, the 
combination of ES and TP gives no additional therapeutic advantage. 
BOS indicates stability of the trunk of the animal and is defined as the 
average width between either the front or hind paws. In agreement with the 
literature describing gait alterations after spinal cord injury, we observed no 
consistent difference in BOS of the front paws of axotomized animals compared 
to uninjured animals (Hamers et al., 2001). Treatment with either ES or TP 
resulted in a decreased front paw BOS that was similar to uninjured animals. In 
contrast to results within the literature, hind paw BOS increased at 3 weeks post-
axotomy relative to uninjured animals (Deumens et al., 2007), which is most 
likely due to differences in type of injury. For example, Deumens et al. measured 
the BOS of hind paws using a transection injury, rather than a crush injury as 
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presented in the current study. It is likely that a more severe nerve injury results 
in a shorter hind paw BOS. Interestingly, we observed no treatment effect on 
hind paw BOS. Moreover, the combination of ES plus TP resulted in an even 
wider hind paw BOS, relative to axotomy alone. Taken together, these data 
suggest either treatment alone is effective in treating distal sciatic nerve injury; 
whereas, the combinatorial treatment of both ES and TP provided no additional 
benefit. 
Regularity index measures the degree of interlimb coordination and is 
expressed as the number of normal step sequence patterns and paw 
placements. In healthy uninjured rats, the regularity index is valued at 100%. 
After injury, there is a loss in interlimb coordination and decrease in regularity 
index. Relative to uninjured animals, we observed a significant decrease in the 
regularity index all axotomized groups regardless of treatment; accordingly, these 
data suggest injured animals exhibited extra paw placements and irregular 
walking patterns (Hendriks et al., 2006). Minor, yet significant, improvements 
were detected in all treated animals within the first two weeks following axotomy. 
These results are similar to our observations with swing, step cycle, and stride 
length. Together, these results indicate an alteration in gait immediately after 
injury. Deumens et al. (2007) report no change in regularity index following 
sciatic nerve resection in comparison to our findings.  It should be noted that our 
results indicate recovery of regularity index by 7 days post-axotomy which is in 
accordance with their data.  
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Max contact max intensity is the average maximum intensity when the 
paw is in maximum contact with the glass floor. Intensity ranges from 0 to 255 
and depends on the degree of contact between the paw and glass floor. Vrinten 
and Hamers examined paw intensity utilizing a sciatic nerve constriction injury 
model, which causes neuropathic pain (Vrinten & Hamers, 2003). Following 
nerve injury, they observed a decrease in paw intensity of the injured hind limb 
that gradually returned to pre-injury levels over time. In addition, Vrinten and 
Hamers demonstrated a high correlation between intensity and mechanical 
withdrawal thresholds.  
In the current study, all axotomized groups, regardless of treatment, 
exhibited a significant decrease in max contact max intensity mean of the injured 
paw. These results are similar to what have been observed by others (Vrinten & 
Hamers, 2003; Deumens et al., 2007; Bozkurt et al., 2008). ES of the sciatic 
nerve led to a delayed increase in the max contact max intensity mean, relative 
to systemic treatment with TP. In addition, the combination of ES and TP 
significantly increased the max contact max intensity mean similar to that 
observed with treatment of TP. Surprisingly, the combinatorial treatment led to a 
synergistic effect in intensity at 1 week post-axotomy relative to either individual 
treatment, an effect that was not observed with any other behavioral measure.    
From these tests, our results indicate that either ES or TP alone 
demonstrate therapeutic potential following sciatic nerve crush injury. In addition, 
the combination of ES and TP did not demonstrate any improvements in 
functional recovery, with the exception of max contact max intensity mean. 
193 
 
Despite this difference, the combinatorial difference appeared to worsen recovery 
in some measurements. In accordance with our molecular data, the inability of 
the combinatorial treatment to enhance functional recovery may be due to 
suppressed expression of regeneration-associated genes.  
 
D. TP attenuates axotomy-induced dendritic hypertrophy 
There is a dichotomy in motoneuron death in rodents following injury that 
is contingent upon age. It is well-established that newborn rat motoneurons are 
susceptible to cell death following spinal nerve axotomy (Schmalbruch, 1984); 
however, there is very limited motoneuron death in adult rats (Gu et al., 1997). 
One study published by Gu et al. (1997) investigated the effect of spinal nerve 
axotomy on motoneuron loss in adult rats. They discovered there was no 
motoneuron loss in the spinal cord if the lesion site was at least 4 mm distal to 
the soma. In the current study, we observed a comparable number of HRP-
labeled tibialis anterior motoneurons to that observed in the literature 
(Nicolopoulos‐Stournaras & Iles, 1983). Moreover, crush injury did not affect 
motoneuron number (Gu et al., 1997), and motoneurons were healthy with 
respect to similar soma volumes across all groups. 
Dendritic morphology is directly correlated with the electrophysiological 
response of a neuron (Rumberger et al., 1998; Lu et al., 2001; Grudt & Perl, 
2002). Moreover, the dendritic morphology of motoneurons is influenced by injury 
(Standler & Bernstein, 1982; Wellman & Sengelaub, 1995). For example, the 
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dendritic fields of spinal motoneurons undergo a cyclic pattern of degeneration 
and regeneration following ventral root crush (Standler & Bernstein, 1982). In the 
current study, we found that crush axotomy led to hypertrophy of the dendritic 
arbor that extended in a radial and rostrocaudal direction. In addition, we 
discovered that TP treatment attenuated the axotomy-induced dendritic 
hypertrophy. At first, we were surprised that our results contradict what others 
have reported (Bowe et al., 1992; O'Hanlon & Lowrie, 1995); however, these 
morphological differences could expain why animals do not regain normal 
functional recovery by 2 months post-axotomy. Consequently, attenuation of the 
dendritic tree by TP treatment may reflect a restoration of synaptic inputs similar 
to that of an uninjured state and is one possible explanation for why TP treatment 
demonstrated the greatest therapeutic effect in regards to our behavioral data.  
After closer examination, several differences exist between the current 
and preceding studies. The study led by Bowe et al. (1992) investigated the 
effects of a distal sciatic nerve crush injury in adult female rats on motoneuron 
morphology, including the dendritic arbor, at 5 and 10 months post-axotomy. It 
should be noted that their distal sciatic nerve injury was at mid-thigh level and 
proximal to the lesion performed in the current study. At 5 months post-axotomy, 
Bowe et al. observed no differences in the morphology of ipsilateral sciatic 
motoneurons relative to contralateral motoneurons. However, at 10 months post-
axotomy ipsilateral sciatic motoneurons displayed an increase in perikaryal area 
relative to contralateral sciatic motoneurons. The results from the current study 
demonstrated sciatic nerve axotomy resulted in dendritic hypertrophy of tibialis 
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anterior motoneurons which are a subset of sciatic motoneurons. It is highly 
possible that sciatic nerve axotomy, regardless of injury location, leads to a 
hypertrophy in dendritic arborization by 2 months post-axotomy that regresses by 
5 months post-axotomy. This question could be answered with further 
experimentation. 
In opposition to our findings, O’Hanlon and colleagues discovered that 
sciatic nerve crush injury led to a smaller dendritic tree of hallucis longus 
motoneurons at 1 and 2 months post-axotomy (O'Hanlon & Lowrie, 1995). 
Several similarities exist between the study executed by O’Hanlon et al. and the 
current study, such as rat age and sex and location of injury. However, it should 
be noted the authors examined dendritic properties of a different pool of 
motoneurons. It is highly possible that different pools of spinal motoneurons 
respond differently to axotomy and could explain the contradictory results. If we 
assume that all spinal motoneurons respond the same to axotomy, several other 
differences between the two studies are worthy of discussion. First, O’Hanlon et 
al. limited their analysis to isolated motoneurons and did not take into account 
the dendritic tree from motoneurons that had overlapping dendritic arbors. 
Second, their analysis was restricted to within one tissue section. As a result, 
their analysis was biased toward smaller motoneurons that were isolated. 
Moreover, the entire dendritic length of each cell (in both the transverse and 
longitudinal planes) was not considered in their final analysis. Together, these 
differences could have led to a decrease in total dendritic length and thus a 
smaller dendritic tree. 
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E. Conclusion  
Decades of regeneration studies have impacted our detailed 
understanding of the mechanisms by which ES and/or TP treatment mediate 
axonal regeneration and improve functional recovery following axotomy. This 
dissertation analyzed whether ES and TP enhance axon regeneration and 
functional recovery following a distal sciatic nerve crush injury, and evaluated the 
effects of ES and TP on axotomy-induced molecular expression of genes 
involved in motoneuron regeneration. Our results indicate that treatment with TP 
accelerates functional recovery and attenuates axotomy-induced dendritic 
hypertrophy following a distal sciatic nerve crush injury. In addition, we 
demonstrated that either treatment alone or in combination led to an early 
increase in regeneration-associated gene expression, but the combination 
treatment exhibited a late suppression in regeneration-associated gene 
expression. In support of our molecular results, we observed no added 
therapeutic benefit with administration of both ES and TP in combination. Based 
on these results, we propose two separate mechanisms by which ES and TP 
ultimately enhance functional recovery. First, systemic treatment of TP may 
activate the internal growth state by upregulating the expression of bdnf to 
maintain synaptic homeostasis. As a result, axonal elongation is enhanced and 
successful functional recovery is achieved. Second, we propose ES upregulates 
the expression of gdnf to increase regeneration specificity and promote functional 
recovery. Together, the combination of ES and TP would activate both of these 
mechanisms to enhance functional recovery. 
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 With respect to earlier findings from our laboratory, either treatment alone 
may be beneficial for treatment of distal nerve injuries (Monaco et al., 2013); 
however, the combination of both ES and TP may be an advantageous treatment 
for proximal nerve injuries (Hetzler et al., 2008; Sharma et al., 2010b). Together, 
our results support the concept that not all injuries respond equally to treatment. 
Furthermore, our data support the importance of treatment strategy development 
in an injury-dependent manner and based upon distinct functional characteristics 
of spinal vs. cranial nerves. 
 
F. Future Directions  
In the preceding chapters, the effects of ES and TP on regeneration-
associated gene expression and functional recovery following sciatic nerve crush 
injury in rats were delineated. The results from this dissertation present several 
avenues to complete our understanding of the therapeutic benefits of ES and TP 
following axotomy. 
It is likely that the change in mRNA levels of regeneration-associated 
genes reflect concomitant alterations in with protein expression, however future 
studies will need to be done to validate the mRNA expression data with protein 
analysis. The current study provided a time-line of functional recovery where 
recovery was observed as early as 2 weeks post-axotomy. Future studies will 
need to be done to examine intact NMJ and dendritic morphology on a weekly 
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basis after axotomy for 8 weeks, and correlate these morphological changes with 
improvements in functional recovery.        
This dissertation primarily focused on motor recovery. Since the sciatic 
nerve is a mixed nerve, the effects of ES and TP on sensory recovery should be 
examined. This could be accomplished by repeating the study and measuring 
mechanical and thermal nociceptive responses of the injured paw. We are aware 
that nerve cuffs have been reported to elicit pain-like behavior in rodents (Pitcher 
et al., 1999; Benbouzid et al., 2008). To rule out this effect, the study should be 
repeated without the use of a nerve cuff.  
Future experiments could also include multiple and/or longer sessions of 
ES. Importantly, it should be determined whether ES and TP elicit a 
combinatorial effect after a proximal nerve injury. These findings could be 
correlated with regeneration-associated gene expression changes to elucidate 
potential mechanisms by which ES and TP may be mediating their effects. Based 
on the molecular results, future studies could include genetic mouse models with 
the ability to overexpress/knockout candidate genes and assess functional 
recovery as an outcome measure.     
Although the combination of ES and TP did not demonstrate a therapeutic 
effect after distal sciatic nerve crush injury, ES and TP may prove to be beneficial 
after transection injury. One substantial challenge that remains with transection 
injuries is guiding regenerating nerves back to functionally appropriate Schwann 
cell tubes. The work by Bittner et al. demonstrates great promise at maintaining a 
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conduit for the axons to regenerate into after sciatic nerve transection with the 
use of microsuture, hypotonic Ca2+, methylene blue, and PEG (Bittner et al., 
2012). Combining surgical and non-surgical approaches, such as surgical repair 
with membrane fusion followed by ES and TP administration could have 
significant potential in maintaining an appropriate channel for axons to 
regenerate back to their appropriate target. Moreover, ES and TP would 
decrease the time before sprout formation and accelerate axon regeneration 
rate, respectively.  
In summary, there are multiple aspects of the post-injury response that are 
amenable as treatment targets, including the severity, location, and type of nerve 
injury, rapidity of recovery, and regeneration distance to target. The data 
presented in this dissertation do not support the concept of a “blanket” treatment 
approach that could be applied in a generalized manner to PNI, regardless of the 
nature of that injury. Instead, we propose different treatment strategies, 
depending on injury severity. With a severe nerve injury, in close proximity to the 
cell body and far from target, there is a prolonged regenerative response needed 
to accommodate protracted recovery times accompanying proximal lesions.  
Moreover, prolonged target disconnection times and longer regeneration 
distances compromise target end-organ viability and suitability for re-innervation.  
As such, administration of a combinatorial treatment, targeting multiple post-
injury stages or phases following proximal nerve injury, is essential for maximal 
enhancement of axon regeneration and, by extrapolation, functional recovery. In 
contrast, distal nerve injuries have relatively rapid recovery time, as axons have 
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shorter distances to reach and reinnervate target tissues. Due to fast recovery 
times, less damaging effects occur at the target end-organ. Administration of 
selected treatments targeting a single phase or stage can, therefore, reduce the 
time to functional recovery in less severe PNI effectively, thus eliminating the 
need to build multi-tiered treatment approaches necessary in more severe injury 
situations.  An important future direction will be to translate the conclusions 
obtained in this study using a crush axotomy injury paradigm to a complete 
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